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Abbreviation list 
 
CMRI = cardiac magnetic resonance imaging 
EDV = end-diastolic volume 
EDPVR = end-diastolic pressure-volume relationship 
ESV = end-systolic volume 
ESPVR  = end-systolic pressure-volume relationship 
LV = left ventricle 
MAP = monophasic action potential 
NYHA = New York Heart Association 
PA = pulmonary artery 
PAB = pulmonary artery banding 
PI = pulmonary insufficiency 
PR = pulmonary regurgitation 
PRF = pulmonary regurgitant fraction 
PRSW = preload recruitable stroke work 
PV = pulmonary valve 
PVR = pulmonary valve replacement 
RBBB = right bundle branch block 
RV  = right ventricle 
RVEF = right ventricular ejection fraction 
RVH = right ventricular hypertrophy 
RVOT = right ventricular outflow tract 
RVOTO = right ventricular outflow tract obstruction 
TAP = transannular patch 
TAPSE = tricuspid annular plane systolic excursion 
TOF = tetralogy of Fallot 
VSD = ventricular septal defect 
VT = ventricular tachycardia 
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Chapter I : General introduction 
A. Tetralogy of Fallot : From ‘curable’ disease to surgical paradigm 
 
1. Historical background 
 
In 1888, the French physician Etienne-Louis Fallot reported on a congenital heart disease consisting of 
four cardiac abnormalities, i.e. a ventricular septal defect, an aorta overriding both right and left 
ventricle, narrowing of the right ventricular outflow tract with infundibular and/or pulmonary valve 
stenosis, and right ventricular hypertrophy. Based on these four elements, the malformation was 
named ‘tetralogy of Fallot’. Later anatomo-pathological analysis cleared out that the basic feature was 
the presence of the VSD with anterior deviation of the outlet septum, leading to infundibular 
subpulmonary stenosis and positioning the aorta partially over both ventricles. 
 
 
Figure. Anatomical heart specimen showing  the relationship between the VSD, the aorta and morphology of the 
RVOTO 
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Tetralogy of Fallot (TOF) occurs in approximately 1 in 3600 live births, accounting for 3.5 % of all 
congenital heart defects, and is known as the most common cyanotic heart disease. 
1
 
 
Figure. Physiology of the right-to-left shunt across the VSD, depending on the severity of RVOTO, resulting in 
systemic hypoxemia 
 
 
 
 
The surgical treatment started  in 1945, when Alfred Blalock and Hellen Taussig initiated a method to 
improve the severe hypoxemia by placing a shunt between the systemic circulation and the pulmonary 
artery, in order to increase the pulmonary flow 
2
. The first complete correction of TOF was performed 
by Walter Lillehei in 1955, in an 11-year old boy, with the use of cross-circulation. Six out of the first 
10 patients survived the operation, making this disease amenable for definitive treatment 
3
. Due to 
rapid improvement of cardiopulmonary bypass technology and myocardial protection, many TOF 
patients were offered surgical therapy, obviating them from a near-certain death from cyanosis. Early 
experience with complete repair usually involved children at the median age of 5 to 8 years, treated 
first with a shunt in 20-30 %. The operative technique yielded a generous right ventriculotomy, large 
enough to allow closure of the VSD, and wide relief of the RVOT obstruction. Although this approach 
remained fundamentally unchanged for the ensuing 20 to 30 years, operative mortality progressively 
declined due to increased experience with the cardiac surgical management in general. The perspective 
on a survival rate of more than 80 % after 30- to 36 years, strengthened the idea that repair of TOF 
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was ‘curative’, even though a small number of patients  succumbed lately from sudden death 4, 5. 
However,  Kirklin et al. were the first to point on the deleterious effect of chronic pulmonary 
insufficiency (PI) on RV function, advanced by the use of extensive transannular patches (TAP). 
Within 20 years of follow-up, 7 % of the patients needed reoperation by pulmonary valve implantation 
for RV failure, whereas this number increased to even 20 % in presence of co-existent distal 
pulmonary artery stenosis 
6
.    
 
Figure. Freedom from reoperation-plot for simple repair versus transannular patch  repair of TOF : Use of TAP 
repair increases the late risk for reoperation due to PI (Kirklin et al. Ann Thorac Surg 1989) 
 
 
 
2. Pulmonary regurgitation: A not so benign lesion     
 
2.1 Pathophysiology of pulmonary incompetence 
 
Loss of anatomical integrity of the pulmonary valve leaflets and/or annulus results in pulmonary 
insufficiency. Its effect on the RV depends on the degree and the time duration of the regurgitation, as 
well as on the intrinsic properties of the RV and of the distal pulmonary arteries. 
One of the main reasons for PI to be well tolerated for several years, is related to the low resistant 
pulmonary microvascular bed. Moreover, the pulmonary capillary system has a valve-like effect in 
presence of severe PI, as the blood compelled through the alveolar capillaries in systole is unlikely to 
flow back in diastole, by absence of a significant reversal of gradient.  
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Based on the Torricelli principle 
7
, the severity of PI is proportional to the regurgitation orifice area (= 
RAO),  the diastolic pressure gradient between RV and PA (= P1 – P2),  the diastolic time (= DT) and 
the compliance of the pulmonary arterial circuit ( = C), according to the formula:  
 
PR-volume = RAO. C. DT. (P2 – P1)
0.5
 
 
The chronic volume-overload entails some functional changes to the RV function, which are 
additionally furthered by procedure- and patient-related factors,  finally resulting in progressive RV 
dysfunction with clinical impairment, as depicted in this diagram. 
 
 
 
 
2.1.1 Role of the pulmonary artery characteristics 
 
Alterations at macro- or microscopic level of the pulmonary arteries may affect the amount of PI. 
Albeit pulmonary vascular disease with pulmonary hypertension in TOF is uncommon, branch 
pulmonary artery stenosis is frequently observed. Distal pulmonary artery stenosis enhances right 
ventricular afterload and increases PI. It has been shown in a neonatal animal model that relief of a left 
pulmonary branch stenosis by stenting resulted in significant regression of the pulmonary regurgitant 
fraction from 39% to 27%, with secondary improvement of RV performance 
8
. In particular, the 
contribution of the left pulmonary artery to the regurgitant fraction appears to be important but 
physiologically unclear 
9
. In a MRI study of TOF patients with significant PI, the left pulmonary artery 
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participated in 54% of the regurgitant fraction, while it received only 44% of the forward flow. They 
speculated that the smaller left lung is responsible for a higher vascular impedance, which is furthered 
by the cardiomegaly in TOF. 
Another pulmonary artery component with impact on the degree of PI, is the pulmonary artery 
compliance. Pulmonary artery compliance is quantified by the volume change of that elastic wall-
compartment per unit of pressure change during the cardiac cycle. Based on a mathematical model 
extracted from CMRI-images from various RVOT configurations, Kilner et al. has demonstrated that 
the high compliance of the proximal pulmonary artery increases the amount of PI, in absence of a 
competent pulmonary valve. Conversely, a greater proportion of  blood volume ejected from the RV, 
is propagated through the pulmonary arterial system when the compliance of the pulmonary arteries is 
reduced. This phenomenon underscores the negative effect of large akinetic RVOT patches, but with 
preserved elastic properties, on the pulmonary regurgitant fraction 
10
. Such capacitance effect is even 
more pronounced in presence of a real aneurysmal dilatation of the RVOT after TAP. The deleterious 
effect of RVOT aneurysm on the degree of PI and the RV function has been clearly shown by CMRI-
investigation of  the RV in adult patients late after TOF repair 
11
. 
 
2.2.2 Role of the right ventricular properties       
   
Pulmonary insufficiency results in diastolic volume-overload of the RV, with first increase of the end-
diastolic volume, and with time, gradual increase of end-systolic volume and impairment of the 
systolic pump function. The extent of RV dilation is commonly related to the severity of PI as well as 
to the duration of volume-overload exposure. This process  is often slow and insidious, and evokes 
clinical symptoms in 6% at 20 years and in 20% at 40 years for isolated congenital pulmonary 
insufficiency 
12
. Hence, this course is certainly accelerated after TAP repair of TOF. 
Pulmonary regurgitation is driven by the diastolic pressure difference between the pulmonary artery 
and the RV. This pressure difference is determined by the compliance of the RV, as a poorly 
compliant RV will raise the intraventricular diastolic pressure and systemic venous pressure 
proportionally, thereby decreasing the gradient for PI. In consequence, the intrinsic diastolic properties 
of the RV undeniably affect the adaptive response of the RV to chronic volume-overload. The group 
of London has identified the phenomenon of restrictive RV physiology by echocardiography,  through 
demonstrating the presence of an atrial wave in the pulmonary artery flow wave pattern at late diastole, 
throughout the respiratory cycle, which corresponds to the transmission of the contraction kick of the 
right atrium at elevated pressure 
13
. Physiologically the RV acts then as a stiff and passive conduit 
during diastole, limiting thereby the amount and the duration of diastolic regurgitation. According to 
the same  physiological mechanism active in the non-compliant hypertrophied RV, increased 
resistance proximal to the origin of PI reduces the regurgitant fraction by resisting the diastolic 
10 
 
backflow, but often at the cost of some remnant obstruction 
10
. Limitation of PI  has been illustrated 
similarly in an animal model wherein the RV has been subjected to the chronic effect of combined PI 
and pulmonary stenosis 
14
.  
 
3. Clinical manifestations of chronic pulmonary incompetence 
 
Although many patients with PI after TOF repair may remain asymptomatic for several years to 
decades,  there is growing awareness of  increased morbidity as well as mortality related to progressive 
RV dysfunction by chronic volume-overload. Actually the relationship between RV dysfunction and 
the clinical status could be inconstant. The majority of adult TOF patients, having undergone repair 
during childhood, reports subjectively on a good level of functional health status and quality of life, 
allowing a normal social participation, despite significant constraints of physical activity 
15
. 
However, when clinical symptoms appear, common manifestations are exercise intolerance, 
congestive heart failure, atrial and ventricular arrhythmia and sudden cardiac death.  
 
 3.1  Exercise intolerance 
 
 Wessel et al. examined the factors leading to diminished exercise capacity in a large group of 
TOF patients, at least one year after repair. They found a close correlation with cardiomegaly, residual 
RV hypertension, pulmonary regurgitation, residual VSD and documented arrhythmia 
16
. Carvalho et 
al. found that patients with a predicted peak oxygen consumption of less than 85 % had more PI, 
pointing on a direct relationship between exercise performance and the degree of PI 
17
. Several reports 
have further investigated the relation between variables of RV function and clinical status after repair 
of TOF, based on new insights into the mechanisms of RV dysfunction through the use of CMRI. 
Geva et al. demonstrated the negative impact of moderate to severe LV and/or RV dysfunction on the 
NYHA functional status of long-term survivors of TOF, suggesting the unfavorable role of RV 
distension on inter-ventricular interaction.
18
 The same group later specified that, before concomitant 
impairment of LV function occurred, the systolic function of the RV, expressed by RV ejection 
fraction, correlated best with the exercise capacity 
19
. Exercise capacity also appeared to deteriorate 
over time, but this longitudinal change was subjected to  individual variability and was primarily 
related to the incapacity to maintain forward stroke volume at peak exercise 
20
.  
Increasing focus on the effects of regional RV dysfunction demonstrated that a greater extent of 
RVOT dysfunction is probably one of the main contributors to exercise intolerance after TOF repair 
21
. 
In addition, extensive myocardial fibrosis of the RV on late gadolinium enhancement suggested 
decreased RV function and was associated with adverse clinical markers as poor exercise performance, 
arrhythmia and increased neuro-hormonal activation 
22
. 
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Considering specifically the functional properties of the RV, the presence of a restrictive RV 
physiology has been associated with improved exercise performance by limiting the RV dilation 
23
. 
However, in TOF patients with severely dilated RV, a restrictive RV physiology on the long-term has 
been related to impaired exercise capacity 
24, 25
. This controversial issue has been clarified later by 
identifying different subtypes of restrictive RV function, entailing on one hand smaller right ventricles 
with so-called ‘primary restriction’ and better exercise function, and on the other hand, massively 
dilated and dysfunctional right ventricles with unfavorable functional capacity 
26, 27
.    
Finally, an abnormal heart rate response during exercise is commonly noticed in many adult patients 
with congenital heart disease. More than half of the adult TOF patients showed evident chronotropic 
incompetence, correlating strongly with decreased peak oxygen consumption. Based on the dismal 
impact of these findings on prognosis, it has been advocated to include exercise testing routinely into 
the late follow-up evaluation of repaired TOF patients 
28
. 
       
3.2  Arrhythmia and sudden death  
 
The incidence of sudden death during the late follow-up after repair of TOF has been 
estimated to vary from 2 to 6 % 
4, 29
. The main cause of arrhythmic death is largely attributed to the 
occurrence of ventricular tachycardia and ventricular fibrillation 
29-31
. In rare instances, a complete 
heart block accounts for mortality in these patients 
32, 33
. Although ventricular ectopy yielded most 
emphasis for its impact on mortality, atrial arrhythmia are a major cause of morbidity in one third of 
the repaired TOF patients 
34
. 
Malignant ventricular arrhythmia in TOF is primarily based on re-entrant circuits originating from the 
RVOT, that includes the scarred areas from closure of the VSD, from the ventricular incision and 
RVOT aneurysm formation 
35, 36
. Electrophysiological mapping has supported this reentry 
phenomenon by showing fractionated potentials as well as inducible ventricular arrhythmia by 
premature excitation 
37, 38
. Another important substrate of arrhythmia is related to the mechano-
electrical interaction between the RV dilation by chronic volume-overload and secondary alterations 
of intrinsic conduction properties 
39
. Histopathological analysis of the RV myocardium has 
demonstrated degenerative cellular changes and increased interstitial fibrosis, as co-existent features of  
both increased RV dysfunction and arrhythmia. These changes were more pronounced if patients were 
older at the time of repair, suggesting here the negative role of long-standing cyanosis and pressure-
overload on RV tissue characteristics 
40
.  
Risk assessment of malignant ventricular arrhythmia in TOF has merely been based on retrospective 
studies of relatively small patient cohorts. The timing and type of corrective surgery has an important 
influence on the arrhythmogenic potential. Older age at repair was a significant risk factor in studies 
reporting on a population of TOF patients treated in former eras, as well as the use of extensive RVOT 
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patches and large ventriculotomies 
32, 40, 41
. In a comparison between the transventricular versus 
transatrial approach, Dietl et al. has shown a  risk reduction of arrhythmia by the more recent 
technique, without concomitant increase of atrial arrhythmia 
42
.  
Pioneering work on the prediction of sudden death in TOF patients has been done by Gatzoulis and 
co-workers, emphasizing the relation between surface ECG changes and the risk of malignant 
arrhythmia as the so-called mechano-electrical feedback within the RV. Based on the duration of the 
QRS complex as a marker of arrhythmia propensity, they found a QRS duration ≥ 180 msec to be a 
sensitive predictor of sustained VT and sudden death in TOF patients with more than 20 years of 
follow-up since complete repair 
43
. In a multicenter study, the same author not only confirmed the 
value of QRS duration as such, but also identified the rapid progression of the QRS duration as an 
additional risk factor 
44
. The utility of monitoring this simple parameter has been validated later, by 
showing stabilization and even reduction of QRS duration after effective pulmonary valve 
implantation, reversing the mechanical as well as the electrical remodeling of the RV 
45
. Accordingly, 
an  increased QT dispersion > 60 msec  has been withhold as predictive marker of arrhythmia, 
unrelated to the presence of right bundle branch pattern, and independent of the size of the RV 
46
.   
Late RV dysfunction in TOF is associated with perturbation of autonomic cardiac regulation. Blunting 
of cardiovascular response at exercise with decreased heart rate variability correlates with RV dilation 
and with QRS duration 
47, 48
. However, its predictive effect for arrhythmia remains unproven.  
Further evolution into the understanding of the different mechanisms of tachy-arrhythmia focused also 
on the adverse influence of LV dysfunction in TOF 
49
. Besides the functional effect of the dilated RV 
on the LV through ventricular interdependency, impairment of the LV function has been attributed to 
LV asynchrony in the setting of the usual RBBB in TOF patients 
50
. However, its value in the risk 
stratification of ventricular arrhythmia remains unclear.  
 
While ventricular ectopy on ambulatory ECG monitoring is frequently observed in adult TOF patients, 
the question raised whether this potential precursor of inducible ventricular tachycardia has to be 
investigated more properly by electrophysiological testing. Several studies on the role of prophylactic 
screening of asymptomatic TOF patients have produced conflicting results. In a multicenter cohort of 
252 TOF patients, sustained VT and polymorphic VT were induced in respectively 30% and 4% in a 
programmed ventricular stimulation protocol. The authors concluded that such program has a 
diagnostic and prognostic value in the risk assessment. Especially the induction of sustained 
polymorphic VT should not be disregarded as a non-specific finding
51
. Otherwise, the yield of 
electrophysiological testing in asymptomatic TOF patients is low, revealing a positive study in only 
10%
52
. 
Regarding the therapeutical implications, the risk of ventricular arrhythmia and sudden death is 
usually reversed by timely pulmonary valve implantation with or without concomitant cryoablation, 
which parallels the secondary RV size remodeling 
53
. The favorable effect of this surgery on the 
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regression of QRS duration and improvement of the repolarization properties has already been 
mentioned 
45, 54
. The use of implantable cardioverter-defibrillator devices in the secondary prevention 
of sudden death is of proven benefit, although increasing experience with guided electrical mapping 
enhances the chance to successfully  identify the unstable circuit at the critical right ventricular 
isthmus for effective catheter ablation therapy 
55, 56
. The role of resynchronization therapy in TOF 
seems promising in improving biventricular function, but needs further investigation 
57, 58
.   
       
4. Contemporary surgery of tetralogy of Fallot: the search for the ideal 
repair 
 
4.1 Technical evolution of the RVOT reconstruction  
 
Early surgery of TOF focused mainly on complete relief of the RVOTO, but usually at the cost of free 
and severe PI. Based on the growing knowledge of its deleterious long-term sequelae, changes in the 
surgical approach were justified. 
In 1976, Edmunds et al. reported on the closure of the VSD in TOF via the transatrial route 
59
. The 
transition towards a transatrial-transpulmonary repair of TOF was  further popularized by the surgeons 
of Melbourne 
60
. Their technique consisted of a transatrial approach for closure of the VSD and 
resection of the obstructive muscle bundles in the infundibulum. Additional relief of the RVOT was 
achieved through the pulmonary artery, using a TAP incision not extending beyond the anatomical 
basis of the infundibular part of the RV. Early survival was excellent, with an operative mortality of 
0.5% in 366 patients. Freedom from reoperation at 5 years was 95%.  
 
Figure. Transatrial approach  for closure of VSD and resection of hypertrophic infundibular muscle bundles in 
the RVOT (from Hirsch et al., Ann Surg 2000, 232(4):508-514) 
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As TOF patients show a widely variable morphological spectrum, most attention was directed at the 
particular group of TOF patients with small PV annulus, initiating the quest ‘how small is too small’ 
for the adequate pulmonary valve size. Based on the use of z-values for PV annulus size, the believers 
of a pulmonary-valve preserving strategy adapted this surgical strategy successfully in more than 80% 
of the TOF patients with a PV z-score > - 4, often concomitantly with an additional  infundibular 
incision. The success rate was guaranteed particularly in presence of a trileaflet PV, in contrast to 
those with a bicuspid PV 
61
. Similar results were reported by Rao et al, claiming that preservation of 
the PV annulus was facilitated by operating on younger aged patients 
62
. Other surgical groups focused 
preferably on the preservation of the RV, by an infundibulum-sparing approach 
63, 64
. Here the 
infundibular incision was kept minimal, even when the PV size needed a transannular extent. In 
comparison with the prior technique, separate patch enlarging of the infundibulum was obsolete. 
A drawback of the RVOT-sparing strategy is the increased rate of reoperation for residual obstruction. 
Peri-operative revision was required in up to 16%, while reoperation after transventricular repair was 
necessary in less than 10% 
61, 65
. Intra-operative assessment of the RVOT relief became crucial, in 
order to differentiate between a fixed, anatomical obstruction versus a dynamic residual gradient. 
Besides relying on the post-repair measurement of the RV/LV pressure ratio, the addition of 
transoesophageal echocardiography appeared to be essential 
64, 65
. 
Long-term results of this novel approach are limited. Nevertheless, 10-year follow-up of such 
transatrial-transpulmonary repair of TOF showed smaller RV size and better RV function, shorter 
QRS duration and less ventricular ectopy in comparison with conventional repair techniques 
66
.  
 
 
Figure. Transpulmonary access for relief of pulmonary valve obstruction  with additional infundibular patch or 
transannular patch  (from Jonas R, Semin Thorac Cardiovasc Surg Pediatr Card Surg Ann 2009; 12: 39-47) 
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Lastly, the application of a hybrid approach has recently gained interest in the pursuit of a valve-
sparing repair, through intra-operative balloon dilatation of the hypoplastic PV annulus 
67, 68
. 
Preservation of the PV was possible in 37% of patients with a PV annulus z-score of -2 to -4, without 
compromising the growth rate of the valve. The early results seemed promising, except for a higher 
rate of early reintervention.  
 
4.2 What about the age versus strategy for repair ? 
 
In addition to the change in surgical technique for RVOTO relief, there has been an increasing trend to 
perform primary repair at an earlier age. It has been shown that lowering the age of repair to less than 
1 year of age has been performed without major  impact on the surgical outcome. Based on the use of 
physiological end-points as ventilation time, length of stay and lactate clearance, the group of Toronto 
has revealed that the optimal age for TOF repair might be between 3 and 11 months of age 
69
. In 
contrast, routine primary correction of TOF in neonates or infants less than 3 months of age has been 
advanced by Hanley and colleagues 
70
. The claimed advantage relates to the avoidance of cyanosis and 
its negative effect on organ maturation, the decrease of RV hypertrophy and the beneficial effect on 
myocardial function and pulmonary angiogenesis and alveologenesis in a situation of decreased lung 
perfusion as in TOF. At the same time, the use of a palliative shunt with its associated risks is 
abolished. However, repair yielded the use of a TAP in 60%. A comparable policy was adopted by 
other groups, resulting in a higher frequency of TAP repair, reaching even 100% in some series 
71-73
. 
The common conclusion from the results of this strategy, aiming early primary correction of TOF in 
infants before the age of 3 months, is that operative mortality remains low, but at the cost of increased 
morbidity resulting in prolonged ventilation time and hospital stay. Within the available follow-up of 
maximum 5 years, the need for secondary reoperation and reintervention is substantial, with 24 
reoperations in 22 of the 61 patients in the series of Hirsh et al.
73
, and 20% of  additional procedures 
for residual stenosis and severe intolerable PI in others 
71
.  
 
Albeit the transatrial-transpulmonary approach is favored as the first choice in the surgical therapy of 
TOF, there is less consensus in the surgical community regarding the strategy on a direct one-stage 
complete correction versus a two-stage approach including first a palliative shunt, in symptomatic 
young TOF infants. In contrast with the aforementioned results, the polemic on the choice between 
immediate repair versus shunt has recently been addressed by Kanter et al. on a series of 37 
symptomatic neonates with TOF. The results showed no difference in mortality, but a shorter intensive 
care and hospital stay in the shunted group compared to the repaired group. Moreover, a TAP repair 
was necessary in all patients undergoing primary repair 
74
. Based on a 40 years’ experience in 2175 
TOF patients, Fraser and coworkers from Houston derived a surgical management protocol for  each 
16 
 
patient individualized to its age and to its RVOT morphology. In a series of 144 patients, this concept 
offered excellent results with no operative mortality, a late death rate of 2.1%  and a reoperation rate 
of 3%  within a follow-up of 5 years. They concluded that there is still a place for judicious shunting 
in symptomatic young infants, while elective complete repair at the age of 6 to 12 months affords a 
rational strategy that optimizes the outcome and minimizes the surgical risk 
75
 
. 
B. The right ventricle in tetralogy of Fallot : understanding the 
target 
 
 
Increased understanding of the mechanisms involved in the progressive RV remodeling and RV 
dysfunction has directed the focus on serial investigation of the RV during the follow-up of TOF 
patients after surgical repair. Beside to the easily performed bed-side echocardiography, CMRI has 
evolved to the golden standard for clear determination of the cardiac status in TOF. Over the past 
decade, many efforts have been made, both in the field of echocardiography and CMRI, to search for 
early predictors of RV dysfunction, before reaching an irreversible status. In addition, the impact of 
the culprit lesions has gradually been refined. 
 
1.1       Follow-up of the pulmonary regurgitation and RV remodeling process 
 
Based on the crucial role of PI on prognosis of repaired TOF, proper quantification of the severity of 
PI has emerged beyond the commonly used semi-quantitative grading of PI by echocardiography. 
Assessing PI by CMRI is currently done by calculation of the pulmonary regurgitant fraction (PRF) as 
the ratio of backward to forward pulmonary artery flow. Because this parameter might underestimate 
the physiological magnitude of PI, the use of regurgitant volume has been proposed as a more accurate 
reflection of RV volume-overload 
76
. Quantification of PI by echocardiography has been attempted by 
calculation of the duration of the PI over the total diastolic time by continuous-wave Doppler analysis 
of the pulmonary artery, but this method appeared to be poorly contributive to the common assessment 
of PI 
77, 78
.  
Closely related to the degree of PI, progressive increase of diastolic volumes and stroke volumes can 
be followed by CMRI, until decrease of RVEF occurs by loss of systolic compensation 
79
. Presently, 
identification of  significant RV dysfunction  has been solely based on the determination of  global RV 
volume at end-diastole and end-systole. Chronic follow-up of TOF after repair is therefore focused on 
the longitudinal evaluation of the RV dilation process. The impact of regional RV deformation after 
repair has been forwarded firstly for the adverse effect of a RVOT aneurysm or a large akinetic 
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ventricular patch, in a qualitative way 
11, 80
. In the majority of TOF patients, the global RV volume and 
systolic RV function are significantly affected by the post-surgical RVOT anatomy  
81-83
. Based on the 
use of late gadolinium enhancement, CMRI allows to quantify the magnitude of RVOT dysfunction, 
by determining  the spatial extent and displacement of dyskinesia. 
21, 54
. In contrast, echocardiography 
is limited in the accurate assessment of global RV volumes. Moreover, specific investigation of the 
RVOT component by this technique is hazardous by difficult and inconsistent windowing of that area.   
 
 
Figure. Flow pattern of the main pulmonary artery showing forward flow at systole and backward flow at 
diastole, allowing measurement of regurgitation volume and duration 
 
 
 
 
1.2       Follow-up of the systolic and diastolic RV function  
    
Determination of proper systolic RV function by echocardiography is mainly based on the 
measurement of longitudinal contraction changes at the level of the RV basis. The longitudinal 
function of the RV free wall by TAPSE is mostly decreased in TOF, but this parameter rarely allows 
to differentiate between a preserved or impaired systolic RV function within this population 
84
. 
Contrary to the prognostic value of TAPSE as marker of RV dysfunction in left-sided heart disease 
and primary pulmonary hypertension, its validity in the serial follow-up of TOF is less clear 
85
. Using 
color Doppler myocardial imaging techniques, longitudinal strain and strain rate are already decreased 
in asymptomatic children with TOF, in correlation with the degree of PI 
86
. Recently, this specific 
echocardiographic feature has been demonstrated to be an important determinant of exercise 
performance in TOF patients, superior to global RVEF by CMRI 
87
. However, longitudinal tissue 
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velocity at the base of the RV free wall incompletely reflects the global systolic RV function, 
excluding the variable impact of RVOT dysfunction on systolic performance 
88
.   
Validated as a less load-sensitive marker of contractile function, the isovolumic contraction 
acceleration of the RV myocardium has been correlated with the severity of PI 
89
. Albeit proposed as 
an early and sensitive index of subclinical RV dysfunction, it has not yet been included into the 
decision-tree to justify pulmonary valve implantation for severe PI. 
 
Diastolic dysfunction has been identified early in the history of TOF. Decreased RV compliance 
through restrictive RV physiology is confirmed by echocardiography, as the presence of antegrade 
diastolic flow in the pulmonary artery throughout the respiratory cycle. Investigation of its underlying 
substrate has revealed that the early presence of restrictive RV physiology occurred more frequently in 
patients older at the time of operation, often presenting with more RV hypertrophy and cyanosis, and 
treated with a TAP 
90
. Clinically, TOF patients with restrictive RV physiology had a slower 
postoperative recovery through a temporary state of low cardiac output and increased fluid retention  
13
.  
Accordingly, younger age at repair yielded a decreased incidence of restrictive physiology, regardless 
of the use of TAP 
91
. A restrictive physiology seemed to have a beneficial long-term effect on the RV 
remodeling, with a less dilated RV and a better exercise tolerance in adulthood 
23
. Intrigued by the 
paradoxical effect, further study observed that presence of  restrictive physiology in the postoperative 
phase was a significant predictor of late restriction 
92
.  
However, it has been noticed that not all patients with a restrictive physiology at late follow-up have a 
small RV. A restrictive RV physiology has also been described in the severely dilated RV with 
impaired systolic and diastolic RV function, in correlation with poor exercise performance. CRMI 
investigation in this more contemporary cohort of TOF patients indicated that poor RV compliance in 
this condition was a precursor of subclinical RV failure with marked ventricular dilation and systolic 
dysfunction 
93
.  
The difference between echocardiography and CMRI in assessing the pulmonary artery flow pattern is 
that the end-diastolic forward flow might be more easily interfered by the respiratory cycle during 
CMRI.  The additional value of CMRI relates to information on the myocardial structure, revealing 
more fibrosis in the RV and RVOT of the dilated RV 
93, 94
. This contradictory finding has later been 
elaborated by Lee et al., highlighting the difference between ‘primary’ restriction in relation to 
hypertrophy and fibrosis, and ‘secondary’ restriction in relation to RV dilation 27. The first group 
commonly  had a smaller RV and preserved exercise capacity, the latter had a larger and dysfunctional 
RV and decreased exercise tolerance. There is however growing agreement that the notice of late 
restrictive RV physiology in contemporary operated TOF patients often coincides with an over-
distended RV, beyond its compensatory state 
25, 95, 96
. Here, a relationship between the early 
postoperative and the late appearing decreased RV compliance has not yet been confirmed.   
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Study of diastolic RV function  based on transtricuspid flow assessment of early RV filling, indicated 
decreased E/A-ratio and reduction of E-wave deceleration  in correlation with RV enlargement 
97
. 
Others groups have similarly found larger RV volumes in TOF patients and end-diastolic forward flow 
at CMR,  but failed to show any relationship between passive RV compliance and indices of early 
relaxation through echocardiographic assessment of transtricuspid flow signals and diastolic strain rate 
measurement 
95, 96
. Although the identification of  advanced diastolic dysfunction of the RV, 
concomitant to RV dilation, has been proposed as a criterion for pulmonary valve replacement (PVR) 
98
, its actual value in the longitudinal follow-up of TOF remains a topic for further research. 
 
C. Pulmonary valve replacement in Tetralogy of Fallot : the definite 
solution ? 
 
Surgical  implantation of a competent pulmonary valve has been proposed as an effective therapy to 
tackle the adverse effects of chronic PI-related volume-overload on RV performance and clinical 
status. For many years, TOF patients with severe PI have been referred for PVR based on overt 
symptoms, attributed to RV dysfunction and PI. Since it has been shown that objective RV function 
impairment might be out of proportion to the subjective clinical tolerance, the focus has been directed 
to select proper criteria on indications and timing of PVR in asymptomatic TOF patients during long-
term follow-up. 
 
1. Timing of pulmonary valve replacement 
 
The benefit of PVR in TOF has first been demonstrated by Bove et al. showing that RV dysfunction 
due to PI is reversible, entailing a reduction of RV size and improvement of RVEF, in association with 
subjective improvement of exercise tolerance 
99
. Despite successful PVR, a few studies reported on the 
absence of RV function recovery in some patients with severely dilated RV and longstanding PI, 
emphasizing the key role of timing PVR  
100, 101
. Subsequently, efforts have been  elaborated on the 
quantification of the extent of RV dilation in relation to massive PI, to identify the best cut-off value 
of RV size that should lead to the optimal chance of restoring RV volume and normalization of RV 
function. Therrien et al. noticed that patients with a preoperative end-diastolic volume > 170 ml/m² 
evolved worse than those with a smaller RV 
101
. Buechel et al. found an upper threshold of 200 ml/m²  
of diastolic volume responsible for incomplete recovery of RV function, while normalization was 
certified when the lower limit was taken at 150 ml/m² 
102
. Most series were however not able to 
demonstrate significant improvement of RVEF, unless correction of the effective stroke volume for 
20 
 
the amount of regurgitant volume was considered. In contrast to the usual reduction of both end-
diastolic and end-systolic RV volumes after PVR, part of the inconsistency concerning RV function 
improvement has been attributed to lack of integrating the effect of surgical reduction of the akinetic 
RVOT, and on the preferential use of end-diastolic volumes for cut-off. Based on the modest 
correlation between EDV and EF, the additional importance of an end-systolic RV volume of 80 
ml/m² has been suggested for PVR 
103-105
.  
Another issue regarding timing of PVR is related to the issue of ventricular arrhythmia. A QRS 
duration > 180 msec has been shown to be a significant risk factor of malignant arrhythmia in TOF 
patients with severely dilated RV 
43
. It has been observed that PVR favorably affects the electrical 
component by decreasing the QRS duration and improving the depolarization characteristics, 
concomitant to reduction of RV size 
45, 54
. Since the risk of arrhythmia after PVR remains substantial 
in 25% of the patients with a QRS > 180 msec, PVR is recommended before that specific threshold is 
achieved 
106
.  
There is common agreement that PVR should be proposed to the TOF patient with evident symptoms 
due to its cardiac disease, showing significant PI and RV dilation. In the asymptomatic TOF patient 
with significant PI (PRF > 25%), the co-existence of at least 2 of the following criteria should be 
considered for PVR 
107
 :  
 RVEDV index > 150 ml/m² 
 RVESV index > 80 m:/m² 
 RVEF < 45 % 
 LVEF < 55 % 
 QRS > 160 msec 
 Sustained tachyarrhythmia related to RV volume load 
 Associated hemodynamically significant abnormalities : 
o Residual RVOT obstruction with RV systolic pressure > 2/3 of systemic pressure 
o Severe branch pulmonary stenosis poorly amenable for prior transcatheter therapy 
o Residual VSD resulting in pulmonary-to-systemic flow ratio > 1.5  
o Significant aortic regurgitation with/without aortic dilatation (> 5 cm) 
Exercise performance criteria have not yet been validated to be incorporated into the decision for PVR. 
According to the prognostic value of the anaerobic threshold based on determination of the VE/VCO2 
slope on long-term survival in non-cyanotic congenital heart disease, this variable has been advanced 
for eventual  inclusion by Frigiola et al. who observed complete normalization of the VE/VCO2 ratio 
when PVR was performed before the age of 17.5 years, in TOF patients that were repaired at the mean 
age of 3.3 years, with 77% use of a TAP 
108
.  
21 
 
2. Effects of pulmonary valve replacement  
 
Numerous publications have reported on the positive effect of PVR on the clinical status, commonly in 
relation to elimination of PI and reverse RV remodeling. Most patients have less cardiac symptoms 
and show improvement of the NYHA functional class. In addition, improved exercise capacity has 
been shown quantitatively based on the use of respiratory anaerobic threshold, unrelated to the change 
of contractile RV  performance 
109, 110
. 
Beside shortening of QRS duration, the data  on the effect of PVR on arrhythmia propensity are 
inconsistent. In contrast to Therrien et al, who observed a significant decrease of ventricular 
tachycardia from 23% to 9% after PVR 
53
, such favorable results were not confirmed by others 
110, 111
, 
suggesting a role for adjuvant intra-operative ablation therapy of the re-entrant isthmus circuits. 
The effect of PVR on RV size remodeling has already been described. Based on the use of CMRI, 
rapid restoration of systolic function is achieved, in contrast to the delayed improvement of diastolic 
function 
112
. According to the LV changes after aortic valve replacement for chronic aortic 
insufficiency, one may speculate here on the effect of a disproportionate regression of RV mass to RV 
size. Nonetheless, recovery of diastolic RV function was identical for patients with proven restrictive 
RV physiology as for patients without end-diastolic forward flow in the main pulmonary artery. 
Similar changes in systolic and diastolic RV performance have been noticed after PVR by a 
percutaneous implantable pulmonary valve 
113
. 
 
3. Techniques and outcome of pulmonary valve replacement  
 
The operative mortality of surgical PVR is commonly low (1%), but there is an ongoing risk of late 
death after PVR. While Therrien et al. reported respectively 92% and 86% survival at 5 and 10 years 
53
, 
the 10-year survival in the series of Discigil et al. and Harrild et al. dropped to respectively 76% and 
41% 
111, 114
.  
Commonly, homografts have been used to valvulate the RVOT after TOF repair. These have the 
advantage of avoiding the need for anticoagulation treatment, but are susceptible for degenerative 
changes, limiting their life-expectancy. A long-term study of Caldarone et al. showed a freedom from 
reoperation for homograft failure of 81% at 5 years, 58% at 10 years and 41% at 15 years 
115
. In many 
series, younger age at implantation has been associated with an increased rate of conduit failure.  
The use of a bovine valved jugular vein conduit has been suggested as an attractive alternative, 
providing excellent hemodynamics, but these are equally prone to structural failure 
116, 117
. Other 
alternatives such as xenografts and mechanical prostheses have been used for PVR in adult TOF 
patients with acceptable results, despite their well-known shortcomings 
118-120
. 
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Based on the adverse effect of RVOT dysfunction through a largely akinetic or aneurysmal patch, 
surgical remodeling of the RVOT at the time of PVR has been proposed in order to enhance  the RV 
mechanics, concomitant to correction of PI 
21
. However, in a randomized trial, the additional value of 
such procedure appeared to be limited in comparison with isolated PVR. The sole predictors of early 
normalization of RV size and function at 6 months were a preoperative end-systolic RV volume < 90 
ml/m² and a QRS duration < 140 msec 
103
.  
During the past decade, the percutaneous  implantation of a stent-mounted bovine jugular vein valved 
conduit has been introduced for  valvulation of the RVOT in congenital heart diseases 
121
. This 
technique has been proven to be equally effective as surgical PVR, for relief of RVOT obstruction 
and/or elimination of PI, in case of failure of a pre-existing RV-PA conduit 
122
. At this time, its role in 
restoring a competent pulmonary valve in TOF is hindered by the huge variability of RVOT 
malformation after surgery. But technological adaptations of the stent profile based on sophisticated 
CMRI calculations, have entered the experimental phase 
123
 
 
Based on these findings, the decision for PVR in patients with repaired TOF and significant PI has to 
balance the risk-benefit ratio between protecting the right ventricle at one hand and choosing a 
pulmonary valve substitute with limited durability on the other hand. Initiating PVR too early will 
inevitably compromise the patient by an increased risk for reintervention, whereas deciding PVR too 
late might be detrimental for RV function recovery. Even with the advent of a less invasive PVR by 
transcatheter techniques, further refining of the criteria that establish the optimal timing of PVR is 
mandatory.   
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Chapter II : Objectives of the thesis 
 
During repair of TOF, the surgeon mainly has to deal with the morphology of the RVOT. Particularly 
concerning the TOF spectrum with hypoplasia of the RVOT components, the surgical therapy is 
challenged in coupling the immediate operative result with an optimal long-term outcome in terms of 
survival, quality of life and risk of late reoperation. Up to now, the surgical management of TOF is 
weighing  the choice of surgical technique to reconstruct the RVOT and the timing of complete 
primary repair, taking specific interfering anatomical and physiological issues into consideration. 
Despite more than 60 years experience with the surgical treatment of TOF, there is still debate on that 
subject within the surgical community. 
The physiological adaptation of the RV to volume- and/or pressure-overload in the setting of TOF has 
extensively been studied. However, the continuous changes in surgical management  has put the 
understanding of the RV mechanical and electrical properties into an indistinct perspective.  
The aim of this work is to elucidate some of the controversial aspects regarding the contemporary 
surgical management of TOF, through investigating the mechanical alterations of the RV in relation to 
RVOT dysfunction, and through delineating a proper vision on the RV performance in order to 
improve the clinical outcome of the individual patient with TOF. 
 
To investigate purely the physiological effect of a surgical intervention on cardiac performance, 
animal models are a well established method of experimental design. Some of the intriguing clinical 
questions relevant to the actual treatment of TOF, have been characterized in an animal model of 
growing, immature swine, concordant to the growing child after TOF repair. As part of the 
contribution of this thesis is related to the study of the RV by mimicking the culprit pathophysiological 
features of repaired TOF in an animal model, the used experimental methodology is presented in 
chapter III. Assessment of RV function in the acute and chronic setting is based on the analysis of 
pressure-volume loops by the conductance catheter technique. The relationship with the commonly 
used clinical tools as echocardiography and magnetic resonance imaging is additionally discussed.   
 
Regarding the late attrition of TOF, most attention has been focused on pulmonary valve insufficiency, 
usually in the context of a large transannular RVOT patch. The role of the infundibulum has only 
occasionally been touched. In view of the unknown long-term result of the RVOT-sparing strategy, the 
interactive effect of both RVOT components, i.e. pulmonary valve and infundibulum, on RV 
performance deserves renewed interest. In chapter IV, the differential contribution of infundibular 
dysfunction versus pulmonary valve insufficiency is studied for its acute and chronic effects on RV 
performance, in a juvenile porcine model.  Assessment of RV performance was based on the 
conductance technique and validated by CMRI. 
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The management of TOF concerning age and strategy of repair has to be taken in consideration with 
the RVOT morphology and the eventual physiological consequence after surgical repair. Relying on 
the relationship between the duration of pressure-overload and age at repair, the physiological effect of 
RV hypertrophy on RV performance merits closer analysis. In chapter V, we describe the role of RV 
hypertrophy on the acute and chronic effects of PI-related  volume-overload of the RV, by performing 
a TAP reconstruction of the RVOT in a growing swine model. RV function was analyzed with the 
conductance technology, and correlated  with basic echocardiographic observations. 
 
In chapter VI, the clinical outcome of the contemporary surgical management of TOF in our 
department has been investigated through a retrospective analysis. The effect on RV remodeling has 
been evaluated based on the differential contribution of surgically-induced dysfunction of the main 
components of the RVOT, transmitting the link between the clinical setting and the research theorem 
of the experimental study reported in chapter IV. 
 
In chapter VII, the focus has been moved to the long-term alterations of the RV after TOF repair, by 
examining the functional impact of the main anatomical components of the RV on global RV function 
and exercise performance. A suggestion for eventual refining the assessment of the RV during follow-
up of TOF patients is made to help the decision-making for pulmonary valve replacement. 
 
In chapter VIII, the findings of the experimental and clinical studies are integrated in order to offer a 
new perspective on the surgical management of TOF.  Deeper insights into the mechanisms of RV 
adaptation in relation to dysfunction of the main components of its outflow tract, as commonly is 
observed after repair of TOF, are discussed for their clinical relevance. 
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Chapter III : Experimental methodology and design 
 
 
Extrapolation of the acquired knowledge on LV function to the RV has been limited by the various 
anatomical and physiological differences between both ventricles. The main differences are:  
 
1) Morphological geometry : the RV has a complex, banana-like shape composed of three 
components, i.e. the inlet, the trabecular apical part and the outlet or infundibulum. 
2) Myocardial architecture: the RV myocardium consists of two muscle layers with a 
longitudinal organization for the inner layer and a circumferential arrangement for the outer. This 
myofiber structure explains the particular contraction pattern, producing an effect of peristalsis, with 
greater longitudinal than radial shortening. 
3) Location into the circulatory system: the RV is coupled with the pulmonary vascular bed 
characterized by it low impedance and high capacitance. Consequently, the right-sided pressures are 
normally much lower than in the LV. As the RV systolic pressure exceeds rapidly the low pulmonary 
artery diastolic pressure, the isovolumic contraction time of the RV is shortened. This entails that the 
end-systolic flow may continue in presence of a negative ventriculo-arterial pressure gradient, referred 
to as the ‘hangout interval’ 1. 
4) Heart-lung interference: the RV functions mainly as a volume-pump, making the 
hemodynamic response susceptible to pre-load alterations during the respiratory cycle in relation to 
changes of intrathoracic pressure. Even modest changes in pulmonary airway resistance can affect the 
RV performance significantly. 
5) Effect of the LV by the ventricular interdependency: the influence of the LV function on RV 
function has been documented by Damiano et al., showing that 30% of the contractile energy of the 
RV is generated by the LV 
2
. This physiological effect is mediated by the parallel interaction through 
the interventricular septum, and is dependent on the preserved RV geometry. Once the RV size is 
distorted by right-sided pressure- or volume-overload, the contribution of the LV is attenuated by 
adverse interaction.    
 
1.1. Introduction to the conductance technology 
 
Assessment of ventricular function is ideally based on the simultaneous and instantaneous 
measurement of volume and pressure, affording at the same time the global ventricular as well as the 
intrinsic myocardial function properties. The conductance technology has been developed for cardiac 
function determination by Baan et al. 
3
. The principle is based on the measurement of the electrical 
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conductance of blood in the ventricular cavity, differentiating the effect of blood as a good electrical 
conductor and myocardial tissue as a poor conductor. The catheter consists of several electrodes, 
producing an electrical field, and at each electrode, the measured volume of blood is considered as a 
cylinder of which the boundaries are defined by the inner cardiac wall. The total volume of blood 
within the ventricular cavity corresponds to the  sum of the included segmental blood cylinders, 
distributed at equal distances over the catheter. Through an alternating current between both outermost 
electrodes, a homogenous intracavitary field of conductance is generated. Conductance is defined as 
the applied current divided by the potential difference between adjacent electrodes.  
 
Figure. Intraventricular conductance catheter with electrodes measuring the intracavitary blood volume as a 
cylinder at each segment S. The total blood volume is the sum of all included segments. 
 
  
 
Adjustment for interfering effects includes calibration for (1) the dimensionless slope factor α 
(correction coefficient between the conductance-derived volume and the true volume obtained by a 
validated alternative technique as thermodilution or ultrasonic flow probe) and for (2) parallel 
conductance (subtraction of the conductivity measured in structures extrinsic to the intraventricular 
blood pool as myocardial tissue, the atria and LV, based on the dilution through injecting a hypertonic 
solution). Accounting for the individual resistivity of blood to the electrical current, the time-varying 
measured volume by the conductance catheter in the ventricle is calculated by the formula:  
 
Vt = 1/α(L2/ρ)(Vc – Vp) 
 
with Vt = total intraventricular segmental volume, α = dimensionless slope factor, L = interelectrode 
distance, ρ = blood resistivity, Vc = measured segmental conductance volume and Vp = parallel 
conductance.  
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This technique has been widely validated in the homogeneous LV, and has been introduced to study 
the RV function in a later phase 
4
. Due to the complex geometry of the RV and the dense trabeculation 
structure, the exact quantification of the absolute RV volume by this method has long been questioned. 
Further study has demonstrated that, through proper calibration, the conductance-derived RV volumes 
are equally reliable as with CMRI 
5
. The normal pressure-volume relationship of the RV appears as a 
triangular- or trapezoidal-shaped loop 
6
. Subsequent to its relation with the low-resistant pulmonary 
system, the isovolumic periods, relaxation rather than contraction, are usually ill-defined. In contrast 
to the LV, the RV ejection continues well beyond the end-systolic point, during pressure decline, 
reducing or eliminating hereby the isovolumic relaxation phase
 7
.  
The major advantage of this method is related to the quantification of the real-time intrinsic systolic 
and diastolic myocardial properties of the studied ventricle, during modulation of loading conditions 
through occlusion of  inferior vena cava inflow.  In consequence, the obtained load-independent 
indices represent the systolic function - or contractility - and the diastolic function of the global 
ventricle, including the contribution of regional dysfunction.   
The systolic function of the RV has been validated by the end-systolic pressure-volume relationship 
(ESPVR), using preferably the maximal elastance – defined as the instantaneous maximal pressure-to-
volume ratio – instead of the end-systolic elastance as a load-independent marker of contractility 8, 9. 
Together with the slope of the linear ESPVR, the intercept with the volume axis is an important 
covariate of contractility.  
Karunanithi et al. later reported that the slope of the linear regression of  stroke work in function to 
changing end-diastolic volume – the preload recruitable stroke work (PRSW) – is a more reproducible 
linear marker of contractile function, and more reliable than the ESPVR because of its afterload 
insensitivity 
10
. In addition, the PRSW-slope does not depend on the definition of the exact end-
systolic point at the right ventricular pressure-volume loop.    
Diastolic function is analyzed by the end-diastolic pressure-volume relationship (EDPVR), showing an 
exponential curve as volume increase is paired with a steeper pressure raise, for higher end-diastolic 
volumes. After linearization of the exponential fit P = CeβV into dP/dV = βP,  the slope of the EDPVR 
is defined as the chamber stiffness coefficient β, addressing the passive compliance of the ventricle 11, 
12
. In contrast to the LV, determination of early relaxation in the RV is hampered by the poorly 
delineated period of isovolumic relaxation. Furthermore, the peak rate of  pressure decay (min dP/dT) 
and the time constant of pressure decay τ (tau) as  measure of early diastolic function are strongly 
load-dependent and therefore less reliable 
13
.   
 
This method has been validated for evaluation of RV function in several pathological conditions in 
both the clinical and experimental setting, such as RV pressure-overload 
14, 15
, RV volume overload 
16, 
17 
and ischemic RV disease 
18
. A similar methodological approach was used in our animal experiments 
to study  the RV in relation to the surgically induced anomalies at the RVOT level, according to the 
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pathophysiological features of repaired TOF. The conductance catheter was uniformly positioned in 
the RV, from the outflow tract to the apex. Correction for cardiac output was obtained by use of the 
ultrasonic flow probe, or by the thermo-dilution method with pulmonary artery catheter, or by  
instantaneous arterial pulse wave contour analysis. RV performance was based on the analysis of the 
pressure-volume loops, including the measurement of pre-load independent systolic and diastolic 
indices during transient inferior vena cava occlusion.  Assessment of RV function was done at two 
time episodes : an acute phase to evaluate the postoperative effect,  and a chronic phase, set at 3 
months of survival, to define the midterm effect, according to the rapid organ maturation and growth 
of the used animals 
19, 20
. 
 
Figure. Intra-operative picture of the experiment with the conductance catheter in the RV from the PA (black 
arrow), and the flow probe around the pulmonary artery (white arrow), after surgical performance of a 
transannular patch of the RVOT through thoracotomy 
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Figure. Regression of PV-loops during occlusion of inferior vena cava  (Blue line = ESPVR – Green line = 
EDPVR)  
 
 
   
1.2. Comparison with clinical tools for assessment of RV performance 
 
The conductance technology is the standard technique for correct assessment of the pure systolic and 
diastolic ventricular performance, by giving simultaneous information on the pressure-volume 
relationship, independent of the loading conditions. The measurements are reflecting the functional 
state of the global RV, regardless of the complex RV geometry, and it incorporates thereby the 
functional effect of  eventual regional deformations. But since it is an invasive catheter-based 
technique, it is mostly applied for academic purposes. 
40 
 
In clinical practice, echocardiography and CMRI are the cornerstone for the evaluation of RV structure 
and function. Echocardiography offers the advantage of greater availability and versatility, whereas 
CMRI is increasingly advanced as the golden standard for accurate assessment of RV volumes and its 
derived variables. Moreover, both imaging tools give relevant information on structures adjacent to the 
RV as the pulmonary arteries, and abnormalities of inflow and/or outflow valve function. However, a 
major shortcoming of both techniques to study ventricular function is the lack of instantaneous 
pressure information.  
 
Echocardiography for assessment of the RV function 
 
Two-dimensional echocardiography is currently used as the first line imaging modality for assessment 
of RV function. RV size is often qualitatively compared to the LV size, in both the short- and long-
axis views, to define eventual RV dilation. Quantitative evaluation of RV function can be obtained by 
endocardial border contouring during the cardiac cycle,  and subtracting the end-systolic volume from 
the end-diastolic volume to determine RV ejection fraction, following the Simpsons’ rule. However, 
the volume-based estimation of RV by 2-D echocardiography is globally less precise. The 
development of 3-D imaging technology has certainly opened perspective for more accurate RV 
volume assessment, including the exact attrition of the outlet part 
21
.  
The change of fractional area between the systolic and diastolic phase in the 4-chamber view by 
echocardiography probably approximates the RVEF best 
22
. Other usable indices of systolic RV 
function are the tricuspid annular plane systolic excursion as a marker of longitudinal RV function 
23, 24
, 
and the RV myocardial performance index as the ratio of isovolumic time interval to ejection time 
25
.  
Tissue Doppler imaging allows quantification of the RV systolic and diastolic function, based on the 
measurement of myocardial velocities. Pulsed Doppler and color coded techniques are applicable for 
estimation of RV function, usually taken from the RV free wall at the level of the tricuspid annulus 
26
. 
Myocardial isovolumic acceleration time (IVA) has been advanced as an index of contractility, less 
dependent on loading conditions. This parameter is calculated as the ratio of the maximal isovolumic 
myocardial velocity to the time to peak velocity. Vogel et al. demonstrated the reliability of this index 
in comparison with the conductance-derived ventricular elastance 
27
. However, beside to the time-
consuming off-line analysis, the reproducibility of the results is often a concern due to the large inter-
observer variability and proper accuracy of  ultrasound positioning. Recently, strain and strain rate are 
increasingly studied in the RV. In contrast to radial strain, longitudinal strain is determined more 
reliably, correlating best with changes in stroke volume. Longitudinal strain rate is however 
representing better local contractile function 
28
. However, most of these parameters are reflecting the 
regional contractile function at the location of echocardiographic tissue sampling, and do not always 
correspond with the true systolic function, especially considering the complex geometry of the RV. 
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Diastolic function by echocardiography is based on the tricuspid inflow signals, including E-wave and 
A-wave velocity and E-wave deceleration time. Simultaneously, this has to be correlated with 
distension and flow wave reversal in the inferior caval vein and hepatic veins. The use of Tei-index as 
time constant of pressure decay, and minimal dP/dT are controversial in assessing specifically  the RV 
diastolic function 
13
. Increased deceleration of early rapid filling has been proposed as index of 
decreased compliance, but this may be difficult to measure correctly in the RV with poorly defined 
early rapid filling and atrial systolic phases as well as in presence of fast heart rates like in children. 
Hence, correlation between the RV filling profiles and diastolic ventricular characteristics are not 
clearly established. Compared to the method of conductance, only the demonstration of antegrade end-
diastolic flow into the pulmonary artery by both echocardiography and CMRI has been validated as a 
marker of restrictive RV physiology.  
In summary, the echocardiographic quantification of the RV function is hampered by the complex 
geometry of the RV, with inconsistent windowing of specifically the RVOT in older children and 
adults. Moreover, identifying accurate and reliable parameters for the functional study of the RV still 
remains a challenge 
29
 
 
RV function by Cardiac Magnetic Resonance Imaging 
 
Considering the complex anatomy of the RV and its functional inter-relationship with the LV, CMRI 
has become nowadays the standard method to reflect RV function. Optimal imaging results are 
obtained using fast breath-hold real-time acquisition, affording accurate volume determination by 
endocardial contour delineation 
30
. RV volume calculation equally includes the contribution of 
regional deformities of RV morphology. In the clinical setting, the systolic RV function is still 
frequently based on determination of RVEF, knowing that this parameter is highly load-dependent and 
therefore elusive with regard to its relevance for contractile performance. Hence, by accurate 
determination of pulmonary or tricuspid regurgitation volume, CMRI allows correction of stroke 
volume and so RVEF, in presence of important volume-overload.  
CMRI is also used for measurement of flow velocities by phase contrast mapping, giving essential 
information on valve function and cardiac output. According to echocardiography, diastolic function 
can be evaluated by analysis of transvalvular time-varying flow wave patterns. Recent pre-clinical 
investigation has opened perspective on the assessment of diastolic and systolic ventricular function, 
through constructing single-beat pressure-volume curves, by integration of instantaneous 
intraventricular pressure recording, CMRI-derived volume and real-time blood flow measurement.
31
   
A main advantage of CMRI through the method of contrast enhancement, is related to the possibility 
to study the intrinsic myocardial tissue characteristics, by differentiating between muscular tissue with 
preserved contractility and fibrosis or scar tissue. 
42 
 
Despite the excellent image quality and reproducibility, CMRI includes the inconvenience of time-
consuming data acquisition and analysis, and limited environmental accessibility. Moreover, its 
application needs consideration in small children, requiring anesthesia because of inadequate breathing 
cooperation, and in patients with intra-corporeal devices such as pacemakers 
32
.  
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Abstract 
 
Objective:  This study investigates the contribution of infundibular versus pulmonary valve (PV) 
dysfunction on right ventricular (RV) function in a porcine model. 
 
Background : Clinical outcome after repair of tetralogy of Fallot is determined by the adaptation of the 
RV to the physiological sequelae of the right ventricular outflow tract reconstruction. Recent surgical 
techniques are pursuing a PV versus infundibulum-sparing approach. 
 
Methods and Results : In a porcine model, 3 types of RVOT dysfunction were created and compared 
to sham-operated controls : infundibular dysfunction (INF), PV insufficiency (PI) and combined 
infundibular-PV dysfunction (TAP). Both acute and chronic effects on RV function were studied with 
conductance technology.  
In animals with PI, pulmonary regurgitant fraction progressed more in presence of concomitant 
infundibular dysfunction (+54 % in TAP versus +14 % in PI ; p = 0.03). Subsequently, RV end-
systolic and end-diastolic volume increased more in both groups, resulting in decreased ejection 
fraction after 3 months. Preload-independent systolic indices showed acute impairment of RV 
contractility in all treatment groups but most in animals with infundibular scarring (INF and TAP). 
Further chronic deterioration was observed in animals of group TAP. RV compliance improved 
proportionally most in groups PI and TAP, in relation to the extent of RV dilation. 
 
Conclusion : Surgical RVOT dysfunction, whether it includes the infundibulum and/or the PV, has an 
immediate effect on RV performance. While impaired RV contractility is due to intrinsic myocardial 
damage by infundibular distortion, it is chronically furthered by PI-related RV dilation. These findings 
support the adoption of a RVOT-sparing strategy to treat tetralogy of Fallot.  
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Introduction 
 
Surgical RVOT reconstruction during repair of TOF often results in PV insufficiency and in the long-
term, progressive RV dysfunction due to chronic volume-overload 
1
. Most clinical studies focusing on 
the sequelae of TOF repair have been incriminating the use of a TAP as major determinant of late RV 
dilation 
2
. Its detrimental role is even more pronounced by the additional development of extended 
RVOT akinesia or aneurysm, often occurring in patients operated in former eras, when a large 
ventriculotomy was used for closure of the ventricular septal defect and relief of the infundibular 
obstruction 
3
. To overcome these late effects, recent surgical management of TOF is pursuing a 
RVOT-sparing approach, including maximal preservation of PV function and/or minimal infundibular 
scarring 
4-6
. However, the long-term results of either strategy preference are unknown. 
The chronic effects of PI-related volume-overload on RV function have already been studied in animal 
models 
7-9
. Kuehne et al. demonstrated impaired biventricular systolic function and decreased RV 
contractility in growing swine, in relation to PI through transcatheter stent implantation across the 
pulmonary valve 
8
. Hence, in contrast with the usual clinical setting, the impact of the commonly 
associated surgically-induced infundibular dysfunction on RV function has rarely been studied. 
We developed an experimental model in growing pigs, to investigate the differential contribution of 
dysfunction of each RVOT component on RV function, in order to mimic properly the acute and 
chronic physiological effects of surgical RVOT reconstruction. Hemodynamic assessment was 
performed using the conductance catheter technology for quantification of RV volumes and indices of 
systolic and diastolic RV performance.    
 
Material and Methods   
 
The study protocol was performed according to the standards of “The guide for the Care and Use of 
Laboratory Animals” published by the National Institutes of Health (publication 85-23, revised 1996) 
and approved by the local ethical committee of the University Hospital of Ghent (ECD 08/30) 
 
Study protocol 
 
The experimental model included 16 land-race pigs (Rattlerow Seghers, Lebbeke, Belgium). Three 
groups with each 4 pigs underwent a surgical RVOT dysfunction. In group PI, an isolated pulmonary 
valve insufficiency was created by excision of one anterior PV leaflet through a transverse pulmonary 
arteriotomy. In group INF, infundibular dysfunction was obtained by infundibulotomy and closure 
with a polytetrafluorethylene (PTFE) patch of 30 by 20 mm  (GORE-TEX, Gore & ass, Delaware, 
USA). The third group TAP combined a PV insufficiency by excision of 1 leaflet and infundibular 
dysfunction by using a transannular plasty with a 40 mm long PTFE patch. In both groups INF and 
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TAP, the length of infundibular incision was made equal at 25-30 mm. Four animals served as control 
group and were sham-operated (SHAM). None of the animals comprised any RVOT obstruction. The 
conduct of the study protocol is depicted in figure 1. 
 
 
Figure 1. Time course of the experimental protocol 
 
 
In the acute phase, surgical RVOT dysfunction was induced via left thoracotomy. The hemodynamic effect was 
assessed by conductance technique, followed by MRI study of the RV within a week. The chronic phase was 
determined at 3 months, and included first MRI and then hemodynamic evaluation through sternotomy. 
Subsequently the animal was euthanized for heart harvesting and histological RV analysis.  
 
Operative procedure 
 
Following pre-medication with intramuscular tiletamine and zolazepam, in a combined solution with 
xylazine 2% (0.2 ml/kg), anesthesia was induced with intravenous propofol 3 mg/kg, sufentanil 0.005 
mg/kg and rocuronium bromide 1 mg/kg. After endotracheal intubation, the animals were 
mechanically ventilated with FiO2 40% and tidal volume of 0.1-0.15  l/kg. Anesthesia was maintained 
with continuous sevoflurane ET 2.5% administered through the AnaConda
®
 system (Sedana Medical, 
Sundbyberg, Sweden), and eventually additional boluses of sufentanil 0.005 mg/kg. Basic monitoring 
included electrocardiogram, body temperature and ventilatory CO2 emission through capnography. 
Oxygenation was controlled by arterial blood gas sampling. Hemodynamic monitoring included 
continuous arterial pressure through a 8.5-F catheter into the left carotid artery, and central venous 
pressure through a 7.5-F catheter into the right atrium via external jugular vein puncture. 
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Through a left thoracotomy, the different types of RVOT dysfunction as previously described, were 
performed with the use of right heart bypass and partial clamping of the RVOT. In sham-operated 
animals, only right heart bypass was installed during an equal time period. At the end of the procedure, 
the animals were extubated and treated with intramuscular buprenorphine 0.03 ml/kg and intercostal 
bloc with levobupivacaine 5 mg/ml. 
A follow-up interval of 3 months was used to determine the chronic phase, according to the rapid 
organ maturation and growth of these animals 
8,10
. At that time, hemodynamic effects were assessed in 
a way similar to the acute phase, but cardiac exposure was obtained through median sternotomy.  
 
Hemodynamical study with conductance catheter 
 
In the acute, post-surgical phase, a 7-F dual field pressure-volume catheter (CD Leycom, Zoetermeer, 
Netherlands) was introduced into the RV from the RVOT directed towards the apex. Correct catheter 
positioning was confirmed by radioscopy. The conductance catheter was connected to a Sigma M 
module and digitized at 250 Hz for on-line computer analysis with the Conduct NT CFL-512 software 
(CD Leycom). A 16 or 20-mm perivascular flow probe (Transonic Systems, Ithaca, NY, USA) was 
placed around the pulmonary trunk for cardiac output measurement. Pre-load modulation was 
achieved by radioscopically guided placement of a pulmonary artery balloon catheter (PTS-303 
NUMED , Heart Medical, Best, Netherlands) into the inferior vena cava, via puncture of the right 
jugular vein. In the chronic phase, conduction of the conductance catheter measurements was similar, 
but inferior vena cava occlusion was done surgically by a tourniquet.  
Acquisition of pressure and volume data was obtained at end-expiration. Volume calibration was 
performed by integration of slope factor α for cardiac output, and by parallel conductance during 
injection of 0.02 ml/kg hypertonic saline. Baseline measurements included end-systolic and end-
diastolic RV volumes with subsequent calculation of stroke volume (SV), ejection fraction (EF) and 
cardiac output (CO). In order to correct for growth variability between the animals over the groups, 
volume-dependent variables were indexed to body surface area (BSA), following Kelley’s equation for 
swine 
11
 : BSA (cm²) = 734 x weight (kg)
0.656 
 
Based on the instantaneous pressure-volume relationship changes during transient occlusions of the 
inferior vena cava, RV contractile function was quantified by the slope (Mw) of the PRSW and the 
slope (Emax) of the ESPVR. In addition, the volume intercept of the ESPVR was determined at the 
pressure level of 25 mmHg. Only recordings with less than 10 % change of heart rate and a correlation 
coefficient of the linear regression line r² > 0,90 were considered eligible.  
Evaluation of diastolic RV function was based solely on passive ventricular compliance, as active 
isovolumic relaxation (τ) was not reliable in the groups with PI. RV compliance was expressed as 
chamber stiffness constant β, derived from the exponential fit of the EDPVR. 
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MRI study            
 
MRI was performed with a 1.5 Tesla imager system (Siemens Avanto, Erlangen, Germany) with 
maximum gradient strength of 200 mT/m and slew rate of 45 mT/m/ms. Under anesthesia with 
intravenous propofol 1%, 3 mg/kg and manual-hold ventilation via endotracheal intubation, the 
animals were positioned on the MRI table in right lateral position. The MRI protocol consisted of 
ECG-triggered TrueFISP images in 3 orthogonal planes, ECG-gated trueFISP cine imaging of long 
and short cardiac axes, and phase-contrast acquisition through plane flow mapping perpendicular to 
the blood flow in the aorta and in the pulmonary artery. If TrueFISP images were artefacted by vivid 
aortic flow, a spoiled gradient echo sequence was used instead. All images were taken during end-
expiratory ventilation stop. LV and RV volume measurements on the short axis stack, as well as post-
processing of phase-contrast images were performed by a single investigator, with the use of the Argus 
software package (Siemens). MRI allowed validation of the RV volumes obtained by the conductance 
technique as well as determination of the PI grade. Pulmonary regurgitation fraction was calculated as 
the ratio of pulmonary retrograde to antegrade flow volume, expressed as percentage.  
 
Euthanasia and Histopathology 
 
At the end of the study, the animals were euthanized with an intravenous solution of embutramide 200 
mg, mebenzoniumiodide 200 mg, tetracaine hydrochloride 5 mg, dimethylformamide 1 mg (T61) at a 
dose of 0.3 ml/kg. The heart was harvested and tissue samples of the basal and free wall of RV and 
LV, and a papillary muscle of tricuspid valve were excised for histological analysis. Hematoxylin-
eosine and Masson’s trichrome staining were used for delineation of interstitial collagen extent. 
 
Statistical Analysis 
 
All data are expressed as mean ± SD. Data distribution was tested for normality by Shapiro-Wilks 
testing. Normal distributed data are compared between groups by one-way ANOVA, with Tukey or 
Dunnett-T3 correction for multiple comparisons, depending on homogeneity of variance. The change 
of each variable per individual animal between acute and chronic phase is expressed as the 
proportional change between both variables in percentage. This calculated variable was also analyzed 
by one-way ANOVA with post-hoc Tukey correction. For not normally distributed data, group 
comparisons were made with Kruskal-Wallis analysis and subsequent Mann-Whitney testing, with 
adjustment for multiple comparisons, for defining inter-group differences. Evolution of RV function 
variables for individual animals between the first and second phase was evaluated with paired t-test or 
Wilcoxon-signed rank test. Bland-Altman processing was used for validation of agreement of volume 
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measurement between MRI and conductance technique 
12
. Statistical analysis was done with SPSS 
19.0 software (SPSS Inc., Chicago, Illinois). A p < 0.05 was considered significant.   
 
Results 
 
At the start, all pigs had a comparable weight and BSA, according to their age of 8-9 weeks. After 3 
months, some growth variability resulted in a relative BSA increase of respectively 95 ± 28 % in 
group SHAM, 105 ± 12 % in group INF, 117 ± 6 % in group PI and 121 ± 8 % in group TAP (p = 
0.15). Although these differences  were not significant, the use of indexed RV volumes seemed more 
appropriate to differentiate growth versus dilation. In addition, the extent of surgical infundibulotomy 
was identical in group INF and TAP, shown by an indexed incision length of respectively 47.2 ± 1.6 
mm/m² and 46.6 ± 2.3 mm/m² (p = 0.65). 
 
Determination of RV volumes and global RV function variables (table 1) 
 
Measurement of RV volumes showed a close reliability between the conductance method and MRI, 
with a correlation coefficient of respectively 0.93 (p < 0.0001) and 0.85 (p < 0.0001) for EDV and 
ESV. Bland-Altman analysis confirmed agreement between both methods, with a bias of 8 ml and 
limits of agreement (-13;31 ml) for ESV, and a bias of 7 ml and agreement limits (-17;36) for EDV.  
Post-surgical PI was only present in group PI and TAP (PRF 29 ± 4 % and 22 ± 9 %, p = 0.14). After 
3 months, PRF changed respectively to 34 ± 5 % and 36 ± 13 %, resulting in significantly greater PRF 
progression in presence of concomitant infundibular dysfunction (14 ± 2 % versus 54 ± 24 %, p = 
0.03). Isolated infundibuloplasty did not induce PV dysfunction.  
The PI in groups PI and TAP induced a direct significant increase of mainly EDVi, and furthered RV 
dilation in the chronic phase, as evident from the significant increase of ESVi and EDVi, in 
comparison to the SHAM group and to their own postoperative volumes. Late ESVi was even 
significantly larger in group TAP than in group PI (p = 0.004). RV volumes of the INF group evolved 
similarly to the control group. Although stroke volume was increased in group TAP versus SHAM (p 
= 0.03), the relative SVi increase was not statistically different between groups. Conversely, RVEF 
decreased significantly with respectively 6 ± 3 % and 9 ± 6 % compared to their baseline value in 
group PI and TAP, while EF remained unchanged in both other groups. RV cardiac output decreased 
in both groups with PI, achieving nearly significant difference in group TAP (16 ± 6 %, p = 0.05), 
mainly due to physiological adoption of lower heart rates.  
RV pressures decreased significantly between the acute and chronic phase in all groups, and was more 
pronounced for diastolic pressures (ESP: p = 0.015; EDP: p < 0.0001). 
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Table 1. Global RV volumes and hemodynamics 
 SHAM INF PI  TAP 
ANOVA  
p-value 
Weight (kg)      
acute 23 ± 5 24 ± 4 22 ± 5 24 ± 1 0,12 
chronic 63 ± 15 73 ± 17 72 ± 14 81 ± 7 0,86 
% Δ 175 ± 56 199 ± 27 229 ± 30 235 ± 19 0,37 
BSA (m²)       
acute 0,57 ± 0,08 0,59 ± 0,06 0,54 ± 0,08 0,59 ± 0,01 0,85 
chronic 1,10 ± 0,18 1,21 ± 0,18 1,19 ± 0,19 1,30 ± 0,07 0,35 
% Δ 95 ± 28  105 ± 12 117 ± 6 121 ± 8 0,11 
Heart rate (bpm)       
acute 102 ± 19 89 ± 4 94 ±4 97± 9 0,34 
chronic 89 ± 5 88 ± 8 67 ± 7 
c
 65 ± 2 
c 
  < 0,0001 
% Δ - 14 ± 18 - 6 ± 4 - 19 ± 6 - 26 ± 10 0,13 
PRF (%)       
acute 0 0 29 ± 4 22 ± 9 0,14 
chronic 0 0 34 ± 5 36 ± 13 0,74 
% Δ 0 0 14 ± 2 54 ± 24 b 0,03 
ESP (mmHg)       
acute 26 ± 10 23 ± 4 24 ± 6 26 ± 5 0,94 
chronic 20 ± 5 21 ± 9 17 ± 4 20 ± 6 0,86 
% Δ - 18 ± 26 - 4 ± 62 - 29 ± 21 - 21 ± 24 0,82 
EDP (mmHg)       
acute 16 ± 9 12 ± 3 13 ± 2 13 ± 0,8 0,78 
chronic 7 ± 6 6 ± 5 4 ± 1 7 ± 5 0,53 
% Δ - 53 ± 25 - 50 ± 39 - 70 ± 9 - 47 ± 30 0,45 
ESVi (ml/m²)       
acute 55 ± 13 54 ± 7 66 ± 9 71 ± 6 0,06 
chronic 57 ± 9 59 ± 7 87 ± 9 
c
 109 ± 6 
b
 < 0,0001 
% Δ 7 ± 19 9 ± 5 31 ± 16 c 46 ± 10 c < 0,0001 
EDVi (ml/m²)       
acute 99 ± 17 104 ± 5 126 ± 13 
c
 129 ± 10 
c
 0,01 
chronic 113 ± 12 111 ± 4 158 ± 20 
c
 181 ± 15 
b
 < 0,0001 
% Δ 14 ± 21 11 ± 6 28 ± 14 c 41 ± 15 c 0,01 
SVi (ml/m²)       
acute 44 ± 6 51 ± 3 54 ± 7 57 ± 4 
a
 0,03 
chronic 56 ± 11 53 ± 4 66 ± 13 78 ± 10 
a
 0,03 
% Δ 12 ± 24 4 ± 10 16 ± 14 25 ± 23  0,12 
SWi 
(ml.mmHg/m²)       
acute 700 ± 283 741 ± 64 822 ± 213 948 ± 154 0,34 
chronic 794 ± 285 842 ± 181 949 ± 298 1198 ± 431 0,31 
% Δ 11 ± 29 14 ± 37 29 ± 41 26 ± 40 0,91 
EF (%)       
acute 45 ± 5 51 ± 4 46 ± 3 44 ± 2 0,12 
chronic 50 ± 7 49 ± 4 42 ± 4 38 ± 3 
a
 0,007 
% Δ 9 ± 7 - 3 ± 5  - 6 ± 3 c - 9 ± 6 c 0,003 
Effective CI 
(L/min/m²)       
acute 4,5 ± 0,6 4,6 ± 0,3 5,3 ± 0,8 5,2 ± 0,3 0,11 
chronic 4,9 ± 0,7 4,5 ± 0,3 4,4 ± 0,5 4,2 ± 0,5 0,52 
% Δ 4 ± 8 - 2 ± 4 - 11 ±  6  - 16 ± 6 a 0,05 
      
 
Post-hoc Tukey correction for multiple comparisons 
a
 p<0.05 between TAP and SHAM 
b
 p<0.05 between TAP and PI 
c
 p<0.05 between TAP - PI and SHAM 
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Legend : 
BSA = body surface area ; PRF = pulmonary regurgitation fraction ; ESP = end-systolic RV pressure ; EDP = 
end-diastolic RV pressure ; ESVi = indexed end-systolic RV volume ; EDVi = indexed end-diastolic RV volume 
; SVi = indexed stroke volume ; SWi = indexed stroke work ; EF = RV ejection fraction ; CI = cardiac index   
 
 
Assessment of load-independent systolic and diastolic RV performance (table 2) 
 
Surgical RVOT dysfunction induced acute impairment of RV contractile function as shown by the 
decreased Emax - and Mw - slope, with regards to the SHAM group. In comparison with isolated PI, 
infundibular dysfunction in groups INF and TAP resulted in a lower Emax and Mw at the early stage, 
but the difference with group PI was not significant. RV contractility decreased further after 3 months, 
and was proportionally most significant in group TAP as Emax and Mw decreased respectively 64 ± 22 
% and 37 ± 4 % , in relation to its previous value. According to the decrease of  ESPVR slopes, V25-
intercepts shifted to the right, consistent with progressive deterioration of contractility in all treatment 
groups. In the chronic phase, group PI showed less impaired contractility in comparison with group 
TAP, as evidenced by a significantly steeper Emax (0.47 ± 0.12 versus 0.20 ± 0.05, p = 0.02) and Mw –
slope (13.3 ± 1.6 versus 8.9 ± 1.4, p = 0.01). The lower Mw – and Emax –slope of groups INF and TAP 
illustrated the significant impact of surgical infundibular injury on RV contractile function in 
comparison with the reference group SHAM. Despite absence of secondary volume remodeling 
process, both contractility indices were still lower after 3 months, compared to group PI.   
RV compliance improved in all groups after 3 months (table 2). However, RV chamber stiffness 
decreased relatively more in groups PI and TAP (84 ± 6 % and 91 ± 5 % respectively) compared to 
group SHAM, in relation to the extent of secondary RV dilation and increasing PRF in both groups. 
   
 
Table 2. Pre-load independent indices of systolic and diastolic RV function 
 
 
 
 Emax (mmHg.ml
-1
) 
SHAM INF PI TAP ANOVA 
p value 
acute 1,63 ± 0,22 
a
 0,71 ± 0,38  0,96 ± 0,23  0,66 ± 0,24  0,001 
chronic 1,34 ± 0,18 
a
 0,33 ± 0,05 0,47 ± 0,12  0,20 ± 0,05 
c
 < 0,001 
% Δ - 17 ± 11 - 43 ± 29 - 46 ± 17  - 64 ± 22 b 0,05 
 V25 (ml)       
acute 16 ± 3 21 ± 4 18 ± 4 30 ± 7 
b
 0,005 
chronic 36 ± 12 48 ± 10 43 ± 10 79 ± 17 
b
 0,002 
% Δ 120 ± 50 132 ± 29 145 ± 26 164 ± 26 0,36 
 Mw (mW.s.ml 
-1
)        
acute 23,4 ± 2,9 
a
 13,8 ± 1,9 17,8 ± 2,4 14,2 ± 3,0 0,001 
chronic 22,5 ± 3,1
 a
 10,6 ± 1,3 13,3 ± 1,6 8,9 ± 1,4 
c
 < 0,001 
% Δ - 2 ± 12 - 23 ± 3 - 24 ± 14 - 37 ± 4 b 0,03 
 β (ml -1)        
acute 0,37 ± 0,21 0,42 ± 0,15 0,33 ± 0,03 0,62 ± 0,27 0,18 
chronic 0,12 ± 0,02 0,10 ± 0,08 0,05 ± 0,02 0,05 ± 0,02 0,09 
% Δ - 61 ± 12 - 77 ± 13 - 84 ± 6 d - 91 ± 5 d 0,006 
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Post-hoc correction for multiple comparisons 
a
 p<0.05 between SHAM and other groups 
b
 p<0.05 between TAP and SHAM 
c
 p<0.05 between TAP and PI 
d
 p<0.05 between TAP-PI and SHAM 
 
Legend : 
Emax = maximal elastance ; V25 = volume intercept of end-systolic pressure-volume relationship at RV pressure 
of 25 mmHg ; Mw = slope of preload recruitable stroke work relationship ; β = chamber stiffness constant of end-
diastolic pressure-volume relationship 
 
 
Histopathological results 
 
Macroscopic evaluation after 3 months showed a patent RVOT in all animals, with only scar fibrosis 
around the patched area in groups INF and TAP. In animals with PI, the most anterior PV leaflet was 
lacking, and was associated with effective PV annulus disruption in the group TAP. Both posterior 
leaflets were intact. The PV was anatomically and functionally normal in groups SHAM and INF.  
Microscopy revealed normal myocyte architecture and absence of interstitial fibrosis in group SHAM. 
However, increased interstitial collagen proliferation and enhanced myocardial bundle disarray were 
seen in groups INF and TAP, while these changes were only mildly present in group PI. Tissue 
samples are illustrated in figure 2.   
 
Figure 2. RV tissue histology 
 
Masson’s trichrome stained tissue samples of the right ventricular wall showing the extent of 
myocardial bundle disarray and interstitial fibrosis in the different groups (magnification x 10) : (a) 
SHAM, (b) INF, (c) PI, (d) TAP 
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Discussion 
 
In this study on a growing swine model, RV function was assessed in relation to dysfunction of the 
different anatomical components of the RVOT. Effective surgically induced PI resulted in secondary 
RV remodeling, affecting mainly the end-diastolic volume in the acute phase. After 3 months, RV 
dilation was associated with regression of RVEF by the higher ratio of end-systolic to end-diastolic 
volume increase. The presence of infundibular dysfunction concomitant to PI, promoted the RV 
dilation process, merely by increasing the PRF. As isolated infundibular dysfunction had no effect on 
RV geometry, and as RV remodeling was less pronounced in isolated chronic PI, the role of the 
preserved structural integrity of the infundibulum in sustaining the PI-related volume overload is 
suggestive. These data are in accordance with Kuehne et al. who found identical changes in RV size 
along with impaired pump function 
8
. In his model, isolated PI was created by pulmonary valve 
stenting, which resulted in 33 % PRF. This acute PI was higher compared to the one in our series as 
well as to the usual early clinical observation. Moreover, PRF increased to 49 % after 3 months, 
corresponding to 50 % PRF progression in their experiment. This was only seen in our study by 
adding infundibular dysfunction, which renders the comparison with the physiological  sequelae of 
TOF after TAP repair more consistent.  
Based on the analysis of indices as PRSW and ESPVR, any RVOT dysfunction resulted in instant 
impairment of RV contractile performance. Contractile function seemed particularly more attenuated 
through infundibular dysfunction, certainly due to intrinsic myocardial damage of that part of the RV. 
Even though further deterioration was enhanced by PI-related volume load, in correlation with the 
extent of the secondary RV remodeling process, contractility still appeared to be superior by 
preserving infundibular function. At last, systolic RV performance was worst after TAP 
reconstruction. This observation is currently in line with the clinical findings of Frigiola et al, who 
demonstrated reduced RV contractility in relation to the degree of PR and subsequent RV dilation, 
occurring mainly after TAP repair of tetralogy patients 
13
. Here, they used isovolumic myocardial 
acceleration, a tissue Doppler based parameter, which was previously validated as a load-insensitive 
marker of contractility, comparable to the conductance-derived slopes Emax and Mw 
14
.  
In contrast with other animal models addressing the RV properties after chronic PI 
8,9
, we noticed 
already a decreased RV contractile state after isolated PI at baseline conditions. Although contractility 
indices were lower at rest, contractile reserve only appeared to be impaired during dobutamine stress 
testing in these studies. This distinct finding might be attributed to differences in experiment 
conduction. First, the placement of the conductance catheter - which was aligned from the RV inlet to 
the apex in their studies - might have underestimated the real contribution of the infundibulum when 
challenged by the volume overload. Previous reports examined the effect of catheter position in the 
inhomogeneous RV and demonstrated that a larger part of the ventricular cavity is assessed by placing 
the catheter in the RV apex from the RVOT 
15-16
. From this point of view, the measurements in our 
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study are probably reflecting more adequately the functional changes at the level of interest, namely 
the RVOT. Secondly, the technical way of achieving PV dysfunction in our experiment might have 
been more detrimental for RV function. However, the use of mechanical right heart support could not 
be incriminated for its influence on RV contractility, since the indices were significantly altered in 
comparison with the sham-operated animals, which were also subjected to the myocardial effects of 
partial circulatory assistance. 
Regarding diastolic performance, RV compliance increased proportionally the most in correlation with 
increasing PI-related volume overload and RV dilation. This is in accordance to Pasipoularides et al.
17
, 
who demonstrated improved passive myocardial compliance in a canine model of volume overload, 
due to significant tricuspid regurgitation. Also the experiment of Kuehne et al. confirmed the transition 
of a non-compliant restrictive RV to a compliant non-restrictive RV as a natural adaptation mechanism 
to volume overload 
8
. Nonetheless, the impact of cardiopulmonary bypass on diastolic RV properties 
must be assumed in our model, as the stiffness coefficient decreased also in the control group, equally 
to the decreased end-diastolic RV pressures at 3 months.  
The functional RV properties of the different groups are globally corresponding to the histological 
alterations after 3 months. The impaired contractility observed in the 3 groups of RVOT dysfunction 
correlated with the increased presence of myocardial bundle disarray and interstitial fibrosis, 
suggesting already some secondary remodeling at cellular level. Similarly, modest increase in collagen 
concentration, with preserved diastolic compliance, was noticed in a pig model of volume overload 
through an A-V fistula 
18
. Our results further support the clinical findings of Babu-Narayan et al. that 
the extent of late cellular RV remodeling, indicated by fibrosis, is adversely related to the systolic RV 
function after TOF repair. Moreover, this process seemed to be advanced by the magnitude of the 
surgical RVOT insult as by progressive ventricular dilatation 
19
.  
 
Clinical implications        
  
In clinical practice, the kind of applied RVOT reconstruction is mainly determined by the RVOT 
morphological features including the degree of RV hypertrophy. Hence, a TAP with its subsequent 
deleterious long-term expectations, is still clinically used in many patients 
20
.          
The current study confirms that a transannular patch affects the RV performance the most by 
combining the adverse early effect on myocardial contractility by infundibular dysfunction and, on top 
of this, the gradual RV volume remodeling due to chronic and progressive PI. Our data support 
therefore the adoption of a RVOT-sparing approach, although it remains open whether this should be 
achieved by pursuing a PV- versus infundibulum-sparing technique. Protagonists of the PV-sparing 
repair admit that the major advantage is merely related to preservation of the pulmonary annulus, as 
more than one third of the patients experience PI at midterm follow-up. Besides, in more than 25 % of 
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the cases, an infundibular patch is associated for adequate relief of the infundibular hypertrophic 
stenosis 
4
. 
The role of the infundibulum after TOF repair has currently been studied on patient cohorts operated 
in former eras, with the use of extensive RV incisions closed with liberal patches 
21
. Two MRI studies 
on the functional analysis of the RV components in TOF patients demonstrated that the decreased 
ejection performance of the RV outlet portion was related to the extent of post-surgical scarring. RV 
dysfunction was only evident once the adaptive response of the larger trabecular part of the RV to PI 
became insufficient 
22-23
. Our experimental findings indirectly underscore the importance to maintain 
the infundibular function because : (1) large infundibular scarring negatively affects the RV contractile 
function, and (2) the preserved infundibular integrity resists to progression of associated PR and 
delays the secondary dilation process. Meanwhile, early clinical data on the use of an infundibulum-
sparing RVOT repair are promising in those infants with severe pulmonary valve hypoplasia, in whom 
relief of the PV annulus is deemed necessary at the cost of a minimal infundibular incision 
5-6
. 
 
Study limitations  
 
Even though the induced RVOT dysfunctions are clinically relevant and the hemodynamic 
measurements are homogeneous, extrapolation of these animal data to the clinical setting of TOF 
patients needs careful consideration. Confounding effects on RV function by factors as cyanosis and 
RV hypertrophy were not taken into account. The investigation of infundibular dysfunction was solely 
based on the complete surgical incision of the infundibulum. Consequently, the effect of a more 
conservative infundibular surgery, appropriate to actual techniques, was not fully ascertained. In 
addition, this model did not include the contribution of some residual low-gradient RVOT stenosis, 
with its beneficial effect on the PI-related RV dysfunction 
24
. 
The chronic phase in this porcine model has been determined by a 3-months time interval, 
corresponding approximately to midterm follow-up in humans. However, it remains debatable whether 
longer follow-up in these animals is desired for clearer discrimination of the effects of RVOT 
component dysfunction.  
Due to several peri-procedural incidents, the sample size of each group is limited, which might 
undermine the power of the intentional study sample. Nonetheless, we feel confident with the 
conclusions on our data as the differences between the hemodynamic effects among the groups were 
indicative within an acceptable range of variance.    
 
Conclusion 
 
In a juvenile chronic pig model, RV function was assessed in relation to dysfunction of the main 
components of the RVOT, based on analysis of pressure-volume loops. Although RV performance 
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was significantly affected by any surgical-induced RVOT dysfunction, involving the infundibulum 
and/or the pulmonary valve, the most detrimental effect was observed by combined dysfunction of 
both components through TAP repair. RV contractility was immediately impaired by infundibular 
distortion, due to intrinsic myocardial damage, while it was chronically furthered by PI-related RV 
dilation. Preservation of the structural and functional integrity of the infundibulum appears to delay 
the extent of the volume load-dependent secondary RV remodeling by impeding PR progression. 
Based on these findings, the adoption of a RVOT-sparing strategy for repair of TOF seems justified.  
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Abstract  
 
Aims: The age for repair of tetralogy of Fallot has progressively declined to the postnatal period, often 
at the cost of  an increased rate of transannular RVOT repair. The long-term effect of premature 
exposure to chronic PI-related volume-overload on a less hypertrophied RV has to be awaited.  
This study aims to investigate the role of hypertrophy on RV performance after chronic volume-
overload in a growing animal model. 
 
Methods and Results: RV hypertrophy,  induced by PA-banding, was studied in animals with 
(RVH+PI) and without subsequent PR (RVH). The effect of volume-overload was compared to 
animals without RV hypertrophy (PI) and to controls (SHAM). Both acute and chronic effects on RV 
function were studied with conductance technology, and validated by echocardiography. 
After chronic volume-overload, end-systolic and end-diastolic volumes were smaller in group 
RVH+PI compared to group PI, including a lower PRF (25±5% versus 35±5%, p=0.002). RV 
hypertrophy preserved better systolic function, confirmed by increased PRSW-slope (14.7±1.8 versus 
9.3±1.3 Mw.s/ml, p=0.025) and higher RVEF (51±3 versus 45±4%, p=0.05). Myocardial stiffness  
was  impaired in group RVH+PI versus PI (β: 0.19±0.03 versus 0.12±0.02 ml-1, p=0.001), presenting a 
restrictive physiology only in the condition associating hypertrophy and volume-overload at the acute 
and chronic phase.  
Conclusion: This study demonstrated that RV hypertrophy attenuates the RV remodeling process 
related to chronic volume-overload by pulmonary insufficiency. It enables better preservation of 
contractility, but at the cost of sustained diastolic impairment. These findings might help to conduct 
timing and strategy for repair of tetralogy of Fallot when RVOT morphology indicates a definite need 
for transannular reconstruction.  
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Introduction 
 
Despite more than 50 years experience with the surgical management of tetralogy of Fallot (TOF), the 
optimal timing as well as  the surgical approach  are still a matter of debate. Over the past decade  
primary repair has been advanced to the first months of life and even the neonatal age, without 
compromising the surgical outcome in terms of mortality 
1-3
. Besides avoiding the use of a palliative 
shunt and its potential complications, protagonists claimed the physiological benefit of early 
elimination of  hypoxemia with its adverse effects on organ maturation, improved pulmonary 
angiogenesis and alveologenesis, and reduced RV hypertrophy (RVH). A  major concern is the high 
frequency of transannular patch (TAP) reconstruction of the RVOT, subjecting these young children 
prematurely to the physiological consequences of pulmonary insufficiency (PI). Hence, the long-term 
effects on RV function need to be seen.  
Pressure-overload usually results in compensatory myocardial hypertrophy. Previous work has shown 
improved contractile performance of the RV by gradual and chronic afterload increase, but at the cost 
of  impaired diastolic function 
4,5
. This ambivalent phenomenon has to be considered for its effect on 
RV performance when challenged by acute and chronic PI-related volume-overload as a common 
sequel of TOF repair.  Since  there is a direct relationship between age of the patient and extent of RV 
hypertrophy, insight in this process might help the decision-making concerning the timing of surgical 
therapy with regards to the RVOT morphology. 
The purpose of this study was to mimic the physiological condition of TOF repair with postoperative 
PI  in a growing swine model, with first inducing RV pressure-overload to have RVH, followed by 
chronic volume-overload by surgical TAP reconstruction of the RVOT . The impact of RVH on RV 
remodeling and function was hemodynamically assessed with the conductance technique for 
quantification of RV volumes and pre-load independent indices of systolic and diastolic function.  
 
Material and Methods   
 
The study protocol was performed according to the standards of “The guide for the Care and Use of 
Laboratory Animals” published by the National Institutes of Health (publication 85-23, revised 1996) 
and approved by the ethical committee for animal research of the Ghent University Hospital (ECD 
11/27) 
 
Study protocol 
 
Twenty-eight  landrace pigs entered the study protocol. These were divided into 4 groups: (1) group 
RVH+PI (n=7) with pressure-overload induced RVH and subsequent PI-related volume-overload by 
TAP, (2) group RVH (n=7) underwent isolated pressure-overload by PAB, with secondary relief of 
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pulmonary artery obstruction, (3) group PI (n=7) was subjected only to volume-overload by TAP-
mediated PI, and (4) group SHAM (n=7) as control group, without exposure to any pathophysiological 
loading condition. 
Fourteen animals were submitted to gradual pressure-overload by fixed PAB at the age of 6-7 weeks 
(mean weight 17.9±1.8 kg). Follow-up by transthoracic echocardiography (TTE) was done for serial 
evaluation of RV function and PAB gradient. After ca. 8 weeks, they were equally and at random, 
divided into group RVH+PI and group RVH. One pig out of each group died during the study period 
and was excluded. All animals underwent evaluation of RV function with the conductance catheter, 
respectively at the acute, postoperative phase and at the late, chronic phase, respecting a time interval 
of ca. 3 months (mean 13.1±1.4 weeks) according to previous work 
6,7
. Animals of group PI and 
SHAM were age-matched to the former groups at the time of the first hemodynamic assessment. TTE 
was performed within the same week of hemodynamic investigation for assessment of the procedural 
effect on the RV. The conduct of the study protocol is shown in figure 1. 
 
Figure 1. Time course and conduct of the study 
 
 
Operative procedures 
 
The anesthesia protocol and basic hemodynamic monitoring of all surgical procedures was identical to 
the one used in previous study 
6
. 
PAB was performed through a small left thoracotomy, by encircling the pulmonary artery with a 5 mm 
large band of silicone elastomere (Perthese, Bornel, France), to obtain a gradient of at least 10 mmHg, 
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while systemic blood pressure remained stable. Further growth of the animal should result in 
progressive afterload increase. The hemodynamical effect of PAB was assessed by direct measurement 
of RV pressure in relation to aortic pressure and distal PA pressure.  
The second surgical step, done at phase 1, comprised a redo-thoracotomy for removal of the banding 
and  resection of the surrounding fibrous tissue, which mostly  relieved the obstruction effectively. In 
3 pigs, an additional patch plasty of the pulmonary trunk was needed to obtain a residual target 
gradient of less than 10 mmHg. To create significant PI, a longitudinal incision across the ventriculo-
arterial junction was made under partial clamping of the RVOT, the anterior PV leaflet was excised 
and a transannular polytetrafluorethylene patch (GORE-TEX, Gore&ass, Delaware, USA) of 30 by 20 
mm was inserted. In group RVH, no further surgery than band removal was done. In group PI, PI was 
obtained as first procedure likewise to group RVH+PI. SHAM-operated animals underwent a left 
thoracotomy for hemodynamical testing, without RV surgery.  
At the end of each  procedure, the animals were extubated and treated with intramuscular 
buprenorphine 0.03 ml/kg and intercostal bloc with levobupivacaine 5 mg/kg. 
Finally, at the last phase, cardiac exposure was obtained for solely hemodynamic testing through 
median sternotomy, with release of pericardial adhesions.  
 
Hemodynamical study with conductance catheter 
 
In the acute phase, a 7-F dual field pressure-volume catheter (CD Leycom, Zoetermeer, Netherlands) 
was introduced into the RV from the RVOT directed towards the apex. Correct catheter positioning 
was confirmed by fluoroscopy. The catheter was connected to a Sigma M module and digitized at 250 
Hz for on-line computer analysis with the Conduct NT CFL-512 software (CD Leycom). Pre-load 
modulation at phase 1 was achieved by radioscopically guided placement of a pulmonary artery 
balloon catheter (PTS-303 NUMED , Heart Medical, Best, Netherlands) into the inferior vena cava, 
via puncture of the right jugular vein. During phase 2, work-out of conductance measurements was 
similar, but inferior vena cava occlusion was done surgically by a tourniquet.  
Acquisition of pressure and volume data was obtained at end-expiration. Volume calibration was 
performed by integration of slope factor α for cardiac output, verified by effective cardiac output 
measurement based on pulse-pressure waveform analysis of the aortic pressure signal  (Vigileo, 
Edwards Lifesciences, Irvine, USA).  Calibration for parallel conductance was acquired during 
injection of 0.02 ml/kg hypertonic saline. Baseline measurements included end-systolic and end-
diastolic RV volumes with subsequent calculation of stroke volume and ejection fraction. In order to 
correct for growth variability between animals over the groups, volume-dependent variables were 
indexed to body surface area (BSA), following the equation for swine 
8
: BSA(cm²)=734 x weight 
(kg)
0.656
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As described previously 
9
, PRF was quantified as the ratio of the amount volume increase during 
pressure decline to stroke volume during a cardiac cycle at baseline (figure 2). 
Figure 2. Baseline P-V loop of RV in animal of group RVH+PI, showing the method of PRF calculation 
 
Based on the instantaneous pressure-volume relationship changes during transient occlusions of the 
inferior vena cava, RV contractility was quantified by the slope (Mw) of PRSW and the slope (Emax) of 
ESPVR. The volume intercept of ESPVR was determined at pressure level 25 mmHg and indexed to 
BSA (V25-I). Only recordings with less than 10% change of heart rate and a correlation coefficient of 
the linear regression >0,90 were considered eligible. Evaluation of diastolic RV function was based 
solely on passive ventricular compliance, as active isovolumetric relaxation was not reliable in the 
groups with PI. RV compliance was expressed as chamber stiffness constant β, derived from the 
EDPVR relationship. 
 
Echocardiography 
 
Transthoracic echocardiography was performed with the portable Vivid-I ultrasound system (General 
Electrics Healthcare, Buckinghamshire, UK) and a 3MHz transducer, by one single observer (KVDK) 
blinded for  the invasive hemodynamical results. The primary goal of  TTE was directed to validate 
the functional effect of each surgical procedure. The timing of each examination is indicated in 
figure1. Echocardiography included two-dimensional anatomical imaging of the RV for size 
estimation at the basal, mid-ventricular and RVOT level. RVH was quantified by measurement of RV 
free wall(FWT) and interventricular septal thickness(IVST), adjusted for BSA.  The tricuspid and 
pulmonary valve were evaluated by color-flow mapping and  the degree of regurgitation was semi-
quantitatively nominated as grade 1 to 4, according to standard criteria. Tricuspid inflow signal 
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analysis included determination of E-wave and A-wave velocity, E-to-A-wave velocity ratio,  E-wave 
deceleration time and E-wave deceleration slope. Pulse-wave Doppler analysis of the main pulmonary 
flow was performed to (1) estimate the flow velocity over the RVOT to follow the gradient during 
PAB, and to exclude residual obstruction after de-banding, and to (2) calculate the duration of 
diastolic regurgitant jet in presence of PI. The presence of an A-wave at late diastole throughout the 
respiratory cycle was categorized as a restrictive pattern. Estimation of systolic RV function was based 
on tricuspid annulus plane systolic excursion (TAPSE) and fractional shortening (FS) measurement at 
mid-ventricular level on M-mode.   
 
Euthanasia and Histopathology 
 
At the end of the study, the animals were euthanized with an intravenous solution of embutramide 
200mg, mebenzoniumiodide 200mg, tetracaine hydrochloride 5mg, dimethylformamide 1mg (T61) at 
a dose of 0.3 ml/kg. The heart was harvested and discarded from atria and great vessels; the ventricles 
were divided into the free wall of RV and LV and the interventricular septum. Each component was 
weighed separately to calculate the RV-to-heart ratio and RV mass/end-diastolic volume ratio, 
adjusted for BSA. Tissue samples of RV and LV were taken for histological analysis, with 
hematoxylin-eosine and Masson’s trichrome staining for delineation of interstitial collagen extent. 
Myocyte cell area was counted for defining hypertrophy, including presence of cell apoptosis.   
 
Statistical analysis 
 
All data are expressed as mean ± SD. Data distribution was tested for normality by Shapiro-Wilks 
testing. Normal distributed data are compared between groups by one-way ANOVA, with Tukey or 
Dunnett-T3 correction for multiple comparisons, depending on homogeneity of variance. For non-
parametric data, group comparisons were made with Kruskal-Wallis analysis and subsequent Mann-
Whitney testing with Bonferroni correction. Evolution of RV function variables for individual animals 
between phase 1 and 2 was evaluated with paired t-test or Wilcoxon-signed rank test. 
Correlation between conductance-related and echocardiographic observations was based on Pearson or 
Spearman rank test as appropriate. Statistical analysis was done with SPSS 19.0 software(SPSS Inc., 
Chicago, Illinois).A p<0.05 was considered significant.   
 
Results 
 
Validation of RV hypertrophy by PAB-induced pressure overload 
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PAB caused a comparable postoperative gradient and RV/LV-pressure ratio in groups RVH+PI and 
RVH, respectively 12.5±2.0 versus 14.1±6.1 mmHg (p=0.57) and 51±6 versus 52±5 % (p=0.64). This 
corresponded to an echocardiographic gradient of 26.5±10.1 and 26.3±15.4 mmHg (p=0.97). After 8 
weeks, the echo-gradient increased to respectively 63.9±14.4 and 52.8±18.8 mmHg (p=0.28). RVH 
was confirmed by a significant and comparable increase of RV wall thickness in both groups (FWT: 
5.9±1.2 to 9.3±1.7 mm, p=0.005 and IVST: 6.8±1.4 to 10.2±2.5 mm, p=0.007). Additionally, both 
PAB groups had increased FWT  in comparison with the non-PAB groups, shown by TTE at phase 1 
(RVH+PI: 11.0±1.4 mm and RVH: 10.8±1.8 mm versus SHAM: 7.6±0.6 mm and PI: 7.0±0.4 mm, 
p=0.002).    
 
RV volume- and pressure-related results (table 1) 
 
PRF was greater in group PI than in group RVH+PI at the acute stage. Because the PRF had increased 
proportionally after 3 months in both groups, the late difference in PRF remained significant.  
This had an immediate effect on the RV volumes, resulting in smaller indexed RV end-systolic and 
end-diastolic volume in group RVH+PI compared with group PI in the acute phase. This was equally 
reflected in the chronic phase, with a less dilated RV in group RVH+PI than in group PI. Both 
volume-overloaded groups had a larger RV than the RVH and SHAM groups.  
RV pump function was globally preserved in all groups at phase 1, reaching only a small significant 
difference of RVEF between group PI and RVH (62 ± 3 % versus 69 ± 5%, p=0.009). After 3 months, 
RVEF had worsened significantly in group PI  than in the other groups, whereas group RVH+PI also 
had a lower RVEF than group SHAM (mean difference 8 ± 2%, p=0.008). Global RV function was 
comparable between groups RVH and SHAM regarding RVEF at both phases, but included a smaller 
ESVI and EDVI for group RVH in the acute phase. 
The groups with previous pressure-overload had higher RV end-systolic and end-diastolic pressure at 
phase 1. At the chronic stage, only the RVEDP remained significantly elevated in these groups, while 
RVESP had equalized. Pulmonary valve dysfunction resulted in lower PAEDP in group PI, while 
PAEDP remained comparable between group RVH+PI and the groups RVH and SHAM in the acute 
phase, despite significant PI. This phenomenon was identical after 3 months, indicating then also a 
significantly lower PAEDP in group RVH+PI. Finally, the stroke work was significantly increased in 
all study groups in comparison with group SHAM at phase 1. Three  months later, no difference was 
found in SW between group SHAM and RVH, probably owing to regression of RVESP. Chronic 
volume-overload led to increased SW in group RVH+PI and even more in group PI, in comparison 
with group SHAM. 
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Table 1. RV volume and pressure data 
 RVH+PI RVH PI 
 
SHAM 
ANOVA  
p-value 
Weight (kg)      
acute 39 ± 8 44 ± 4  32 ± 4 31 ± 12
*
 0.02 
chronic 102 ± 16 109 ± 4  89 ± 11 77 ± 19
*
 0,002 
BSA (m²)       
acute 0,81 ± 0,11 0,88 ± 0,05  0,71 ± 0,06 0,69 ± 0,17
*
 0,02 
chronic 1,52 ± 0,16 1,60 ± 0,03  1,39 ± 0,12 1,26 ± 0,21
*
 0,002 
Heart rate (bpm)       
acute 96 ± 7  93 ± 6 96 ± 4 90 ± 4 0,11 
chronic 78 ± 3
 
  81 ± 3 78 ± 9 79 ± 5 0.77 
PRF (%)       
acute 19 ± 4 - 26 ± 4 - 0,02 
chronic 25 ± 5 - 35 ± 5 - 0,002 
% Δ 29 ± 4 - 39 ± 21 - 0,3 
RVESP (mmHg)       
acute 33 ± 4 32 ± 3 26 ± 4 24 ± 5 0,001
#
 
chronic 25 ± 3 27 ± 5 19 ± 5 21 ± 6 0,05 
RVEDP (mmHg)       
acute 14 ± 0,9 15 ± 3 10 ± 2 8 ± 3 <0.001
#
 
chronic 11 ± 1 12 ± 1 6 ± 2 7 ± 3 <0.001
#
 
PAESP (mmHg)      
acute 29 ± 4  28 ± 4 27 ± 4 24 ± 5 0.16 
chronic 25 ± 3 25 ± 5 19 ± 5 22 ± 7 0.17 
PAEDP (mmHg)      
acute 18 ± 3 18 ± 2 10 ± 2
**
 17 ± 5 <0.001 
chronic 11 ± 2 15 ± 2 8 ± 1
**
 14 ± 3 <0.001 
ESVI (ml/m²)       
acute 40 ± 3  27 ± 5  46 ± 4  34 ± 4 <0.001
†
 
chronic 62 ± 5  51 ± 4  76 ± 7  43 ± 6 <0,001
‡
  
EDVI (ml/m²)       
acute 111 ± 4  88 ± 8   123 ± 9  101 ± 5 <0.001
†
 
chronic 127 ± 3  111 ± 5 140 ± 7  103 ± 9 <0.001
‡
 
SVI (ml/m²)       
acute 71 ± 4 61 ± 7  76 ± 8
§
 66 ± 5 0.001 
chronic 65 ± 4 60 ± 3 64 ± 7 61 ± 6 0.38 
SWI (ml.mmHg/m²)       
acute 1244 ± 207 1032 ± 370 1004 ± 192 777 ± 148
¶
 0.02 
chronic 1090 ± 87 752 ± 110 1222 ± 214 813 ± 147 <0.001
║
 
EF (%)       
acute 64 ± 3 69 ± 5 62 ± 3
***
 66 ± 3 0.01 
chronic 51 ± 3 54 ± 3 45 ± 4 59 ± 4 <0.001
║
 
Effective CI (L/min/m²)       
acute 6.1 ± 0.4 5.0 ± 0.7 6.2 ± 0.6 5.1 ± 0,6 <0.001
║
 
chronic 3.8 ± 0.2 4.0 ± 0.3 3.7 ± 0.4 3.5 ± 0.8 0.45 
Post-hoc Tukey correction for multiple comparisons : 
*p<0.05 between RVH and SHAM 
† p<0.05 for all comparisons excepted SHAM – RVH+PI 
‡ p<0.05 for all comparisons excepted SHAM - RVH 
§ p<0.05 between PI and SHAM -  RVH 
║ p<0.05 for all comparisons excepted SHAM-RVH and PI-RVH+PI 
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¶ p<0.05 between SHAM and RVH+PI 
# p<0.05 for all comparisons excepted RVH-RVH+PI and PI-SHAM 
** p<0.05 between PI and other groups  
***p<0.05 between PI and RVH 
 
Legend : 
BSA=body surface area; PRF=pulmonary regurgitation fraction; RVESP=end-systolic RVpressure; 
RVEDP=end-diastolic RVpressure; PAESP=pulmonary artery end-systolic pressure; PAEDP=pulmonary artery 
end-diastolic pressure; ESVI=indexed end-systolic RVvolume; EDVI=indexed end-diastolic RVvolume; 
SVI=indexed stroke volume; SWI=indexed stroke work; EF=RV ejection fraction; CI=cardiac index   
 
 
 
Assessment of load-independent systolic and diastolic RV performance     
         
Contractile function was mainly impaired in group PI,  illustrated by lower Emax and Mw-slope at phase 
1, although the difference with group RVH+PI was not significant. At phase 2, both  indices evolved 
in disadvantages to both groups with volume-overload. The PRSW-slope was significantly lower in 
group PI than in other groups, and was also significantly decreased  in comparison with group 
RVH+PI. Analysis of the  Emax and volume-intercept V25-I showed a similar trend; however, the 
difference between groups PI and RVH+PI at phase 2 did not reach statistical significance (p = 0.09). 
Contractility was comparable between groups RVH and SHAM in the acute and chronic phases. 
RV compliance was significantly altered by hypertrophy, with a significantly increased stiffness 
coefficient β  in group RVH+PI and RVH at phase 1, that  persisted after 3 months. However, diastolic 
compliance coefficient appeared to be lower in all groups at phase 2. This could be explained by the 
different measurement conditions, minimizing the effect of pericardial restraint by using sternotomy 
for cardiac exposure. Pre-load independent RV function indices are depicted in figures 3 and 4. 
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Figure 3A. Bar-plot of Emax derived from ESPVR at both study phases 
 
 
*p<0.05 between PI and SHAM – RVH 
§p<0.05 between RVH+PI and SHAM - RVH 
 
Figure 3B. Bar-plot of Mw derived from Preload-Recruitable Stroke Work  at both study phases 
 
*p<0.05 between PI and SHAM – RVH 
**p<0.05 between PI and all other groups 
§p<0.05 between RVH+PI and SHAM – RVH 
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Figure 4. Bar-plot of β-stiffness coefficient derived from EDPVR at both study phases 
 
#p<0.05 between RVH – RVH+PI and SHAM - PI 
 
Echocardiographic data (table 2) 
 
Echocardiography at phase 1 confirmed the presence of significant PI in groups RVH+PI and PI, with 
a shorter PI duration (respectively 256±14 and 291±10 msec, p=0.01) in group RVH+PI. After 3 
months, both groups showed a larger RV size at the subpulmonary level, but differences at the basal 
and midventricular level were less pronounced. Again, the PI duration was significantly shorter in 
group RVH+PI, compared to group PI (263±19 versus 293±9 msec, p=0.047).  
A  restrictive physiology was seen mainly in group RVH+PI, in respectively 4 of the 6 animals at 
phase 1, and in 5 animals at phase 2. This was only noticed at phase 1 in one animal of group RVH, 
which disappeared at phase 2. Regarding diastolic function, RVH was only associated with a 
significant decrease of  the E-wave deceleration slope, compared to group SHAM. This parameter 
correlated  inversely with the stiffness coefficient β (ρ -0.70; p=0.001) and RVEDP (ρ -0.53; p=0.026) 
at the chronic phase. In contrast, echocardiographic determinants of systolic RV function as FS (ρ 
0.05; p=0.84) and TAPSE (ρ 0.16; p=0.52) were poorly associated with systolic indices obtained by 
the conductance technique. Echocardiographic RV size estimation showed a good correlation between 
RVEDVI and RV size at basal level (ρ 0.49; p=0.04), midventricular level (ρ 0.34; p=0.07) and RVOT 
level (ρ 0.55; p=0.02).    
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Table 2. Basic echocardiographic data 
 RVH+PI RVH PI SHAM 
ANOVA  
p-value 
TV E-wave (m/sec)      
acute 0.67 ± 0.27 0.80 ± 0.12 0.92 ± 0.16 0.83 ± 0.16 0.40 
chronic 0.73 ± 0.15 0.67 ± 0.10 0.81 ± 0.06 0.89 ± 0.15 0.10 
TV A-wave (m/sec)      
acute 0.63 ± 0,22 0.53 ± 0,16 0,64 ± 0.08 0,43 ± 0.07 0.30 
chronic 0.56 ± 0.06 0.55 ± 0.15 0.66 ± 0.09 0.56 ± 0. 0.47 
TV E/A ratio      
acute 1.11 ± 0.39  1.66 ± 0.64 1.42 ± 0.17  1.95 ± 0.23 0.13 
chronic 1.33 ± 0.34
 
  1.27 ± 0.32 1.23 ± 0.07 1.60 ± 0.26 0.41 
TV E-wave DCT (msec)      
acute 257 ±50 192 ± 17 178 ± 45 181 ± 15 0.05 
chronic 254 ± 47 200 ± 43 202 ± 64 179 ± 10 0.11 
TV E-wave DC slope      
acute 2.7 ± 1.3 4.1 ± 0.7 5.5 ± 2.3 4.7 ± 1.2 0.12 
chronic 2.9 ± 0.7 3.4 ± 0.7 4.2 ± 1.1 5.0 ± 0.7 0.01
¶
 
Restrictive Pattern (n)      
acute 4/6 1/6 0 0 0.04 
chronic 5/6 0 0 0 0.001 
TAPSE (mm)      
acute 13.0 ± 1.4  13.0 ± 3.7 13.7 ± 2.1 15.4 ± 2.5 0.67 
chronic 17.4 ± 4.3 18.0 ± 4.5 14.3 ± 2.9 18.0 ± 1.7 0.58 
FS (%)      
acute 37.3 ± 5.6 38.8 ± 5.7 37.5 ± 0.5 33.1 ± 6.6 0.55 
chronic 33.0 ± 10.5 37.8 ± 6.1 30.7 ± 4.2 38.9 ± 7.2 0.38 
PI grade      
acute 3.4 ± 0.5 0.8 ± 0.8 3.7 ± 0.6 0 <0.0001
║
 
chronic 3.5 ± 0.8 0.6 ± 0.8 3.7 ± 0.6 0 <0.0001
║
 
PI duration (msec)       
acute 256 ± 14 0 291 ± 10 0 0.01 
chronic 265 ± 19 0 293 ± 9 0 0.05 
RV Size (mm/m²)      
Basal level      
acute 43.6 ± 9.1 41.3 ± 4.7 46.1 ± 3.5 34.7 ± 2.6 0.14 
chronic 31.0 ± 3.8 29.3 ± 4.4 34.6 ± 5.4
††
 24.0 ± 3.8 0.04 
Mid-ventricular level      
acute 35.4 ± 7.8 32.0 ± 2.9 39.8 ± 3.5 32.9 ± 0.6 0.19 
chronic 26.2 ± 4.6 24.6 ± 2.8 33.2 ± 7.1 23.4 ± 5.3 0.06 
RVOT level      
acute 28.9 ± 5.8 26.7 ± 6.7  29.9 ± 5.0 27.5 ± 5.4 0.88 
chronic 21.3 ± 3.4 18.1 ± 2.9 26.2 ± 3.6
§
 19.8 ± 4.5 0.008 
FWTI (mm/m²)      
acute 13.2 ± 1.9 12.5 ± 2.8 9.1 ± 0.2 8.9 ± 1.4 0.02
#
 
chronic 9.5 ± 1.0 8.0 ± 0.6 7.0 ± 0.6 5.6 ± 0.6 <0.0001
#
 
IVST (mm/m²)      
acute 16.1 ± 5.5 13.6 ± 3.4 11.2 ± 0.6 8.2 ± 0.8 0.07 
chronic 9.8 ± 1.2 8.0 ± 1.3 6.3 ± 0.7 7.0 ± 0.9 0.003
#
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Post-hoc Tukey correction for multiple comparisons 
¶ p<0.05 between SHAM – RVH+PI 
║ p<0.05 for all comparisons excepted SHAM-RVH and PI-RVH+PI 
†† p<0.05 between SHAM – PI 
§ p<0.05 between PI and SHAM -  RVH 
# p<0.05 for all comparisons excepted RVH-RVH+PI and PI-SHAM 
 
Legend: 
TV=tricuspid valve; DCT=deceleration time; TAPSE=tricuspid annular plane systolic excursion; FS=fractional 
shortening; FWTI=indexed free wall thickness; IVSTI=indexed interventricular septum thickness 
 
 
Histopathological results 
 
A significant difference of RV mass was found between all groups (RVH+PI: 99±10 g/m²; PI: 87±5 
g/m²; RVH: 72±3 g/m²; SHAM 50±1 g/m²; p<0.03). The RV mass-to-total heart weight ratio was 
higher in the volume-overloaded groups (RVH+PI: 36±5%; PI: 38±2%; RVH: 29±1%; SHAM 
26±2%; p=0.001). The RV mass-to-volume ratio was particularly increased in group RVH+PI 
(0.77±0.08 g/ml) compared to group PI (0.62±0.07 g/ml, p=0.003) and RVH (0.64±0.04 g/ml, 
p=0.012), whereas group SHAM had the lowest ratio (0.51±0.05 g/ml, p<0.001), also lower than 
group PI (p=0.05) and group RVH (p=0.03). Microscopy of the RV revealed evident cellular 
hypertrophy and focal apoptosis in groups RVH+PI and RVH, more than in group PI. Interstitial 
fibrosis and myocardial disarray were equally observed in all treatment groups, but to a greater extent 
in group RVH+PI. Microscopy was normal in group SHAM.   
 
Discussion 
 
In the present study, a physiological model was established to investigate the role of RVH, initiated by 
previous pressure-overload, on RV performance during acute and chronic exposure to PI-related 
volume-overload in growing swine. To our knowledge, such an experimental animal model likely 
mimicking the presentation of TOF with its inherent physiological variability in pressure- and volume-
overload sequences, has not yet been elaborated. 
According to our previous work, volume-overload by TAP reconstruction of the RVOT affected  
immediately the systolic RV function, with  impaired myocardial contractility through surgical 
damage of the infundibulum 
6
. Progression of PI  involved significant RV dilation, with further 
deterioration of the systolic function.  
Pre-existing RVH appeared to alter this process in several ways. Previous pressure-overload is known 
to initiate improved contractile performance by increasing the  myocardial cell mass, merely by cell 
hyperplasia, such as has been shown in younger animals 
4,9
. In this study, RVH yielded a contractile 
RV function comparable to that of the control animals, despite significant PI in the acute phase. 
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However, loss of contractile function was observed in relation to chronic volume-overload, owing to 
secondary RV dilation. RVH appeared to attenuate this phenomenon only partially. In contrast, when 
the RV with hypertrophy  was not physiologically challenged after relief of the obstruction, 
contractility was maintained.  
RVH also influenced the  remodeling secondary to chronic volume-overload, by retarding the RV 
dilatation. This might have been related to the lower amount and shorter diastolic duration of PI, even 
though the surgically created TAP was similar. Hence, it seemed more valid that both latter features 
are rather a consequence of the altered mechanical RV properties by hypertrophy, than the primary 
cause. Kuehne et al.
10
 also stipulated the beneficial effect of RVH on the degree of PI. They found in 
analogy, less RV dilation and enhanced myocardial contractility in an animal study, by combining a 
component of stenosis to pulmonary insufficiency. Although they attributed RVH to be responsible for 
this effect, their experimental design involved at the same time a reduction of the regurgitant 
pulmonary orifice.  But it underscores the advantage of leaving an acceptable residual obstruction 
during relief of the RVOT, to prolong the beneficial contribution of RVH on RV performance
 11
.  
In contrast to the favorable effect on myocardial contractility, hypertrophy has commonly been 
associated with decreased diastolic function, by impaired early relaxation and passive compliance
12
. In 
this model, the determinants of early relaxation such as the minimal pressure-versus-time decline 
(dP/dTmin) and time-constant of pressure decay (τ)  were not included because these are known to be 
load dependent and poorly reliable in the context of PI-related disturbance of  isovolumetric relaxation. 
However, RV compliance was significantly worse in both groups with RVH at both the acute and 
chronic stage, and was simultaneously associated with  increased end-diastolic RV-pressure.  
A restrictive RV physiology was noted only in the group combining RVH and significant PI, already 
present  in the acute setting and persisting chronically. This finding highlights the mechanism of  
primary restriction, advancing the role of hypertrophy as its main substrate, and subsequently 
furthered by the volume-overload, through decreasing the diastolic pressure gradient between the stiff 
RV and the pulmonary artery in presence of  significant pulmonary regurgitation.  
Considering the histologic changes after 3 months, including microscopically prominent myocyte 
hypertrophy as well as interstitial fibrosis, and macroscopically an increased mass/volume ratio, the 
advantage of RVH on RV remodeling after chronic volume-overload might eventually be the 
combined result of sustained systolic performance and  impaired diastolic properties of the RV. One 
can assume that a stiffer hypertrophic ventricle, but with preserved contractility, would accommodate 
better to the PI and consequently resist longer to the dilation process. This issue evokes the ambivalent  
role of a primary restrictive RV physiology in the clinical setting of TOF repair, with its detrimental 
effect on the early postoperative course, but its potentially favorable influence on late RV dilation
13,14
.   
 
Clinical implications 
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The present study has demonstrated that RVH entails a benefit on RV remodeling by chronic PI-
related volume-overload by affecting both systolic and diastolic RV performance. In TOF, a direct 
relationship exists between the extent of RVH and the duration of pressure-overload and thus, the age 
of the patient. During the past decade, the age of TOF repair has been decreasing to even the neonatal 
age. Hence, this early repair policy has been accompanied by a frequent  use of TAP, subjecting a RV 
with less hypertrophy to chronic volume overload 
2,3
. This clinical situation corresponds to that of the 
PI group in our experiment, showing the worst outcomes in terms of systolic function and RV dilation. 
Munkhammar et al. revealed an inverse relationship between the presence of restrictive RV 
physiology and patient age at  repair, irrespective of the type of RVOT reconstruction. A restrictive 
physiology was observed  in only 10% of the patients less than 6 months of age
15
. In agreement with 
their doubts on the late effect of early repair, our study supports the execution of primary repair 
beyond the neonatal age, to take advantage of some degree of RVH, particularly in the patient whose 
RVOT morphology will require TAP repair for effective RVOT relief. Considering the risk of 
increased perioperative morbidity after repair in infants < 3 months old 
16
, judiciously choosing a 
palliative shunt in order to postpone complete correction for a few months might be justified. However, 
the design of our experiment could not allow more precise advise on the optimal age for repair, by 
lacking variability in the quantification of RVH.  
Otherwise, if RVOT morphology permits salvage of its functional integrity, early correction might be 
pursued as shown in group RVH, to overcome incomplete recovery of impaired diastolic compliance. 
Therefore, the ultimate answer to this conflicting problem concerning the timing and strategy of TOF 
repair, requires an an individualized approach to each patient, taking into account the specific RV-
dependent characteristics such as RVOT morphology and RVH.  
 
Study limitations 
 
Although this experimental model  is relevant for its hemodynamical effects, extrapolation of these 
data to the clinical setting needs careful consideration by lack of confounding interaction with 
specifically cyanosis. This factor is often advanced by the duration and severity of  RV pressure-
overload and thus, the age of the TOF patient, and might additionally impact RV performance by 
enhancing some histologic alterations. Secondly, RVH was induced as a fixed component and 
precluded investigation of varying degrees of RVH on RV function. Further study on this issue should 
include a wider time span of previous pressure-overload exposure; however, this would be at the cost 
of a larger sample size of animals. Echocardiography was primarily used to validate the surgical result, 
comprising mainly basic measurements. The addition of tissue Doppler data might have allowed more 
subtle examination of the systolic and diastolic RV function, albeit its exact contribution remains 
vague in the setting of TOF.       
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Conclusion 
 
In a model of juvenile growing swine, the role of RVH was studied for its effect on RV function and 
remodeling after acute and chronic PI-related volume-overload. RVH initiated improved contractile 
function, which preserved global RV function longer in relation to chronic PI. However, it entailed 
decreased diastolic compliance, responsible for a restrictive RV physiology when simultaneously 
challenged by significant PI. Both alterations in RV performance affected secondary RV remodeling 
by retarding the dilation process and restricting the amount and duration of PI. From these findings, 
primary repair of TOF during the early postnatal period should not be favored, when RVOT 
reconstruction is definitely deemed to result in significant PI, prematurely loading a less hypertrophied 
RV. These insights on the influence of RVH on chronic PI might help in the decision-making process 
on the timing and surgical strategy as an individualized process for each patient with TOF.   
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Chapter VI 
 
Assessment of a right ventricular infundibulum-sparing approach in 
transatrial-transpulmonary repair of Tetralogy of Fallot  (Eur J Cardio-
Thorac Surg 2012;41:126-133) 
 
Thierry Bové , Katrien François, Kristof Van De Kerckhove, Joseph Panzer, Katya De Groote, Daniel 
De Wolf, Guido Van Nooten 
 
 
Abstract 
 
 
Objective :  to evaluate the outcome of transatrial-transpulmonary repair of tetralogy of Fallot in 
relation to a right ventricular outflow tract (RVOT)-sparing surgery 
 
Methods : 
Based on the surgical management of RVOTO at repair of tetralogy of Fallot, 140 children were 
retrospectively divided into 3 groups : (1) pulmonary valve (PV)-sparing, (2) infundibulum-sparing 
and (3) extended transanular patch (TAP). Clinical and echocardiographic outcome was assessed with 
regards to 3 equally divided study time eras between January 1994 and June 2010. 
 
Results : 
Over a 15-year study period, median age decreased from 11 (2 – 101) to 5 (1 – 11) months (p < 0.001), 
while type of RVOT repair changed significantly between the first and the last era (group 1: 18 to 40 
%, group 2: 25 to 40 % versus group 3: 57 to 20 % (p = 0.002)). 
Mortality was 0 %. Complications were mainly related to clinical restrictive RV physiology (27 %) 
and arrhythmia (10%). This cardiac morbidity remained constant over the eras and was associated with 
younger age (p = 0,04), increased postoperative RV/LV pressure ratio (p = 0,01) and type of RVOT 
repair at the cost of  TAP (p = 0,03).  
Median follow-up of 8 years (1-16 y) showed an overall freedom from RVOT reoperation of 84 % and 
73 % respectively at 5 and 10 years. Most reoperations were for residual/recurrent RVOTO (12 %) 
occurring more frequently in the latter era : 16 % versus 7 % in era 1 (p = 0,08).  
Late echocardiographic evaluation revealed a strong correlation between severity of pulmonary 
regurgitation and increased RV/LV size ratio, which was mainly determined by increased TAP length 
(p < 0,001) and duration of follow-up (p = 0,06). 
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Conclusion : 
In a 15-year’s experience with transatrial-transpulmonary correction of Tetralogy of Fallot, a valve- 
and infundibulum-sparing approach has been advanced by lowering the age for elective repair. This 
change has been performed without compromising immediate clinical outcome, despite an increased 
early reoperation rate for residual obstruction. However, longer follow-up will disclose whether this 
approach is protective against progressive and late RV dysfunction.    
  
 
 
1. Introduction 
 
More than 50 years experience with surgical treatment of tetralogy of Fallot (ToF) has revealed that 
the physiological sequelae of the formerly performed transventricular repair with a large transannular 
patch are not benign on the long-term 
1-3
. Over the past decades, two issues have been addressed in 
order to optimize the surgical outcome : the type of right ventricular outflow tract (RVOT) correction 
and the timing for complete repair. 
Regarding the first issue, the transatrial-transpulmonary approach has gained a lot of popularity by 
minimizing transmural myocardial scarring of the right ventricle 
4,5
. Even though a transannular 
enlargement is required in 60 to 70 % of the patients, leading to pulmonary valve incompetence, 
preservation of the RVOT integrity is often pursued by limiting the infundibular incision, considered 
as a right ventricle infundibulum-sparing procedure 
6
. Some authors have also advocated a pulmonary 
valve or annulus-sparing strategy in selected cases of severe pulmonary annulus hypoplasia, 
eventually associated with a separate transventricular patch plasty for adequate relief of the 
infundibular stenosis 
7,8
.  
The second debate concerns the optimal time of primary repair. Protagonists of early corrective heart 
surgery have introduced complete repair of tetralogy of Fallot in the neonatal period to overcome the 
potentially morbid effects of cyanosis and advanced right ventricular hypertrophy, as well as the 
complications related to prior shunt palliation 
9,10
. Opponents of this early repair have used the 
argument of increased morbidity and even mortality in these neonates, to strengthen their preference 
for a two-stage approach in infants with symptomatic tetralogy of Fallot. In accordance with the ideas 
claimed by Fraser et al. 
11
, we have been adopting an individualized strategy in the surgical therapy of 
children with tetralogy of Fallot. This included the use of modified Blalock-Taussig shunt (BTS) in the 
symptomatic neonate, particularly with ductal dependent pulmonary flow, and in presence of small 
native pulmonary branches. Complete repair has consistently been performed by a transatrial-
transpulmonary approach within the first year of life. However, during this 15-years experience, we 
have gradually introduced a more RVOT-sparing approach, while lowering the age of repair 
simultaneously. The purpose of this study is to report on the early and late effects of both changes on 
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clinical outcome, and to assess specifically the usefulness of an infundibulum-sparing approach in 
comparison with more extensive transannular patch plasty.  
  
2. Patients and Methods 
 
2.1  Patients 
 
This study has been approved by the Ethical Committee of the University Hospital of Gent 
(registration number B67020109388) and informed consent was waived for its retrospective design. 
The medical records of all patients who underwent complete repair of ToF between January 1994 and 
June 2010 were reviewed and consisted of 140 patients (84 males and 56 females). Patients with 
absent pulmonary valve syndrome and pulmonary atresia requiring insertion of a valved conduit for 
primary correction were excluded. 
During the study period, the age at the time of complete repair progressively decreased as depicted in 
figure 1. Based on this graphical analysis, 3 equally divided time periods were differentiated as era 1 
for period 1994-1999, era 2 for period 2000-2004, and era 3 for period 2005-2010. 
 
Figure 1. Evolution of age at repair over study period 
 
 
2.2  Surgical policy 
 
During the whole study period, the operative management of children with ToF remained constant. 
Using standard cardiopulmonary bypass with moderate systemic hypothermia and cold crystalloid 
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cardioplegia, complete repair entailed consistently transatrial closure of the ventricular septal defect 
with a 0.4 mm PTFE patch (Gore-Tex, WL Gore & associates, Flagstaff, AZ) through the tricuspid 
valve, and excision/transsection of obstructive parietal and septal bundles in the infundibulum. Intra-
atrial communications were closed routinely. Via a longitudinal arteriotomy of the pulmonary trunk, 
the size of the pulmonary branches was measured with Hegar dilators. After commissurotomy of the 
pulmonary valve, the adequacy of the pulmonary annulus size was compared to the minimal 
acceptable pulmonary size from Rowlatt’s tables 12. If the pulmonary annulus was found appropriate 
within the lower limits of the expected normalized z-value and relief of the infundibular stenosis 
seemed satisfactory after further transpulmonary resection, the arteriotomy was closed with an 
autologous pericardial patch. When the pulmonary annulus was deemed too small, the pulmonary 
arteriotomy was extended across the annulus, by preference through the most anterior commissure, 
into the infundibulum. Based on this approach, we defined 3 types of RVOT repair : (group 1) a 
pulmonary valve-sparing procedure with preservation of the pulmonary valve annulus after 
commissurotomy, (group 2) an infundibulum-sparing procedure with a transannular incision limited to 
the first 5 mm of the RVOT, and (group 3) an extended transannular patch plasty, where the RVOT 
incision was extended beyond the first 5 mm, to cross the level of the hypertrophic infundibular 
septum.  
At the end of the procedure, peak RV/LV pressure (P) ratio determination and transesophageal 
echocardiography were performed in all patients. The RVOT repair was judged adequate when 
RV/LVP ratio was lower than 0.8 and echocardiography excluded residual anatomic obstruction. 
When RV/LVP ratio was initially higher than 0.8, the decision on the appropriateness of RVOT relief 
was made by echocardiography to differentiate between anatomic versus dynamic obstruction, after 
intra-operative optimization of hemodynamics and withdrawal of inotropics.  
The approximate length of the transannular incision, the Hegar size defining the final z-value of the 
RVOT and the intra-operative RV/LV pressure ratio were noted in the operative record. In addition, 
the length of transannular incision was indexed to body surface area of each patient, in order to allow 
proper comparison of TAP length in function to age at repair. 
 
2.3  Postoperative follow-up 
 
Endpoints of early outcome were mortality, ventilation support time, duration of intensive care and 
hospital stay, and morbidity defined by complications affecting one of the former endpoints. In 
particular, cardiac complications were related to RV dysfunction with clinical signs of restrictive RV 
physiology and temporarily increased need for inotropic support, and/or arrhythmia, mainly defined as 
junctional ectopic tachycardia. 
Median follow-up was 7.7 years (range 6 months – 16 years), and complete clinical data were 
available for at least 1 year since the closing date of this study in 85 % of the patients. Follow-up 
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focused on clinical evolution and need for late reoperation and/or reintervention for RVOT-related 
issues. Clinical data were obtained from routine medical records, QRS duration from the last 
electrocardiogram and parameters as residual RVOT gradient, grade of pulmonary valve regurgitation 
and RV/LV size ratio by measuring the maximal diameter of both ventricles on 4-chamber view on the 
latest trans-thoracic echocardiography.  
 
2.4  Statistical analysis 
 
Continuous data are expressed as mean value ± standard deviation or median value and range. 
Categorical data are expressed as frequencies. Comparison of continuous data between different time 
periods or types of RVOT procedure has been done by one way-ANOVA analysis with Tukey 
correction for multiple comparisons, in case of normally distributed data with equal variance. Kruskal-
Wallis analysis followed by Mann-Whitney analysis for post-hoc subgroup differences, was used for 
non-normally distributed data. Between group differences of categorical data were compared by Chi-
square or Fisher’s exact test. 
Risk factor analysis of categorical outcome was performed by multivariate logistic regression in a 
backward likelihood-ratio model. A multivariate stepwise linear regression model was used to identify 
risk factors for increased RV/LV size ratio at the last echocardiography, after exclusion of patients 
who underwent late pulmonary valve implantation. Additional data exploration with the classification 
tree method has been carried out to determine a significant cut-off value for continuous variables 
reaching statistical significant influence in a multivariate model. 
Freedom from time-related events was calculated with the Kaplan-Meier method with log-rank test for 
univariate analysis. Multivariate Cox regression analysis was used to define independent predictors for 
late reoperation. Statistical analysis was performed with SPSS 18 – PASW software version (SPSS 
Inc, Chicago IL).   
 
3. Results 
 
3.1 Demographic and operative results 
 
Demographic data of the study population are depicted in table 1. In the first era, patients were 
significantly older, having a median age of 11 months at the time of complete correction (p < 0.001). 
Although there was no significant age difference between era 2 and era 3, graphic 1 shows a greater 
variability of age in era 2, whereas the children in era 3 were consistently operated between 3 and 6 
months of age. This evolution involved a higher proportion of children in era 1, that was operated in a 
symptomatic status (66 % in era 1 versus 40 % in era 2 versus 28 % in era 3, p = 0.001), which was 
reflected by the lower arterial saturation (p = 0.03). However, the percentage of patients treated 
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previously by a shunt, as well as the frequency of associated genetic disorders like microdeletion 
22q11 (n = 16) and trisomy 21 (n = 8) were equal over eras.   
 
Table 1. Demographic patient data over study eras 
 
Overall  Era 1  Era 2  Era 3  p-value 
1994-1999 2000-2004 2005-2010 
Number patients  140  44  43  53  0.48 
Median age (m)  6.6  11 
a
  7  5  < 0.001 
Weight (kg)  7.2 ± 2.3 8.1 ± 3.2 
a
 7.3 ± 1.9 6.5 ± 1.4 0.003 
Gender (m/f)  84/56  22/22  28/15  24/19  0.26 
Genetic disorder  24 %  18 %  28 %  25 %  0.55 
Previous shunt  19 %  14 %  26 %  17 %  0.33 
Symptoms  44 %  66 % 
b
  40 %  28 %  0.001 
Median SaO2  87 %  84 % 
b
  86 %   88 %  0.03 
Preop PV z-value  -2.32 ± 1.43 -2.40 ± 1.40 -2.08 ± 1.60 -2.47 ± 1.30 0.41 
 
a
  p < 0.05 between era 1 and era 2-3 
b
  p < 0.05 between era 1 and era 3 
 
 
Within the study period, the morphologic features of ToF remained unchanged. Associated 
malformations were a persistent left superior caval vein (n = 8), a right-sided aortic arch (n = 18), 
atrial septal defect or patent foramen ovale (n = 67), aberrant coronary anatomy (n = 3) and 
atrioventricular septal defect (n = 6). RVOT characteristics showed no significant differences between 
the eras, as shown by the preoperative z-value of the pulmonary annulus. The mean size of the 
pulmonary branches was respectively 6.8 ± 1.1 mm for the right pulmonary artery, and 6.7 ± 1.2 mm 
for the left pulmonary artery.  
The evolution of the surgical approach of the RVOTO is reflecting a significant higher proportion of 
extended transannular patch plasty in era 1, moving progressively to a more frequent valve- or 
infundibulum-sparing approach in era 2 and 3 (p = 0.002) (figure 2).  
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Figure 2. Evolution of type of RVOT repair over study period 
 
 
At the same time, the length of the transannular incision, indexed to the patient’s body surface area, 
decreased significantly from era 1 to era 2 and 3 : 19.9 ± 12.9 mm/cm² in era 1 versus 11.5 ± 13.5 
mm/cm² in era 2 and 11.9 ± 12.8 mm/cm² in era 3 (p = 0.005). In 21 (15 %) patients a pericardial 
patch plasty of a pulmonary artery stenosis was performed. The immediate operative result over the 
different time periods indicated a significant difference of the postoperative RVOT z-value between 
era 1 and era 3 (0.40 ± 0.81 in era 1, 0.22 ± 0.83 in era 2 and - 0.11 ± 0.72 in era 3)(p = 0.007), 
whereas the intra-operative peak RV/LVP ratio remained equal (0.76 ± 0.17 in era 1, 0.74 ± 0.17 in era 
2 and 0.69 ± 0.18 in era 3)(p = 0.16). In 6 (4%) patients, adjacent surgical revision by extending the 
transannular patch was required due to unacceptable residual RVOTO and suprasystemic RV 
pressures.  
When comparing the 3 RVOT treatment categories, some important differences in anatomic and 
physiologic characteristics were observed (table 2). Patients in whom the pulmonary valve was 
preserved, had a better pre-operative arterial saturation, a larger native pulmonary annulus and a more 
favorable RV/LVP ratio at the end of the procedure. However, patients undergoing an infundibulum-
sparing repair or a more extended transannular incision had similar pre- and peri-operative 
characteristics, unless a higher proportion of prior shunt use in the latter group (34 % in group 3 versus 
10 % in group 2, p = 0.004).   
 
 
 
 
 
 
87 
 
Table 2. Demographic and operative data between types of RVOT repair 
 
Group 1  Group 2   Group 3  p-value 
Valve-sparing  Infundibulum-sparing TAP 
Number patients  48   45   47  0.66 
Median age (m)  7   6   7.5  0.21 
Median SaO2  91 % 
b
   87 %   85 %  0.03 
Previous shunt  10 %   11 %   34 % 
c
  0.004 
Preop PV z-value -0.86 ± 1.15 
a
  -2.84 ± 0.75  -3.26 ± 0.95 < 0.001 
TAP length/BSA  -    13.2 ± 3.6  30.2 ± 8.1 
d
 < 0.001 
(mm/cm²) 
Postop PV z-value 0.34 ± 0.94  0.0 ± 0.61  0.12 ± 0.84 0.13 
Postop RV/LVP  0.65 ± 0.17 
a
  0.74 ± 0.16  0.79 ± 0.16 < 0.001 
  
 
a
 p < 0.05 between group 1 and 2-3 
b
 p < 0.05 between group 1 and 3 
c
 p < 0.05 between group 3 and 1-2 
d
 p < 0.05 between group 2 and 3  
 
 
 
3.2 Early outcome 
 
There was no operative mortality. The median ventilation time was 6 h (range 3 – 336). Median ICU 
and hospital stay were respectively 2 d (range 1 - 21) and 9 d (range 7 - 42). 
Two third of the patients (68 %) had an uneventful postoperative course. Major morbidity was mainly 
related to temporary RV dysfunction (27 %) and arrhythmia (10 %) such as junctional ectopic 
tachycardia. Other complications were pulmonary problems (pneumonia, chylothorax) (n = 8), renal 
failure requiring peritoneal dialysis (n = 5) and seizures (n = 4). Four patients needed early reoperation 
during the same hospital period, within 2 – 15 days after repair, because of residual RVOTO and 
subsequent RV dysfunction. 
Table 3 shows an overview of the early results in perspective of the different eras and the type of 
RVOT repair. There were no significant differences between the 3 eras, and regarding the type of 
RVOT procedure, only the patients undergoing a PV-sparing surgery, had less post-operative cardiac 
events. Multivariate analysis revealed 3 independent predictors for increased cardiac-related morbidity 
: higher RV/LV pressure ratio at the end of repair (OR 29.7, 95% CI 2.3-384.5, p = 0.01), type of 
RVOT repair at the cost of an extended transannular patch (OR 3.1, 95% CI 1.1-9.1, p = 0.03) and 
lower age at the time of correction (OR 0.93, 95 % CI 0.86-0.99, p = 0.04), indicating a cut-off value 
at the age of 3 months. 
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Table 3. Early outcome over study eras and between types of RVOT repair 
 
Era 1  Era 2  Era 3   p-value 
    1994-1999 2000-2004 2005-2010 
All complications  27 %  37 %  32 %   0.61 
Cardiac complications  23 %  33 %  26 %   0.58 
Median ventilation time (h) 8  5  5   0.62 
Median ICU stay (d)  3  2  2   0.48 
Early 30 d-reoperation  0 %  2 %  6 %   0.26 
 
    Group 1  Group 2  Group 3   p-value 
    PV-sparing Infund-sparing TAP 
All complications  23 %  31 %  43 %   0.12 
Cardiac complications  15 % 
a
  29 %  38 %   0.03 
Median ventilation time (h) 4  7  8   0.63 
Median ICU stay (d)  2  2  3   0.20 
Early 30 d-reoperation  0 %  2 %  6 %   0.17 
 
a
 p < 0.05 between group 1 and 3 
 
3.3 Late outcome and reoperations 
 
Within the mean follow-up of 7.5 ± 4.7 y (range 6 m – 16 y), there was one late death, occurring 
during a reoperation for recurrent RVOTO 4 months after the primary repair. All  patients in follow-up 
were doing well, with only 3 patients necessitating medication for cardiac reasons. Freedom from 
reoperation and/or reintervention was 93 ± 2 % at 1 year, 84 ± 3 % at 5 years and 73 ± 4 % at 10 years 
(figure 3).  
Figure 3. Actuarial freedom curve from all reoperations 
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Recurrent RVOTO (n = 16, 12%) was the major cause for reintervention, treated by pulmonary artery 
stenting (n = 1), infundibular patch plasty (n = 2), extension of the transannular patch (n = 2), resection 
of residual infundibular muscle (n = 5). In 6 patients with recurrent RVOTO, a pulmonary valve 
homograft was implanted together with resection of obstructing bundles, to treat simultaneously 
pulmonary regurgitation. Valvulation using a pulmonary homograft (n = 8) or a bovine jugular vein 
conduit (n = 1) was performed in 9 (7%) patients for progressive RV dilation due to isolated 
pulmonary insufficiency. Finally, 1 patient required a pacemaker for atrioventricular bloc.  
Univariate log-rank analysis for late reintervention for recurrent RVOTO or pure PI was not 
influenced by the type of RVOT repair (p-value 0.47 and 0.34 respectively). However, there was a 
trend for a higher rate of late reoperation for recurrent RVOTO during the latter era of the study period 
(p = 0.08) (figure 4).  
 
 
Figure 4. Actuarial freedom from reoperation for RVOTO recurrence 
(a) comparison between study eras 
(b) comparison between types of RVOT repair 
 
 
 
Multivariate Cox-regression analysis revealed the following independent risk factors for any 
reoperation : type of RVOT repair, determined by extended transannular patch plasty (HR 12.3, 95% 
CI 2.6-58.7, p = 0.004) and era of surgery (era 3 versus era 1, HR 37.4 , 95 % CI 1.5-913.8, p = 0.005) 
However, concerning specifically reoperation for recurrent RVOTO, only increased RV/LVP ratio at 
the end of repair (HR 111.7, 95 % CI 6.1-2059.9, p = 0.002) was predictive, indicated by a significant 
cut-off value of 0.84 (p = 0.006). Era of surgery achieved statistical significance only regarding the 
comparison of era 3 versus era 1 (HR 5.4, 95 % CI 1.3-22.8, p = 0.02). Considering the late need for 
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PV implantation, type of repair (only group 3 versus group 1) (HR 39.7, 95% CI 3.1-501.1, p = 0.004) 
and increased RV/LV size ratio at echo (HR 2.1, 95 % CI 1.2-4.6, p = 0.03) were relevant risk factors.   
 
3.4 Last echocardiographic assessment 
 
Complementary investigation during follow-up was routinely based on 12-lead electrocardiogram and 
transthoracic echocardiography. Table 4 shows the commonly available measurements in most 
patients by both examinations. Univariate analysis demonstrated a significant higher RV/LV diameter 
ratio (p < 0.001) in group 3, while patients of group 1 had significantly less pulmonary regurgitation (p 
< 0.001 ). Linear regression analysis revealed one major independent predictor for late RV dilation as 
indicated by increased RV/LV size ratio : length of transannular incision (unstandardized β coeff. 0.16 
, 95 % CI 0.009-0.897, p < 0.001). Duration of follow-up reached nearly statistical significance 
(unstandardized β coeff. 0.008, 95% CI 0.000-0.17, p = 0.06).   
 
Table 4. Late echocardiographic results and QRS duration between types of RVOT repair 
 
All  Group 1  Group 2  Group 3  p-value 
    PV-sparing Infund-sparing TAP   
 
Late RV/LV size ratio 0.96 ± 0.20 0.88 ± 0.18 0.90 ± 0.15 1.15 ± 0.16 
b
 < 0.001 
Late PI grade  2.4 ± 0.9 1.9 ± 0.9 
a
 2.5 ± 0.7 3.0 ± 0.9 < 0.001 
Late RVOTO (mm Hg) 15 ± 14  14 ± 14  16 ± 13  17 ± 15  0.62 
Late QRS (msec)  120 ± 19 115 ± 21 122 ± 18 123 ± 17 0.26 
 
a
 p < 0.05 between group 1 and 3 
b
 p < 0.05 between group 3 and 1-2 
 
 
 
4. Discussion   
   
This study actually reviews a single-center experience with the surgical treatment of tetralogy of Fallot 
over the past 15 years. This included a management individualized to the patient by using a two-stage 
approach in symptomatic neonates with duct-dependent pulmonary flow, with first palliation by a 
modified Blalock-Taussig shunt, followed by complete repair in infancy. A one-stage approach was 
adopted beyond the neonatal age, independent of their clinical status, and preferably within the first 
year of life. Complete correction has consistently been achieved by a transatrial-transpulmonary 
technique. According to Fraser et al. 
11
, our strategy has focused primarily on the type of RVOT repair, 
91 
 
preserving by preference the ventricle and then the valve. During the study period, we have gradually 
lowered the age at repair, which facilitated simultaneously a RVOT-sparing approach.  
 
Implications on early outcome 
 
Although the morphology of the RVOTO in tetralogy patients has not changed substantially over time, 
this conceptual change allowed to decrease significantly the extent of the transannular incision, 
especially in patients with pulmonary annulus hypoplasia, and favored the use of an infundibulum-
sparing repair in stead of the more extensive transannular patch relief. 
Advancing the timing of surgery has been an important issue to improve the surgical outcome of ToF. 
Neonatal repair has been favored to avoid the physiological consequences of hypoxemia and right 
ventricular hypertrophy as well as the problems associated to prior shunting. But, even in experienced 
institutions, this approach is associated with increased morbidity, leading to significantly longer 
ventilation times and intensive care stay, and eventual mortality 
9,10
. However, it remains uncertain if 
such early repair is really advantageous to the right ventricle on the long term, considering the high 
proportion of transannular patches and the decreased benefit of restrictive RV physiology. In a study 
of 227 patients reviewing a local change of practice lowering the age for primary repair, Van Arsdell 
and colleagues found that the optimal age for repair, in terms of physiological tolerance, is probably 
between 3 and 11 months of age 
13
. Our results have shown that decreasing the age at repair – at least 
to the age of 3 months -  while adapting a RVOT-sparing policy, did not affect the early clinical 
outcome. Postoperative morbidity was mainly related to transient RV function impairment and 
arrhythmia, which were independently promoted by age younger than 3 months, use of an extended 
transannular patch but especially an increased RV/LV pressure ratio at the end of repair. Both last 
factors are the direct effect of the interaction between repair type and the severity of RV hypertrophy, 
which in se is also age-related. The group of Great Ormond Street and Brompton Hospital have first 
demonstrated that impaired diastolic RV function was determined by the type of repair, in particular 
by transannular patch plasty 
14
. But in a later study, younger age at repair appeared to prevent the 
development of early restrictive RV physiology, as 80 % of their patients aging less than 6 months, 
underwent a TAP repair. Hence, TAP repair was not an independent predictor for later restriction 
15
. 
Subsequently, one can assume that the degree of RV hypertrophy is the main substrate for a restrictive 
RV pattern, certainly when the ventricle is challenged by the volume load due to variable pulmonary 
valve insufficiency. Based on the knowledge that a restrictive RV physiology has a beneficial long-
term effect on RV function 
14,16
, this RVOT-sparing surgery seems justified in the attempt to maintain 
the functional advantage of RV hypertrophy against late RV dilation by pursuing some residual 
restrictive effective opening – as depicted by a lower pulmonary z-value in the last versus the first era.  
Presently, we are proposing elective complete correction between 3 and 6 months of age, irrespective 
of symptomatic status or even previous palliation. To our belief, this age range enhances the 
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opportunity to relief the hypoplastic RVOTO with minimal transannular incision and less infundibular 
resection to deal with the balance between the postoperative adverse, but long-term protective effect of 
a restrictive physiology on right ventricular function. 
A side-effect of the adoption of a RVOT-sparing policy in our series is a higher reoperation rate for 
residual or recurrent RVOTO. At 3 years, the freedom from reoperation was respectively 95 ± 3 % in 
era 1, 88 ± 5 % in era 3 and 86 ± 6 % in era 3. Previous reports have already pointed to the higher 
residual outflow gradients after transatrial correction 
4,17
. Based on a disturbing increased incidence of 
recurrent RVOTO, Alexiou et al. even went back to a transventricular repair in tetralogy patients with 
severe infundibular stenosis 
18
. According to Kaushal et al. 
19
, we have been using the addition of 
transesophageal echocardiography to differentiate between a fixed anatomical obstruction and a 
dynamic obstruction, when systemic or even suprasystemic RV pressures were recorded. On-site 
revision for inadequate RVOTO relief was 12 % in their commonly older population, and noticeably 
higher than the 4 % in our cohort. As a peak RV/LV pressure ratio above 0.84 was the strongest 
predictor of reoperation for recurrent RVOTO in our experience, we should question whether we had 
wrongly appreciated the first surgical result. Therefore, in the pursuit of the optimal equilibrium 
between adequate relief of pressure load and the potential inconvenience of pulmonary insufficiency-
related volume load, the benefit of a RVOT-sparing procedure has to be outweighed against the risk of 
incomplete RVOT relief and subsequent reoperation, by respecting more rigorously the recommended 
threshold of 0.8 for intra-operative RV/LV pressure ratio.  
 
Considerations on late outcome 
 
Since the evidence is growing that the deleterious long-term complications of tetralogy of Fallot repair 
are the result of the interaction between surgical induced RVOT dysfunction and the mode of RV 
compliance, our surgical strategy is aimed to minimize the insult to the RV. Undeniably the infants in 
whom a valve-sparing technique was carried out, are belonging to the better part of the tetralogy 
spectrum, with intrinsically an adequate sized pulmonary valve and less RV hypertrophy. The most 
interesting comparison in this series concerns the patients with the narrowest outflow tract, treated by 
an infundibulum-sparing approach versus a more extensive transannular patch. Basic measurements on 
routine echocardiography at last follow-up, indicated a close relationship between RV dilation and the 
extent of transannular patch repair. Moreover, the time span the RV is subjected to the PI-related 
volume load, is an additional factor for increased RV dilation. These results are not surprising as the 
use of TAP has currently a negative impact on both late clinical outcome and RV function. In a study 
of 59 patients who were evaluated 14 years after contemporary transatrial-transpulmonary repair, Van 
den Berg et al. found impaired functional capacity and moderate RV dysfunction in relation to the use 
of TAP 
20
.  
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However, the question remains whether an infundibulum-sparing repair will ultimately delay this 
physiological post-PI dilation process, as actually the follow-up of these RVOT-sparing procedures is 
too short to be conclusive. The exact role of the infundibulum on the RV function is controversial. In a 
study concerning systolic RV function in young individuals without heart disease, Geva et al. 
demonstrated that the infundibulum contributed for only 13 % of the total RV stroke volume 
21
. 
Otherwise, d’Udekem and colleagues found that patching the subvalvular outflow tract affected both 
PV and RV function equal to transannular patch repair, and subsequently pointed out the peculiar 
function of this anatomic substrate as a kind of contractile support of the pulmonary valve 
22,23
. We 
believe that the main advantage of the infundibulum-sparing technique is related to (1) the proper 
absorptive support to important pulmonary regurgitation and (2) the controlled restriction that helps to 
sustain the long-term benefit of RV hypertrophy. 
 
Study limitations 
 
There are some obvious shortcomings of this study, primarily because of its retrospective design. It 
covers a considerable time span, during which two of the utmost important variables of surgical 
outcome changed, i.e. age at repair and type of RVOT reconstruction. Therefore, it is not easy to 
evaluate the clear effect of each change as the result of the confounding interference between both 
variables on the final results. Moreover, the number of patients in each era and repair group is small, 
perhaps limiting the strength of some interpretations. 
In addition, the differentiation into 3 groups of RVOT repair is subjected to bias. Tetralogy of Fallot is 
known by a wide spectrum of RVOTO morphology. Children treated by a PV-sparing procedure, have 
definitely a more friendly RVOT anatomy, resulting in better functional outcome and prognosis. 
Although it was retrospectively impossible to delineate the features of the infundibular stenosis such 
as the infundibular length and the degree of infundibular septal hypertrophy and malalignment, we feel 
confident that the morphological RVOT differences between group 2 and 3 are negligible. The 
conclusions on the comparison between both repair groups are thereby valid, but need further follow-
up to prove consistency. 
Finally, the echocardiographic analyses are only based on measurements of some rude parameters, as 
afforded by routine ambulatory echocardiographies performed beyond study purposes. More in-depth 
elaboration of parameters of systolic as well as diastolic RV performance, using echocardiography 
and/or magnetic resonance, will probably better clarify the exact contribution of each type of repair. 
 
In conclusion, a valve- and infundibulum-sparing reconstruction of the right ventricular outflow tract 
has been advanced reciprocally through and together with lowering the age at repair during transatrial-
transpulmonary correction of tetralogy of Fallot. This change has been achieved without 
compromising the immediate clinical outcome, but at the cost of an increased early reoperation rate for 
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residual and/or recurrent obstruction. As the length of the transannular relief of the RVOT is, with 
time, the main determinant of right ventricular dilation, further long-term follow-up is needed to 
disclose whether such infundibulum-sparing approach is more protective against progressive right 
ventricular dysfunction.   
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Chapter VII  
 
Functional analysis of the anatomical right ventricular components  : should 
assessment of right ventricular function after repair of tetralogy of Fallot be 
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Abstract 
 
Objective :  Follow-up after Tetralogy of Fallot repair is directed to detect timely RV dysfunction by 
following pulmonary regurgitation and global RV size, with little attention for the effective 
contribution of regional RV dysfunction. This study investigates the contribution of regional RV 
dysfunction on exercise capacity after ToF repair. 
 
Methods :   42 patients were investigated with cardiac magnetic resonance imaging for regional RV 
dysfunction in relation to global RV function by functional quantification of sinus and outflow part of 
the RV. Impact of regional and global RV dysfunction on clinical status was studied by exercise 
testing. 
 
Results :  Global RV function was lower than sinus function (EF 52 ± 12 % versus 58 ± 10 %, 
p<0.001), attributable to the adverse influence of RVOT dysfunction (EF  34 ± 17 %). Percent 
predicted peak VO2 correlated better with RV sinus EF compared to global RVEF (r=0.51, p=0.001 
versus r=0.44, p=0.004). Multivariate analysis revealed EF of RV sinus (β = 0.34, 95% CI 0.07-0.61, 
p=0.013) and extent of RVOT akinesia (β = -0.28, 95% CI -0.50; -0.06, p=0.015) as significant 
determinants of exercise capacity. Impaired exercise performance occurred in 43 % of the patients, 
and was independently determined by type of repair (transventricular versus transatrial : OR. 6.0, 95% 
CI 1.31-17.3, p=0.02) by associating greater sinus and RVOT dysfunction. 
 
Conclusion :  Functional analysis of the RV components shows that exercise capacity after repair of 
tetralogy of Fallot is better predicted by systolic function of the RV sinus as the extent of RVOT 
dysfunction commonly leads to underestimation of global RV function. This method of differential 
quantification of regional RV function might be more appropriate than assessment of global RV 
function during long-term follow up of repaired tetralogy of Fallot patients. 
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Introduction 
 
The long-term outcome of  ToF is commonly determined by the adaptive response of the RV to the 
physiological sequelae after RVOT reconstruction 
1,2
. The advent of CMRI has certainly increased our 
insights into the pathophysiological development of RV dysfunction resulting from the chronic 
volume overload by pulmonary valve regurgitation. Usually the RV has been analyzed as one entity, 
irrespective of its natural complex geometry, which is further distorted after surgical repair. Otherwise, 
the impact of regional RV dysfunction on clinical outcome has predominantly been based on 
qualitative measures of the RV, such as the presence of a RVOT aneurysm 
3
. 
However, recent reports have indicated that the functional evaluation of the global RV does not 
necessarily reflect the true function when the RV components are considered separately. Lytrivi et al. 
observed that patients after ToF repair had reduced global RV systolic function, merely by decreased 
function of the infundibulum, while the ejection fraction of the sinus part was preserved and equal to 
that of normal control subjects 
4
. A similar study on the comparison between ToF patients and healthy 
peers, confirmed that the function of the trabecular part of the RV was maintained, albeit this 
component absorbed the largest part of the volume overload, and this finding was independent of the 
surgical technique for RVOT restoration 
5
.   
In this study, we sought to investigate the effect of the functional contribution of the main anatomical 
components of the RV on global RV function, quantified by CMRI, and to determine its influence on 
the clinical status of  patients after ToF repair, based on their exercise performance.     
 
Methods 
 
Study subjects 
 
Out of the cohort of repaired ToF patients currently in follow-up at the department of  Pediatric and 
Adult Congenital Cardiology, patients were retrospectively included in the study if they had a 
complete CMRI examination and a clinical evaluation including a reliable exercise test within a 1-year 
time span. Patients were excluded when (1) they were treated primarily with a valved RVOT conduit, 
(2) previous pulmonary valve implantation was performed, (3) they had a significant residual RVOT 
obstruction > 30 mmHg at last echocardiography and (4) the time between CMRI and exercise test 
exceeded 1 year.   
Patient data were retrospectively obtained from medical reports including demographic characteristics, 
surgical details of the primary repair and routine echocardiographic assessment at the approximate 
date of the CMRI and exercise test in order to exclude significant residual RV pressure load. The study 
was approved by the ethical committee of the University Hospital of Ghent (registration 
B670201110922), and informed consent was waived by the retrospective study design.  
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Cardiac MRI protocol 
 
CMRI was performed with a 1.5-T imager system (Siemens Avanto, Erlangen, Germany). A complete 
CMRI protocol consisted of ECG-triggered HASTE sequence of images in 3 orthogonal planes, and 
balanced field echo cine-imaging of long and short axis stack from base to apex for volumetric 
analysis of the right ventricle in 2-chamber view, the RVOT and pulmonary arteries. Phase-contrast 
flow-mapping was acquired in-plane for the RVOT view, and through-plane over the pulmonary and 
aortic valve.  
Post-processing volumetric analysis was done with the use of the Argus software (Siemens, Erlangen, 
Germany) on the short axis stack, by semi-automated endocardial delineation of left and right 
ventricular wall at end-diastole and end-systole. In a second phase, the RV sinus and RVOT were 
traced separately, using the septo-parietal bands as anatomical landmark 
4,5
. The sinus component 
comprised the tricuspid inlet and the trabeculated apical part to the septo-parietal muscles distally. The 
RVOT component extended from the defined landmark to the position of the pulmonary valve 
remnants or the presumed transition to the native pulmonary root (figure 1). Accordingly, the end-
diastolic and end-systolic volume of both components were determined, with subsequent calculation 
of stroke volume and ejection fraction. All volume data were indexed to body surface area. The 
volume measurements were done by two investigators blinded to the clinical outcome. 
 
Figure 1. CMRI : endocardial contouring of Sinus and RVOT component of the RV, on the end-diastolic and 
end-systolic short axis sequence after respectively (A) transventricular repair with TAP and (B) transatrial-
transpulmonary repair with TAP. Both figures reflect the different functional properties of the RVOT, with 
preservation of the end-systolic excursion of sinus component. 
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Assessment of the PRF was based on the ratio of pulmonary retrograde to antegrade flow volume, 
expressed as percentage. Based on the fast field cine images with alignment to the RVOT and 
pulmonary trunk, dynamic evaluation of the RVOT allowed to define the extent of the RVOT akinesia 
as the curvilinear distance from the contractile muscular free wall of the RV sinus to the end of the 
fibrotic patch at the RVOT. The posterior part of the pulmonary valve annulus remnant was identified 
unequivocally as a small indentation between RVOT and pulmonary trunk, often at the origin of the 
regurgitant jet. In none of the patients, major calcifications of the RVOT patch were observed. 
All subtracted and native angiographic images as well as the 3D-whole heart dataset are viewed and 
evaluated in a 3D-image analysis tool.  
 
Cardiopulmonary exercise testing 
 
Cardiopulmonary exercise test was performed on an electronically braked cycle ergometer (Ergoselect 
100K, Ergoline, Germany) with a continuous gradual increment of workload adjusted for each patient 
according to the method of Wasserman et al. 
6
. All subjects were encouraged to exercise until 
exhaustion or notice of any adverse event. A 12-lead ECG (ECG, Marquette, GE Healthcare, UK) and 
pulse oximetry (Radical, Masimo Corp., US  or  Accutor Plus, Masimo Corp., US) were recorded 
continuously throughout the test. Cuff blood pressure was measured every 3 min (Tango, SunTech 
Medical, US). A breath-by-breath gas-exchange analysis was made using a calibrated expiratory gas 
analysis system (Oxycon Pro, Jaeger, CareFusion Corporation, US). With this method, the highest 30 
second average of oxygen consumption during the last phase of exercise was defined as the peak VO2. 
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Predicted values were obtained from established values from age- and sex-matched controls, and 
expressed as percentage of the predicted peak VO2 
6
. A % predicted peak VO2 < 85 % was identified 
as subnormal exercise capacity. Minute ventilation (VE, y-axis) and carbon dioxide production 
(VCO2, x-axis) were plotted in a curve and its slope VE/VCO2 was defined as index of gas exchange 
efficiency during exercise. Heart rate variation was obtained from ECG recordings. HR at recovery 
was defined as the HR at 5 min after cessation of exercise. HR reserve was calculated as the difference 
between maximal HR and HR at rest. HR recovery represented the difference between maximal HR 
and HR at the determined recovery time point. Using the formula of Astrand to define the predicted 
maximum HR, the chronotropic index was calculated as (peak HR-baseline HR)/(220-age-baseline 
HR) 
7,8
.      
 
Statistical analysis 
 
Data distribution was tested for normality by the Kolmogorov-Smirnov test. Continuous data are 
presented as mean ± SD or median (range) for respectively parametric and non-parametric distributed 
variables. Categorical data are expressed as number and frequency. The relationship between indices 
of exercise function and CMRI-derived cardiac function variables was assessed by Pearson or 
Spearman rank correlation analysis. Multivariate linear regression analysis was used to evaluate the 
independent effect of patient- and procedure-related factors and cardiac function parameters on 
exercise capacity. Based on the heterogenous distribution of the time interval between date of primary 
correction and date of CMRI examination, this variable was entered into a stepwise linear regression 
model after adjustment by the weighted least squares method. Accordingly, risk factor analysis of 
impaired exercise capacity was achieved by binary logistic regression (backward likelihood-ratio 
method), with correction for time interval variability. 
Comparison of continuous data between groups with normal and impaired exercise performance was 
done by unpaired t-test or Mann-Whitney test as appropriate. Between-group comparison of 
dichotomous parameters was done by Fisher’s exact test. Validation of the inter-observer agreement 
between CMRI-derived global RV volume and the summation of regional RV volumes was based on 
the method of Bland-Altmann.  
Statistical analysis was performed with SPSS 20.0 software (SPSS Inc., Chicago, Illinois). A two-
sided p-value < 0.05 was considered significant.   
 
Results 
 
Patient population 
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Forty-two patients fullfilled the inclusion criteria and were entered into the study. The study cohort 
yielded a time span for inclusion from may 2003 to june 2012.  The patient characteristics are shown 
in table 1. As the study population covered the transition era between a transventricular repair 
performed before 1990 and a transatrial-transpulmonary repair used routinely since 1993, the follow-
up interval of the former group at the time of study inclusion was significantly higher compared to the 
latter group: 29.0 ± 7.0 versus 11.5 ± 3.6 y (p<0.001).  
 
Table 1. Patient characteristics 
Number of patients  42 
Male gender (n, %)  27 (64) 
Median age at repair (y) 1.9 (0.13 – 16.6) 
Median age at MRI study (y) 17.9 (8.2 – 56.0) 
Median time interval between TOF repair and MRI (y)  17.6 (9.1 – 45.5) 
Type of TOF repair (n, %)  
    Transventricular repair 
             With TAP 
             With PV commissurotomy 
20 (48) 
15 
5 
    Transatrial repair 
             With TAP 
             With PV commissurotomy 
22 (52) 
18 
4 
Clinical symptoms (n, %) 
    Dyspnoea 
    Ventricular/supraventricular arrhythmia 
13 (31) 
9 
4 
NYHA functional class 
    NYHA I 
    NYHA II 
    NYHA III 
    NYHA IV 
 
29 (69) 
11 (26) 
2 (5) 
0 
Medication 
   No medication 
   B-blockers 
   Ca+ - antagonist 
 
37 (88) 
3 (7) 
2 (5) 
Mean QRS duration (msec)   145 ± 22 
   
 
Exercise performance 
 
The results of exercise testing are depicted in table 2. Correlation analysis showed a consistent 
association between the achieved % of predicted capacity based on peak VO2 measurement and the 
VE/VCO2 slope (r = -0.54, p=0.001), the maximal HR (r = 0.64, p<0.001), the HR reserve (r = 0.32, 
p=0.04), the chronotropic index (r = 0.38, p=0.02) and the HR recovery (r = 0.47, p=0.002). 
Consequently, patients with subnormal exercise function had prominent chronotropic incompetence, 
with a lower maximal HR (155 ± 18 bpm versus 175 ± 12 bpm, p=0.001), decreased HR reserve (77 ± 
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16 bpm versus 88 ± 15 bpm, p=0.03) and lower chronotropic index (0.70 ± 0.13 versus 0.78 ± 0.11, 
p=0.05). The difference in HR recovery was not significant (52 ± 18 bpm versus 60 ± 23 bpm, 
p=0.22).  
Ten out of the 17 patients with impaired exercise testing were also clinically symptomatic, and were 
later referred for pulmonary valve implantation. 
 
Table 2. Exercise test results 
    Mean peak VO2 (ml.kg
-1
.min
-1
)  19.6 ± 5.9 
    Mean % of predicted peak VO2  (%) 85.9 ± 17.1 
    Number of patients with % predicted peak VO2  < 85 % 17 (43) 
    Mean VE/VCO2 slope 30.6 ± 4.6 
    HR at rest (beats/min) 83 ± 15 
    Maximal HR (b/min) 166 ± 18 
    HR at recovery (b/min)  110 ± 19 
    HR reserve (b/min) 83 ± 16 
    Chronotropic index 0.74 ± 0.12 
    HR recovery (b/min) 56 ± 21 
 
 
 
Assessment of regional dysfunction in relation to global systolic RV function 
 
Measurement of the RV volume by summation of the sinus and RVOT component correlated closely 
with the standard global RV volume calculation (RVEDV: r = 0.98, p<0.0001 and RVESV: r = 0.97, 
p<0.0001), with good inter-observer agreement on both measurements for RVEDV (mean bias: 2.89 ± 
16.88 ml) and RVESV (mean bias: -0.91 ± 13.50 ml). 
 
Table 3. CMRI data of global and regional RV and LV 
 All patients 
n = 42 
Normal exercise function 
n = 25 
Subnormal exercise function 
n = 17 
p-value 
Global RV data     
RVEDVi (ml/m²) 141 ± 38 145 ± 41 139 ± 36 0.96 
RVESVi (ml/m²) 67 ± 31 64 ± 27 77 ± 34 0.18 
RVSVi (ml/m²) 70 ± 19 77 ± 20 64 ± 16 0.03 
RVEF (%) 52 ± 12 56 ±11 47 ± 11 0.02 
PRF (%) 37 ± 11 37 ± 10 38 ± 12 0.97 
RV akinesia (mm) 33 ± 23 29 ± 23 42 ± 20 0.07 
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Regional RV data     
SinusEDVi (ml/m²) 111 ± 30 115 ± 30 107 ± 30 0.33 
SinusESVi (ml/m²) 48 ± 20 47 ± 19 51 ± 21 0.64 
SinusSVi (ml/m²) 62 ± 18 67 ± 16 57 ± 18 0.02 
SinusEF (%) 58 ± 10 60 ± 10 54 ± 9 0.05 
RVOTEDVi (ml/m²) 29 ± 16 26 ± 14 36 ± 17 0.05 
RVOTESVi (ml/m²) 20 ± 15 17 ± 13 27 ± 17 0.03 
RVOTSVi (ml/m²) 9 ± 5 9 ± 5 9 ± 6 0.87 
RVOTEF (%) 35 ± 17 38 ± 15 28 ± 17 0.04 
LV data     
LVEDVi (ml/m²) 77 ± 14 79 ± 15 74 ± 14 0.29 
LVESVi (ml/m²) 27 ± 9 26 ± 9 29 ± 9 0.37 
LVSVi (ml/m²) 50 ± 11 52 ± 10 44 ± 10 0.02 
LVEF (%) 65 ± 9 67 ± 8 61 ± 10 0.05 
 
 
 
All CMRI-derived RV and LV function data are given in table 3. The global RV systolic function is 
lower in comparison with the RVsinus function (RVEF: 52 ± 12 % versus SinusEF: 58 ± 10 %, 
p<0.001), due to the negative effect of commonly decreased RVOT function (RVOTEF: 35 ± 17 %). 
For the whole population, the sinus and RVOT volume attributed respectively 79 ± 8 % and 21 ± 8 % 
to the global RVEDV, and 72 ± 11 % and 28 ± 11 % to the global RVESV. Regardless of the type of 
surgical repair, the systolic function of the sinus component was significantly better than the global 
RV function (mean difference of 8 ± 4 %, p<0.001 and 3 ± 2 %, p<0.001 for respectively TV and TA 
repair). Hence, the decreased global RVEF after TV repair was due to both worse RVOT function (TV 
repair: 22 ± 13 % versus  TA repair: 47 ± 10 %, p<0.001) and worse sinus function (TV repair: 51 ± 8 
% versus TA repair: 63 ± 9 %, p< 0.001).(figure 2) 
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Figure 2. Bar-plot representing the contribution of  Sinus and RVOT component on global RV function in all 
patients and by type of ToF repair 
(Each bar represents the mean ± SD) 
 
 
 
 
Increased PRF was significantly associated with dilatation of both sinus (EDVi: r = 0.58, p<0.001 and 
ESVi: r = 0.50, p<0.001) and RVOT component (EDVi: r = 0.56, p<0.001 and ESVi: r = 0.51, 
p<0.001), but not with systolic function of the components : sinusEF (r = -0.23, p=0.14) and RVOTEF 
(r = -0.26, p=0.10). In contrast, the extent of RVOT akinesia correlated negatively with both sinusEF 
(r = -0.48, p=0.001) and RVOTEF (r = -0.70, p<0.0001), but did not correlate with PRF (r = 0.29, 
p=0.06).  
Regarding the LV function, LVEF was significantly associated with decreased RV function (sinusEF: 
r = 0.43, p=0.005 and RVOTEF: r = 0.56, p<0.0001 and global RVEF: r = 0.54, p<0.0001).  
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Effects of regional RV dysfunction on exercise performance 
 
Percentage predicted peak VO2 correlated better with sinusEF (r = 0.51, p=0.001) than with RVOTEF 
(r = 0.43, p=0.005) and global RVEF (r = 0.45, p=0.004) (figure 3). 
 
Figure 3. Relation between exercise capacity and RV component function 
 
 
 
Based on the use of end-diastolic volume for size of the RV components, a significant association was 
only found with the RVOT size (EDVi: r = -0.39, p=0.013), but not with the size of the sinus 
component (EDVi: r = -0.13, p=0.43) nor global RV dilation (EDVi: r = -0.06, p=0.71). There was no 
relationship between % predicted peak VO2 and PRF (r = -0.047, p=0.39). The correlation between 
exercise capacity and LV function (LVEF: r = 0.30, p=0.06) was not significant. Multivariate stepwise 
linear regression analysis with adjustment for differences in follow-up interval, revealed sinus EF and 
extent of RVOT akinesia as main determinants of  % predicted peak VO2 (table 4). 
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Table 4.  Linear regression analysis of  % predicted peak VO2 in relation to RV and LV function variables 
 Univariate analysis  Multivariate analysis  
 β   (95% CI) p-value β   (95% CI) p-value 
Global RV Data     
RVEDVi -0.03 (-0.17;0.12) 0.71   
RVESVi -0.18 (-0.35;-.007) 0.04   
RVEF 0.70 (0.25;1.23) 0.04   
PRF -0.08 (-0.62;0.46) 0.77   
RV akinesia -0.33 (-0.55; -0.1) 0.005 -0.28 (-0.5;-0.06) 0.015 
Regional RV Data     
Sinus EDVi 0.07 (-0.11; 0.26) 0.43   
Sinus ESVi 0.15 (.13;0.43) 0.17   
Sinus EF 0.74 (0.31;1.14) 0.001 0.34 (0.07;0.61) 0.013 
RVOT EDVi -0.42 (-0.74;-0.09) 0.01   
RVOT ESVi -0.47 (-0.81;-0.15) 0.006   
RVOT EF 0.45 (0.14;0.75) 0.005   
LV Data     
LVEDVi 0.13 (-0.27;0.52) 0.52   
LVESVi -0.36 (-0.99;0.28) 0.26   
LVEF 0.56 (-0.03;1.14) 0.07   
 
 
Seventeen patients (43 %) had subnormal exercise performance, in respectively 13(65 %) and 4(20 %) 
patients after TV and TA repair (p=0.01). Compared to patients with normal exercise capacity, they 
had worse global RVEF by both decreased RVOTEF and sinusEF as well as lower LVEF (table 3). 
Multivariate logistic regression analysis with adjustment for time interval variability, demonstrated 
only TV type of repair as main determinant of poor exercise performance (OR. 6.0, 95 %CI 1.31-17.3, 
p=0.02), by combining lower sinusEF (TV repair: 51 ± 8 % versus TA repair: 63 ± 9 %, p< 0.001) and 
lower RVOTEF (TV repair: 22 ± 13 % versus TA repair: 47 ± 10 %, p< 0.001), as well as impaired 
LVEF (TV repair: 60 ± 9 versus TA repair: 69 ± 7 %, p< 0.001). 
 
Discussion 
 
Longterm surveillance after repair of ToF is focused on the timely detection of RV dysfunction to 
indicate the need for pulmonary valve implantation, and is usually based on the measurement of 
severity of PR and global RV size by echocardiography and CMRI, assessment of clinical functional 
status by exercise testing and follow-up of pro-arrhythmogenic indicators such as increased QRS 
duration 
9,10
.  
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In order to clarify the discrepancy between the residual hemodynamic abnormalities of the RV and the 
clinical performance in these patients, the relation between CMRI parameters and exercise capacity 
has been examined in only a few studies 
11-13
. Assessing global RV function, RV ejection fraction was 
the strongest predictor of percentage of predicted peak VO2, independent of RV size, pulmonary 
regurgitation fraction and systolic LV function
11,12
. The Boston group also demonstrated that greater 
regional dysfunction of the RVOT adversely affected both global RV function and exercise function
13
.    
Through separate quantitative functional analysis of the anatomical RV components, i.e. sinus and 
outflow parts, our study has shown that this conceptual approach reflects more appropriately the real 
RV function after ToF repair, as the commonly depressed or even absent contractile function of the 
RVOT usually results in underestimation of global RV function. In addition, the systolic function of 
the RV sinus component appears to be a better predictor of the exercise performance of these patients, 
supporting the usefulness of such more refined analysis of the RV during late follow-up of ToF 
patients. 
Lytrivi et al. revealed an equivalent conclusion in a ToF population with a wider age variation of 2-42 
years, as they found globally a preserved sinusEF of 43-64 %, in a range comparable to healthy 
control subjects 
4
. Moreover, the relevance of the sinus component on clinical performance is certainly 
pertinent and corresponds to the findings of Bodhey et al. on the functional analysis of the tripartite 
RV in ToF patients, showing that the trabecular part constitutes the major driving force of the RV and 
provides most accomodation to the chronic PR-related volume overload 
5
.   
Otherwise, greater regional dysfunction at the RVOT, quantified by both EF as well as by extent and 
displacement of dyskinetic area, was the predominant factor affecting exercise capacity in the series of 
Wald et al 
13
. According to their results, the extent of RVOT akinesia was another independent but 
negative predictor of exercise tolerance in our study. Here, the technique of primary ToF repair has 
indirectly interfered as a transventricular approach induced worse RVOT function by use of larger 
RVOT patches, in comparison with the more contemporary operated patients. However, since the time 
from ToF repair to study inclusion was indentical to their study, ranging between 8 and 45 years, it 
remains questionable whether this technical issue was underestimated in their analysis by including 
patients with probably different physiological loading conditions, as these treated with a RV-PA 
conduit or with a minimal PRF of  3 %. 
Our data revealed a poor correlation between exercise function and size of the RV, excepted for the 
RVOT component. The latter is comprehensible as the end-diastolic and end-systolic volume are 
approximating, depending on the extent of the RVOT patch. However, the systolic function of the RV, 
and in particular the sinus component, seems more reliable than the degree of dilatation and the 
severity of pulmonary insufficiency. This additionally subscribes the superior value of the end-systolic 
volume over the end-diastolic volume for the serial follow-up of RV function.  
Specific subgroup analysis concerning exercise capacity demonstrated that the type of ToF repair was 
the main determinant of subnormal exercise performance, indicated by a predicted peak VO2 < 85 %. 
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In relation to the CMRI data, this group had worse RV function by both depressed sinusEF and 
RVOTEF. Although this patient cohort had also inferior LV function, it is difficult to assume that a 
LVEF averaging 60 %, is responsible for the decreased exercise tolerance. Besides the potential 
influence of the interventricular functional dependency, other discriminants have to be considered such 
as the proven time-related deterioration of exercise capacity and the reciprocal interactive effect of 
chronotropic incompetence 
8,14
.    
 
Clinical implications 
 
Unless evidence of heart failure symptoms or malignant arrhythmia, current management to restore 
RV function by implantation of a pulmonary valve in patients with repaired ToF is based on 
determination of global RV volumes. However, several studies have reported conflicting results from 
complete normalization of RV size to lack of improvement of RV function, still keeping up the debate 
on the timing of RVOT valvulation 
15-17
. Perhaps, one of the reasons for these inconsistent results is 
related to the fact that most studies have been performed on patients treated in former eras, including a 
variety of surgical techniques for RVOT relief – from pulmonary valvotomy to extensive RV patches 
and RVOT conduits – and different gradations of combined volume- and/or pressure overload 
sequelae. In addition, investigation of the RV remodeling in these studies has usually been based on 
the whole RV as one anatomical entity. However, it is obvious to assume the prognostic difference in 
recovery of RV function after pulmonary valve implantation between two equally volume-sized RV’s 
with equal degree of PR, whereas in the first case the RVOT component is aneurysmal and contributes 
strongly to the global RV volume, while in the second case, most of the dilatation process has 
involved already the sinus part, but preserved RVOT function. By individual functional quantification 
of the main RV components, our method might be more appropriate to further elucidate this decision-
making process. The large akinetic RVOT commonly increases the global RV volume, inducing 
underestimation of the real RV function, as it probably also affects the contractile properties of the 
adjacent segments involved in the remodeling process. Hence, the function of the sinus part might 
represent a more reliable determination of the intrinsic RV function, and correlates best with the 
clinical functional status. The relevance of this contribution has recently been confirmed by Alghamdi 
et al. who identified that the longitudinal strain at the base of the RV, remoted from the RVOT, was a 
stronger predictor of exercise performance than other echocardiographic or CMRI-derived 
measurements 
18
. The precise role of this specific assessment has yet to be confirmed as CMRI is still 
indispensable in the work-out of the repaired ToF patient, for delineation of global RV volume and 
function as well as of RVOT morphology. Basically, there are some similarities with the concept and 
management of the post-infarction LV remodeling. The extent of the scarred aneurysm adversely 
affects LV size and function, and is certainly useful to guide the decision for surgical therapy 
19,20
. But 
it is the contractile performance of the remote, intrinsically undiseased myocardium that best predicts 
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the functional outcome after surgical ventricular restoration, and so helps to improve the patient 
selection 
21
.  
Our data also underscore the statements of Wald et al. on the therapeutical implications, that extensive 
resection of the akinetic RVOT segments should be performed in addition to pulmonary valve 
insertion, for maximal functional recovery of the RV 
13
. Subsequently, it is conceivable that the 
particular patients with a prominent post-surgically scarred RVOT will benefit more from a surgical 
approach with additional operative RVOT remodeling than from isolated transcatheter valve 
implantation.  
 
Study limitations 
 
As a consequence of the retrospective design, the studied patient cohort is subjected to bias. It is 
plausible that merely these patients were included, who had a specific indication, either by clinical, 
electrophysiological or echocardiographic examination, to perform CMRI. Hence, the patient 
characteristics of our study are comparable to others, and incorporates a cohort of  ToF patients treated 
within a time span including the transition of surgical eras from a transventricular to the more actual 
transatrial-transpulmonary correction 
5,11-13
. Although the type of surgical approach was entered as 
study variable, it remains difficult to differentiate the effect of the repair technique from the time effect 
that the RV has been exposed to the pathological loading conditions. However, potential confounders 
were minimized by correlating the CMRI-derived RV parameters with the individual age-adjusted 
exercise function. Nonetheless, we feel confident that the sinus part of the RV corresponds best to the 
intrinsic RV function, irrespective of the kind of RVOT repair, emphasizing the usefulness of a 
differential and more refined functional analysis of the RV. 
In this study, only the effect of purely chronic volume-overload after ToF repair was analyzed, and 
might not be completely representative for the ToF spectrum by excluding patients with significant 
residual obstruction at both ventricular and/or pulmonary arterial level. 
 
Conclusion 
 
After repair of ToF, the RV is challenged by the kind of RVOT reconstruction and its subsequent 
longterm physiological effects. Through separate functional analysis of the anatomical RV 
components, this study has demonstrated that the global RV function is commonly underestimated, 
depending on the extent of RVOT dysfunction. The systolic function of the RV sinus appears to be a 
more reliable determinant of the intrinsic RV performance, by better predicting the exercise capacity 
of the individual patient. Further validation in larger scale studies is needed to postulate whether this 
method of RV analysis is more appropriate than assessment of global RV volumes for timely detection 
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of early RV dysfunction in order to initiate subsequent pulmonary valve implantation with eventual 
associated surgical RVOT remodeling.     
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Chapter VIII : Discussion 
 
Contemporary surgical repair of TOF consists of a transatrial-transpulmonary approach for closure of 
the VSD and relief of the RVOTO. The increasing knowledge on the detrimental long-term sequelae 
of severe PI, acquired in TOF patients operated on in former eras, has stimulated a change in the 
management of TOF on two fronts.  
First, there has been a competitive search to minimize the surgical insult to the RVOT, pursuing 
maximal preservation of pulmonary valve function. Successful valve-sparing RVOT repair has been 
reported in selected TOF patients with moderate hypoplasia of the pulmonary valve annulus 
1, 2
. 
Recently, adepts of this valve-sparing approach started with intra-operative dilatation of the 
pulmonary valve. However, in a substantial number of patients, relief of the infundibular obstruction is 
performed through a separate subvalvular infundibulotomy followed by patch closure, resulting in 
elimination of infundibular function. Moreover, more than half of these patients developed PI at short-
term 
3
. In order to maintain some pulmonary valve function, reconstruction of the RVOT with a 
monocusp patch in the patients necessitating transannular relief, has been proposed as a valid 
alternative. Despite encouraging short-term results, its long-term advantage has never been proven 
4, 5
.  
Others however  have focused on an infundibulum-sparing approach in order to spare preferentially 
the RV 
6
. 
Secondly, to avoid some of the inconvenient physiological features as cyanosis and RV hypertrophy , 
and to get rid of the potential shunt-related complications, complete repair has been advanced as a 
primary therapy in younger aged children with TOF. Presently, experience with TOF repair in 
neonates or within the first months of life has demonstrated the feasibility of this surgery, resulting in 
acceptable mortality but at the cost of prolonged ventilation times and intensive care stay. Moreover, 
RVOTO relief necessitated  a TAP in 60 to even 100 % of the patients 
7-10
.    
However, the long-term effects of this two-sided change - decreasing the age for repair and pursuing a 
RVOT-sparing correction – remain to be seen.  
 
1) Regarding the RVOT-sparing strategy, the role of the infundibulum versus the pulmonary 
valve on RV performance has been investigated occasionally. Based on the history of  the treatment of  
isolated pulmonary valve stenosis, it has been shown that chronic PI with preservation of infundibular 
integrity, unlikely resulted in severe impairment of clinical status before the third decade 
11
. In contrast, 
the effect of PI is accelerated in the setting of TOF, after repair of the RVOT with TAP. d’Udekem et 
al. observed that a large RV patch had a similar effect on the clinical outcome as a transannular patch, 
even though the pulmonary annulus was anatomically kept intact 
12
. However, this analysis concerned 
patients operated on by the former transventricular approach, and in all cases the pulmonary valve 
needed at least concomitant commissurotomy.  
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Since Geva et al. demonstrated that  the infundibulum contributed to only 15% of the total RV stroke 
volume in healthy individuals 
13
, hereby minimizing its participation in RV function, the dilemma on 
the differential contribution of infundibulum versus pulmonary valve in the condition of TOF was 
further clarified in an experimental model, as described in chapter IV. 
In a model of growing swine, RV performance  was studied in relation to isolated PI versus isolated 
infundibular dysfunction, and compared to the effect of combined PI and infundibular dysfunction by 
a TAP. Both the acute postoperative effect and the chronic effect after 3 months were assessed with 
the conductance catheter, with additional validation by CMRI. We found increasing PRF in animals 
with isolated PI after 3 months, but this PRF progression was significantly enhanced by concomitant 
infundibular dysfunction. Subsequently, RV dilation with progressive decrease of RVEF was noticed 
more extensively in animals with TAP repair compared to those with isolated PI. Increasing PRF was 
also found in a similar experiment, where PI was created by stent implantation at the level of the 
pulmonary valve 
14
. In that study, PRF was already high due to the study design, and increased with 
50 % after 3 months, a result that was only seen in our experiment by adding infundibular dysfunction. 
Of interest, isolated infundibular dysfunction did not result in secondary RV remodeling, but induced 
immediate decrease of contractile function due to intrinsic surgical damage of the ventricle. After 3 
months, contractility had decreased in all study groups, with the worst result in animals with TAP 
repair. Although isolated PI also initiated progressive decrease of contractile function, the contractility 
indices were still superior in the animals with preserved infundibular function. The physiological 
effects in terms of RV dilation and contractility, were similar to those observed in other animal studies, 
albeit in one study the infundibular effect was not integrated 
14
, whereas in the other, only the effect of 
the classical transannular patch was examined 
15
. From a clinical point of view, our animal study 
confirmed that TAP reconstruction of the RVOT affected the RV performance most by combining the 
adverse effect on myocardial contractility due to the infundibular dysfunction, and on top of this, the 
gradual RV dilation by progressive PI. The importance of sparing the infundibulum was underscored 
by its impact on RV contractile function, even though it represents only a small part of the global RV, 
and by the enhanced accommodation on progression of PI. In consequence, the results of this study 
certainly supported the actual adoption of a RVOT-sparing strategy for repair of TOF.  
 
2) The policy to perform  primary complete repair of TOF in infants at early postnatal age, has 
been addressed by the second experimental study, reported in chapter V.   
In TOF, one might assume that the degree of RV hypertrophy before correction is related to the 
severity of RV pressure-overload – which is depending on the morphology of RVOTO – and to the 
duration of pressure-overload exposure – which relates to the age of the patient at the time of surgery. 
In a model of growing swine, the effect of RV hypertrophy, first induced by pulmonary artery banding, 
was investigated in function of chronic PI-related volume overload, induced by TAP reconstruction of 
the RVOT. The acute and chronic effects after 3 months were evaluated with the conductance catheter 
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method, and verified with echocardiography. In this experiment,, volume-overload was only created 
by TAP, as it revealed to have the most detrimental effect on RV performance in our previous study.  
The results demonstrated that RV hypertrophy is associated with alterations of intrinsic myocardial 
properties of both systolic and diastolic function. RVH initiates better contractility in comparison with 
animals without RV hypertrophy, and it enables better preservation of systolic function 3 months after 
exposure to PI. However, it entails sustained impairment of RV compliance, in relation to an increased 
mass-to-volume ratio of the RV. In addition, RVH attenuated the amount of PI as well as the duration 
of pulmonary regurgitation time. Subsequently, the RV remodeling in relation to chronic volume-
overload appeared to be significantly less extensive.  
The investigation of the sequential effect of pressure-overload preceding volume-overload has never 
been addressed in animal models. In contrast, RV adaptation to chronic isolated pressure-overload has 
been studied frequently, confirming the positive effect on contractile function and the negative effect 
on diastolic performance 
16, 17
. Although dissimilar to our study design, Kuehne et al. evaluated the 
chronic effect of combined volume- and pressure-overload on RV dynamics 
18
. They found that the 
addition of pulmonary stenosis improved the systolic RV function, at the cost of decreased diastolic 
RV function in relation to PI. Nonetheless,  concluding that the resultant RVH acted protective against 
progression of PI in their study, seemed blunted to us as the method to create combined PI-PS was 
based on the insertion of a partially obstructive stent into the pulmonary valve, with an obviously 
restrictive regurgitant orifice.  
Interestingly, we found a characteristic pulmonary artery flow pattern at echocardiography suggestive 
for restrictive RV physiology, only in animals with RVH and PI, both in the acute as in the chronic 
phase. Precluding other confounding factors thought interacting with this phenomenon 
19-21
, our 
findings revealed that probably RVH is the culprit substrate, promoted specifically by severe PI, 
through decreasing the diastolic pressure gradient between the stiff RV and the pulmonary artery. 
Although the clinical meaning of restrictive RV physiology on the long-term is controversial, it was 
associated with a propitious effect on the late RV remodeling after volume-overload in our animal 
model.  
The clinical consequence of this study is that repair of TOF in a neonate might compromise RV 
performance prematurely, in particular when TAP reconstruction is deemed necessary, by subjecting a 
poorly hypertrophied RV to the acute and chronic effects of PI-related volume-overload. Therefore, 
adapting the strategy to choose for a shunt in a symptomatic neonate, and postponing elective primary 
repair for a few months, might here be justified. However, a neonate or young infant presenting with a 
favorable RVOT morphology in whom the pulmonary valve might be kept functional at the time of 
repair, should benefit from early repair to enhance the reversal of the RVH-related diastolic 
dysfunction.  
Otherwise, this model did not allow speculation on the optimal age for TOF repair by lacking 
variability in RVH quantity. In contrast to the real-time physiology in TOF, affording overload 
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decompression through the VSD,   longer exposure to RV pressure-overload in these animals would 
have resulted in a decompensated state of the RV. In addition, the rate of reversibility of RVH has to 
be considered in long-standing pressure-overload, entailing an adverse effect on RV function rather by 
interstitial fibrosis than by myocyte hypertrophy 
22, 23
. Based on clinically-oriented studies focusing on 
the impact of age on late functional outcome, one might accept that complete repair of TOF should 
ideally be performed before the age of 1 year 
24, 25
. 
 
The link between the findings of the experimental studies and clinical observations is reported in 
chapter VI. In this study, we reviewed our 15-years experience with surgical treatment of TOF, using 
consistently a transatrial-transpulmonary approach in 140 children. During the study period, surgical 
practice evolved from the application of an extended TAP  (57% in the first era) towards a valve- or 
infundibulum-sparing RVOT repair (40% valve-sparing and 40 % infundibulum-sparing in the recent 
era). At the same time, the median age decreased from 11 months to 5 months. We concluded that the 
adoption of RVOT-sparing surgery was advanced reciprocally through and together with lowering the 
age for repair. This change was performed without compromising the immediate clinical outcome, 
however entailing an increased rate of early reoperation (14%) due to residual/recurrent obstruction. 
Echocardiographic assessment confirmed that RVOT-sparing techniques provided a lesser degree of 
PI and lower RV/LV size ratio, revealing that the length of transannular incision was the strongest 
predictor of RV dilation within a mean follow-up of 7.5 ± 4.7 years.  
The advantages on RV remodeling, by attempting preservation of the pulmonary valve or at least the 
infundibular function, have been shown by the data of the first experimental study (chapter IV). Of 
course, as the main objective in the treatment of TOF is the adequate relief of the RVOTO, the extent 
of RVOT reconstruction is largely dictated by the morphology of the RVOT. Pulmonary valve 
preservation is facilitated in TOF patients belonging to the better range of the spectrum with 
appropriately sized pulmonary annulus, whereas extended TAP repair was used rather in the 
anatomically less favorable patients. In the endeavor to limit the surgical damage of the RVOT, the 
immediate operative result is challenged by the risk of early reoperation. Here, critical intra-operative 
appraisal of the RVOT by transoesophageal echocardiography is of utmost importance, to differentiate 
between a fixed anatomical stenosis and a dynamic obstruction, in case of elevated RV/LV pressure 
ratio at the end of repair. According to Uebing et al. 
26
, tailoring the pulmonary annulus by sizing the 
transannular patch to the lower acceptable limit of z-value for each individual patient, might perhaps 
be the ideal compromise concerning a ‘too much, too little’ policy for relief of the RVOTO.  
 
Lowering the age of primary repair of TOF, as shown in the retrospective clinical study, might be in 
conflict with the findings of the second animal study (chapter VI), relying on the beneficial 
contribution of RVH on late RV remodeling by chronic volume-overload. However,  an RVOT-
sparing  repair of TOF was facilitated partially  through the less extensive hypertrophy in these 
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younger infants, assuming that the magnitude of transannular relief is greater in the condition of a 
more hypertrophied and cumbersome outflow tract. Based on the positive effect of some low-grade 
residual obstruction on late RV performance 
27, 28
, resulting in a reduced need for late PVR 
29
,  we feel 
confident that minimizing the surgical aggression on the RVOT, might swing the pendulum slightly in 
favor of the surgical technique above the physiological feature. 
Nevertheless, our experimental and clinical findings are in agreement regarding the issue of repairing 
TOF at a too young age. Our strategy of TOF repair is to preclude primary correction in the 
symptomatic neonate or infant less than 2-3 months old. Instead, an intermediate Blalock-Taussig 
shunt is preferred in order to perform complete elective repair at a later age. However, it is likely that, 
in the symptomatic neonate, the anatomical substrate would trend towards a smaller RVOT, 
explaining the high frequency of TAP in most series 
9, 10, 30
. Such two-stage strategy evokes the 
question on the natural growth of the pulmonary annulus, to predict the potential of performing a 
valve-sparing procedure later. The opinions on this subject are discussable 
31, 32
, but in practice, the use 
of a TAP is avoided in a substantial number of patients who were initially treated with a shunt 
33, 34
. 
Furthermore, if RVOT repair inevitably includes pulmonary valve dysfunction, an infundibulum-
sparing approach is still valid with the additional benefit of already distinct RVH at a slightly older 
age.  
Recently, stenting of the narrow RVOT has been proposed as another alternative to overcome the early 
symptomatic neonatal course. Removal of the stent imbedded in the infundibulum, resulted in the later 
requirement of a TAP in 86 % 
35
, and compromised certainly the possibility of an infundibulum-
sparing approach.             
Finally, besides associated comorbidities as genetic disease or extra-cardiac malformations, the 
decision on the surgical management of TOF should be based on an individualized approach, taking 
into account of the specific cardiac-related factors as RVOT characteristics and associated intra-
cardiac anomalies, to minimize the risk of the early surgery, while assuring the optimal cardiac 
condition for the future. 
 
The concerns on the long-term outcome of TOF are related to the adaptation of the RV to the chronic 
PI-related volume-overload. There is no doubt that PVR is indicated in the patient with evident 
symptoms assigned to the RV dilation and significant PI. In the majority of TOF patients however, the 
relation between RV dysfunction and clinical status is less clear. 
Currently, PVR is advised in the asymptomatic patient, based on a QRS duration > 140 msec and the 
determination of the critical end-diastolic volume of 150-180 ml/m² 
36-38
. Geva et al. also validated the 
importance of end-systolic volume in the judgment for PVR 
39
. However, the question raises whether 
these absolute volumes have a similar significance for the one RV in which one third of the volume is 
comprised in a RVOT aneurysm, versus the other RV accumulating most of that volume in the body of 
the ventricle. 
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In chapter VII, a study on the contribution of the main anatomical components of the RV, i.e. the 
sinus and the RVOT, on global RV function by CMRI, was designed in 42 repaired TOF patients. The 
RV data were related to their exercise capacity as an objective parameter of  clinical status. 
Independent of the type of surgical repair, the global RV function, expressed as RVEF, was commonly 
underestimated, due to the usually decreased function of the akinetic RVOT. This effect was more 
pronounced in the group that underwent transventricular repair. Additional analysis showed that the 
magnitude of PRF correlated significantly with the RV size, but not with the RV function. The pump 
function of the sinus part of the RV correlated best with the exercise performance, based on the 
determination of predicted peak VO2, adjusted for age and gender. Multivariate analysis identified RV 
sinus EF as a positive predictor, and extent of RV akinesia as a negative predictor of exercise 
performance.  
Applying an identical method of analysis comparing TOF patients with healthy peers, other authors 
found that the sinus part of the RV in TOF usually had a preserved function 
40, 41
. In a CMRI-mediated 
study based on the evaluation of the RV as a whole, exercise function appeared to correlate mainly 
with RVEF. Wald et al. demonstrated later that the extent of RVOT dysfunction was the main 
determinant of worse exercise tolerance. In agreement with the similar finding on the qualitative 
assessment of a RVOT aneurysm 
42
, they quantified RVOT function by spatial extent of dyskinesia, 
via the method of late gadolinium enhancement 
43
.  
The relevance of the systolic function of the RV  sinus to the functional capacity is further supported 
by the recent report of Alghamdi et al., showing that the common echocardiographic and CMRI-
related indices of global systolic function are at least weak predictors of exercise performance in TOF 
patients with common RVOT dysfunction. They advanced the longitudinal function of the RV by 
tissue-Doppler echocardiography, measured remotely from the RVOT, as the most reliable 
determinant of exercise performance 
44
. Therefore, as the RV sinus reflects more properly the intrinsic 
contractile reserve of the RV, it is conceivable that the analysis of this RV component should be 
considered separately  for its potentially stronger predictive value for post-PVR functional recovery.   
This largely underscores the method of RV analysis through separate estimation of the contribution of 
sinus part versus RVOT part during the late follow-up of TOF, instead of the integral analysis of the 
RV as one global entity. This might not only contribute to the timing for PVR, but also to the 
technique of PVR. If decreased exercise tolerance is related to large RVOT akinesia with preserved 
RV sinus function, PVR should include additional surgical remodeling of the RVOT in an attempt to 
optimize the global RV performance. In contrast, if exercise intolerance is due to merely impairment 
of sinus function, earlier valvulation of the RV should be proposed, which can be achieved equally 
effective by transcatheter valve implantation in case of adequate RVOT anatomy.    
However, validation in larger scale studies is needed to postulate whether this refined method of RV 
analysis is more appropriate than assessment of global RV volumes for timely detection of early RV 
dysfunction in order to point out the ideal timing of subsequent pulmonary valve implantation. 
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Chapter IX : Future Perspectives 
 
At the time of presentation of this thesis, some studies have already been initiated, while other ideas 
for further research on topics specifically related to this subject are maturing.  
 
1. Experimental research 
 
The experimental animal model as described in chapter III, included already the investigation of 
electrophysiological changes of the RV in relation to chronic volume-overload. The methodology was 
based on the evaluation of locale RV myocardial electrical depolarization properties through 
measurement of epicardial mapping of monophasic action potentials (MAP), measurement of intra-
ventricular conduction propagation of the RV in two axes, and a protocol of induction of malignant 
tachy-arrhythmia. The execution and analysis of this additional study has been done in close 
collaboration with some members of the clinical electrophysiology staff. However, preliminary 
analysis of the data showed inconclusive results in view of the small sampled animal series.   
After modification of the technical application of MAP recording with the use of  the more stable 
endocardial MAP-electrode, the study was further elaborated during the second animal experiment, 
reported in chapter IV. The analysis of these data are currently in process. 
Nonetheless, it is conceivable that the premised period of 3 months to determine the ‘chronic phase’ in 
this animal model, might be relevant for the mechanical changes of the RV, but not for the electrical 
ones. According to a similar study design 
1, 2
, significant electrical disturbances have been found after 
at least 5 to 6 months of chronic volume-overload. Presuming that 3 months in the growing immature 
swine corresponds to a mid-term follow-up span of approximately 10 to 12 years, a preliminary 
conclusion on our data might be that the mechano-electrical feedback mechanism did not yet induce 
important electrophysiological changes, such that the risk of malignant ventricular arrhythmia in the 
TOF patient is negligible at mid-term follow-up. 
Consequently, the intention to extent the experiment by adding a group of animals, subjected to 
chronic PI-related volume-overload for at least 6 months, has already been decided for evaluation of 
the electrical characteristics in relation to the hemodynamical effects. 
 
The future of the history of TOF should probably have a different scenario, once the advent of a 
tissue-engineered valve substitute will lead to a consistent and reproducible result. Besides promising 
initiatives elaborated in our laboratory regarding engineering of tissue valves, we already started a first 
step towards the development of a pericardial patch with contractile properties. Based on the 
successful method of myocyte cultures derived from atrial appendage progenitor cells 
3
, myocyte 
isolation from atrial appendage samples has been performed for an early trial of cell culture in a bio-
reactor. The idea should be to seed a decellularized pericardial patch with living myocytes, in order to 
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obtain a patch with some preserved contractile performance. The hemodynamic contribution of such 
contractile patch might be further examined by the conductance technique and CMRI.  
As the data of our experiment in chapter III emphasized the importance of preserved functional 
integrity of the infundibulum in the process of chronic volume-overload, this alternative approach 
might be of interest for further research in the setting of TOF. 
 
2. Clinical studies 
 
In cardiac surgery there is a growing trend for application of hybrid approaches, gathering the best of 
two techniques to optimize the outcome of a procedure. Convinced by the benefit of the RVOT-
sparing repair techniques in TOF on the long-term, the introduction of intra-operative balloon 
dilatation of the pulmonary annulus has yet been discussed. So far, the technique has already been 
applied successfully in one patient. The feasibility and effectiveness of this approach will be put in a 
prospective pilot study, focusing on selected TOF patients with a hypoplastic pulmonary annulus 
including a z-value ranging between – 1 to – 4.   
 
Confronted with an increasing number of patients with congenital heart disease, reaching adult age, a 
protocol of prospective disease-oriented follow-up has already been discussed in our department of 
pediatric and adult cardiology in collaboration with the members of cardiac surgery, involved in that 
field. Regarding TOF, this includes the serial follow-up of RV function by echocardiography and 
yearly exercise testing. Additional CMRI investigation is performed on a prospective basis, first as a 
baseline evaluation and then every 2-3 years, depending on particular indices suggesting deterioration 
on echocardiography or exercise tests in asymptomatic patients.  
This protocol was partly the fundament of the clinical study reported in chapter VI, concerning here 
the inclusion of the younger aged patients of the cohort. Further elaboration of this protocol with time 
should not only benefit the follow-up of the individual TOF patient, but using the proposed 
methodology of RV assessment by separate analysis of the sinus versus the RVOT, might be of help to 
increase our  insight into the specific adaptation of each RV component in function of the 
contemporary surgical treatment. Moreover, confirmation of the validity of this method definitely 
should be based on larger sample-sized patient groups, in order to derive clear cut-off points for 
decision on timing and type of subsequent surgery.        
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Chapter X : Summary 
 
The surgical treatment of tetralogy of Fallot is one of the success stories in the history of congenital 
heart diseases. Over the years, the operative mortality has decreased to less than 2 % and the long-term 
survival is excellent, affording the majority of these patients an acceptable quality of life. However, 
late attrition has increasingly been recognized in relation to progressive RV dysfunction due to chronic 
and severe PI.  
To cope with the deleterious long-term sequelae of the originally extensive relief of  the RVOTO, the 
focus has moved to the currently performed transatrial-transpulmonary repair of TOF. Moreover, 
during the past decade, surgical management yielded a two-sided change through pursuing RVOT-
sparing techniques on one hand, and through performing primary complete repair in infants during 
their first months of life on the other hand. The late impact of these adaptations are however unknown. 
 
Over the past 15-years, the surgical management of TOF in our center involved a gradual and mutual 
change, that included a trend towards a RVOT preserving policy and lowering the age of repair 
(chapter VI). This policy change was performed without major impact on the clinical outcome but at 
the cost of an increased frequency of early reoperation for residual or recurrent RVOTO. Although the 
midterm effect on RV remodeling appears promising, the controversy whether the protection of the 
pulmonary valve function or the function of the RV should be the primary focus at repair remains 
open. 
In chapter IV, this issue was addressed in an animal study, investigating the differential contribution of 
the infundibulum versus the pulmonary valve on RV performance after chronic volume-overload. This 
study learned us that preservation of the pulmonary valve function prevents progressive remodeling of 
the RV, with its adverse effect on pump function and finally contractile performance. However, as in 
these cases with pulmonary annulus hypoplasia, a valve-sparing technique might not appropriately 
address the obstruction, maximal preservation of the infundibulum is encouraged  because surgical 
damage of the  infundibulum not only is associated with immediate decrease of RV contractility, but 
also further loss of accommodation capacity to progression of PI. Based on these findings, we feel 
confident with the pursuit of a RVOT-sparing strategy during complete correction of TOF. 
The other issue regarding the age at the time of primary repair, was indirectly addressed in chapter V, 
by analyzing the effect of RVH on the RV performance after chronic volume-overload. The alterations 
of intrinsic myocardial properties in terms of systolic and diastolic function, induced by RVH, 
appeared to affect significantly the physiological effect of PI and so, the RV remodeling process. The 
clinical consequence relies on the beneficial effect of reversible RVH through discouraging primary 
repair of TOF at the neonatal age, in particular when RVOTO relief would implicate a transannular 
patch resulting in early severe PI. It additionally strengthens the idea that an intermediate shunt before 
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complete elective repair at a later age, is still a valid option without necessarily compromising the 
child’s RV by a TAP-induced PI. Meanwhile, there is strong evidence that leaving some mild residual 
obstruction might be the best protection against chronic PI, supporting the surgeon’s search for the 
optimal equilibrium between residual pressure-overload and minimal volume-overload, for the benefit 
of the RV. 
Once severe RV dilation due to PI has occurred during late follow-up, the decision for PVR to prevent 
irreversible RV dysfunction, is usually based on the determination of global RV volumes, even in 
asymptomatic patients. Classically, an end-diastolic volume of global RV that exceeds 150-170 ml/m² 
already indicates a threshold for PVR, irrespective of the post-surgical RVOT morphology. In chapter 
VII, we proposed another method of RV analysis by separate functional assessment of sinus and 
RVOT component of the RV, using CMRI. Despite severe PI, the sinus function of the RV in TOF 
patients remains usually well preserved, in contrast to the negative influence of the akinetic RVOT. 
Using exercise testing as objective estimate of clinical status, the percentage of predicted peak VO2  
was independently determined by the sinus function as well as by the RVOT function, in an opposite 
way. Consequently, integration of the sinus function in the choice for PVR might better predict the 
chance of post-PVR recovery of RV function. We suggest that this more refined method of analyzing 
the RV in relation to the contribution of its main components on the global RV function, is more 
appropriate to the decision-making process for eventual PVR in TOF patients.     
 
In summary, through assessment of the RV performance in relation to RVOT dysfunction in 
experimental and clinical studies, we have increased the understanding on the contribution of specific 
components of the RV, from an anatomical standpoint (infundibulum versus pulmonary valve – 
RVOT versus sinus) as well as from a physiological standpoint ( right ventricular hypertrophy – 
myocardial dysfunction versus PI). The results of this research  have consolidated a surgical strategy 
of repair of TOF in favour of a RVOT-sparing approach, best performed in infants beyond the 
postnatal age, to provide the perspective on an optimal longstanding RV performance. Further insight 
into the pathophysiological adaptations of the main components of the RV after repair of TOF might 
also help in the decision to timely detect and reverse RV dysfunction by appropriate valvulation of the 
RVOT.   
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Chapter XI : Samenvatting 
 
De heelkundige behandeling van tetralogie van Fallot behoort ontegensprekelijk tot de succesverhalen 
van de chirurgie in het domein van aangeboren hartziekten. Over de voorbije 50 jaren, is de operatieve 
mortaliteit gedaald tot minder dan 2 % , terwijl de overleving op lange termijn uitstekend is, met een 
aanvaardbare levenskwaliteit voor de meeste patienten. Toch zijn deze patienten niet vrij van 
laattijdige problemen, door het optreden van progressief functieverlies van het RV door chronische 
pulmonalisklepinsufficientie. De chirurgie van TOF was in eerste instantie vooral gericht op het 
maximaal wegnemen van de RV-uitstroomobstructie, waarvoor vaak een uitgebreide chirurgische 
uitruiming werd aangewend. Geconfronteerd met de ernstige  sequelen van deze techniek, werd 
overgegaan naar een transatriale-transpulmonale benadering, die minder agressief is voor het rechter 
ventrikel. Gedurende het voorbije decennium onderging deze benadering bovendien 2 wijzigingen: 
enerzijds werd gestreefd naar technieken om de functionele componenten van de RV-uitstroomtractus 
zoveel mogelijk te sparen, en anderzijds werd een volledige correctie van de hartkwaal voorgesteld 
aan  kinderen op steeds jongere leeftijd, zelfs bij pasgeborenen. De laattijdige gevolgen van beide 
wijzigingen zijn echter onbekend. 
 
Tijdens onze 15-jarige ervaring met de chirurgische behandeling van TOF, hebben wij een graduele 
wijziging in het beleid ingevoerd, gebaseerd op toepassing van RVOT -sparende technieken en 
verlaging van de leeftijd voor operatie. In een retrospectief overzicht (Hoofdstuk V) hebben wij 
aangetoond dat deze beleidsaanpassing geen invloed had op morbiditeit en mortaliteit, doch werd een 
verhoogde incidentie van vroegtijdige reoperatie voor recidief van RV-uitstroomobstructie vastgesteld. 
Hoewel deze verandering op het eerste zicht gunstig lijkt voor de RV functie op termijn, is het 
onduidelijk of men eerder de voorkeur moet bieden aan behoud van de pulmonalisklepfunctie, dan wel 
aan de maximale bescherming van het RV. 
Deze vraagstelling werd uitgewerkt in een dierproefmodel (Hoofdstuk III), waar het differentieel 
effect van infundibulaire versus valvulaire disfunctie op de RV functie na chronische volume-
overbelasting werd onderzocht. Deze studie liet ons toe om vast te stellen dat behoud van 
pulmonalisklepfunctie de graduele volume-toename van het RV, welke verantwoordelijk is voor 
laattijdig verlies van effectieve RV pompfunctie en contractiliteit, voorkomt. Vermits een 
klepsparende behandeling obsoleet is bij ernstige hypoplasie van de pulmonalisklepring, spreken onze 
data in het voordeel van een infundibulum-sparende techniek in vergelijking met een klassieke 
transannulaire patch. Beschadiging van het infundibulum door chirurgische therapie leidt immers tot 
een onmiddellijke aantasting van het contractiele vermogen van het RV, en bovendien gaat hierdoor 
ook de bufferfunctie van het RV tegenover de pulmonalisklepinsufficientie verloren. Dit 
dieronderzoek bevestigt hiermee dat de chirurgische behandeling van TOF, die berust op maximaal 
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behoud van de functionele integriteit van de RV-uitstroomtractus, gerechtvaardigd is met het oog op 
het gunstige laattijdige effect op de RV functie. 
Het andere heikele punt betreffende de toepasselijke leeftijd voor heelkundige correctie van TOF, 
werd bestudeerd in een analoog diermodel (Hoofdstuk IV), waarbij de invloed van RV hypertrofie op 
de RV functie na chronische volume-overbelasting werd onderzocht. RV hypertrofie gaat gepaard met 
specifieke myocardiale wijzigingen met invloed op de systolische en diastolische ventrikelfunctie. 
Hierdoor wordt het progressieve dilatatieproces door pulmonalisklepinsufficientie op voordelige wijze 
beïnvloed. Als men rekening houdt met een rechtstreeks verband tussen RV hypertrofie en de leeftijd 
bij operatie, impliceert dit dat vroegtijdig herstel van TOF op pasgeboren leeftijd niet aan te raden is, 
voornamelijk niet wanneer de chirurgie ter hoogte van de RV-uitstroomtractus onvermijdelijk zal 
leiden tot ernstige pulmonalisklepinsufficientie. Daarom lijkt de strategie om deze TOF patienten eerst 
te behandelen met een tijdelijke shunt in afwachting van een electief herstel op wat oudere leeftijd 
zeker een valabele oplossing. Bovendien sluit deze houding een RVOT-sparende techniek op later 
tijdstip niet uit. Inmiddels wordt deze strategie gesterkt door recente gegevens die aantonen dat een 
beperkte residuele obstructie de beste garantie biedt tegen de nadelige effecten van chronische 
pulmonalisklepinsufficientie, wat de ijver van de chirurg ondersteunt in zijn zoektocht naar het 
optimale evenwicht tussen maximaal opheffen van de obstructie en achterlaten van een minimale 
insufficientie.   
Wanneer ernstige RV dilatatie door pulmonalisklepinsufficientie wordt vastgesteld tijdens de 
opvolging, wordt de beslissing tot pulmonalisklepvervanging meestal genomen op basis van het 
globale RV volume om irreversibele RV disfunctie te voorkomen, ook bij asymptomatische patienten. 
Heden wordt een eind-diastolisch RV volume van 150-170 ml/m² weerhouden als indicatie voor 
pulmonalisklepimplantatie, zonder rekening te houden met de vaak vervormde RV-uitstroomtractus na 
chirurgie. Wij stellen een alternatieve analyse van het RV voor (Hoofdstuk VI) die steunt op de 
afzonderlijke functionele evaluatie van de sinus en van de RV-uitstroomtractus, door middel van 
cardiale magnetische resonantie. Deze studie heeft aangetoond dat de RV sinus functie bij TOF 
patienten meestal bewaard is ten opzichte van de globale RV functie, als gevolg van de varierende 
graad van disfunctie van het uitstroomgebied. Via inspanningstesten bleek de voorspelde 
inspanningscapaciteit – uitgedrukt door maximale zuurstofcomsumptie – positief gerelateerd te zijn 
aan de RV sinus functie en negatief aan  de functie van de RV-uitstroomtractus. Bijgevolg zijn wij van 
mening dat de RV sinus functie een betere indicator voor pulmonalisklepvervanging kan zijn, met een 
grotere voorspellende waarde inzake kans op herstel van de RV functie na klepvervanging. Wij zijn 
dan ook van mening dat deze meer subtiele analyse van het RV via zijn deelcomponenten, een plaats 
verdient binnen de beslissingsboom voor pulmonalisklepimplantatie bij TOF patienten. 
 
Dankzij de evaluatie van het RV in relatie tot disfunctie van de uitstroomtractus via experimentele en 
klinische studies, hebben wij getracht om een beter inzicht te verkrijgen in het specifieke aandeel van 
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elke anatomische deelcomponent die bij het pathologisch proces van TOF betrokken is, dit zowel 
vanuit anatomisch oogpunt (infundibulum versus pulmonaalklep, RV uitstroom versus RV sinus) als 
vanuit fysiologisch oogpunt (RV hypertrofie, intrinsieke myocarddisfunctie versus klepdisfunctie). De 
resultaten van dit onderzoek hebben ons gesterkt in de toepassing van een heelkundig beleid voor TOF 
dat gericht is op het maximaal behoud van de functie van de RV-uitstroomtractus, en dat een volledige 
correctie bij voorkeur verricht wordt bij kinderen van minstens enkele maanden oud, met het oog op 
langdurig behoud van een optimale RV functie. Bijkomend inzicht in de pathofysiologische 
aanpassing van de deelcomponenten van het RV na chirurgisch herstel van TOF, kan een rol spelen bij 
de beslissing tot pulmonalisklepvervanging ter preventie van RV dysfunctie.   
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